data_2myw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2myw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.469 HD22 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.469 ' OG1' HD22 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.525 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.726 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.415 HG21 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.564 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.726 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.553 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.669 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.406 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.892 0 CA-C-O 121.233 0.54 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' HB3' HG23 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 68' ' ' VAL . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.486 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.45 ' HA ' HD11 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 CA-C-O 121.275 0.56 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.41 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 120.765 0.317 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.725 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.478 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.406 ' HA ' HD13 ' A' ' 44' ' ' ILE . 2.4 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.498 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB3' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.688 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.404 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.616 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.447 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.412 ' OG1' HD22 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . 0.407 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 71.9 m-70 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.572 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.485 ' O ' HD13 ' A' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.504 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.4 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.33 -138.33 26.27 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.16 74.55 2.55 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 117.729 0.765 . . . . 0.0 112.726 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -104.44 108.8 20.4 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.02 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -86.74 76.26 9.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 111.978 -172.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.77 136.69 35.42 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.308 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -84.55 108.27 17.22 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.27 136.01 56.08 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.44 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -162.01 110.29 1.43 Allowed 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 72.41 2.63 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -78.03 83.55 4.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 156.12 8.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.75 30.69 2.07 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.81 131.19 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 112.379 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.99 -18.28 16.79 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.305 2.003 . . . . 0.0 111.545 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.21 140.8 36.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.42 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.525 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.469 HD22 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.469 ' OG1' HD22 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.525 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.726 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.415 HG21 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.564 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.564 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.726 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.8 78.02 1.83 Allowed Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -118.87 16.25 13.45 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.474 0.654 . . . . 0.0 112.216 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.29 145.07 29.3 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.279 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -150.43 106.97 3.5 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 mp -87.0 92.3 8.99 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.736 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 71' ' ' THR . 14.3 m-85 -113.91 123.54 50.02 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 122.625 1.202 . . . . 0.0 113.361 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -139.64 -173.59 3.66 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -136.51 93.17 2.84 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.962 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.0 80.42 0.98 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.976 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.87 120.06 18.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.7 mtt -100.08 129.44 46.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.965 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.8 78.19 5.45 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.57 169.16 7.53 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.221 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.86 -39.99 82.24 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.283 1.989 . . . . 0.0 110.707 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.13 118.79 29.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.465 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.422 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.448 ' HA ' ' OH ' ' A' ' 13' ' ' TYR . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.478 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.553 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.14 44.09 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.3 29.86 6.23 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -93.71 13.29 22.72 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.96 0.886 . . . . 0.0 112.071 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.8 -25.08 33.04 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.7 tp -87.52 108.09 18.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.795 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -69.88 117.79 11.91 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -53.92 132.19 41.53 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 124.048 0.842 . . . . 0.0 110.495 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.62 85.88 5.31 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.527 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.7 -172.41 31.28 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 113.167 -1.833 . . . . 0.0 111.492 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -74.77 106.77 6.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.3 tpp -78.54 100.53 6.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.103 -172.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.01 108.44 11.28 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 167.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.73 111.92 2.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.389 1.056 . . . . 0.0 112.636 -172.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.01 -18.18 13.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.147 1.898 . . . . 0.0 110.703 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.04 136.97 33.35 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.517 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.577 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.566 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.433 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.33 86.03 0.74 Allowed Glycine 0 N--CA 1.415 -2.747 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -82.73 76.04 9.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.518 1.152 . . . . 0.0 108.163 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.79 96.96 10.47 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.348 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -148.45 106.22 3.69 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.4 mt -56.94 137.37 55.48 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.229 1.014 . . . . 0.0 113.338 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -101.77 174.93 5.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.554 -1.657 . . . . 0.0 106.661 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.84 91.25 0.83 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.48 0.657 . . . . 0.0 109.376 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -81.24 74.81 8.22 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.675 1.226 . . . . 0.0 112.47 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.17 99.43 0.14 Allowed Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.286 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -71.24 146.62 48.88 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 ttt -76.28 95.46 3.75 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.093 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 116.66 6.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 125.61 57.12 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 124.515 1.134 . . . . 0.0 112.41 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.54 -17.81 26.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.55 2.167 . . . . 0.0 109.996 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.91 139.35 30.54 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.49 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.425 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.563 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.413 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.413 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.484 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.34 94.11 2.29 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -103.89 24.79 10.76 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 123.097 1.427 . . . . 0.0 107.476 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.02 81.83 8.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.645 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -142.56 103.13 4.19 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.39 87.77 0.19 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -103.13 120.88 41.51 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.5 98.43 4.62 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.051 0.929 . . . . 0.0 109.806 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -78.17 87.1 4.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.879 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.61 50.86 1.81 Allowed Glycine 0 C--N 1.273 -2.932 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.274 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -83.43 -29.53 28.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 94.6 mtp -122.22 132.61 54.52 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.767 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.05 22.01 9.03 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.14 138.3 25.08 Favored Pre-proline 0 N--CA 1.418 -2.037 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.18 127.09 9.65 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.179 1.919 . . . . 0.0 109.559 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.58 151.14 26.51 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.033 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.46 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.468 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.468 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.407 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.579 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.406 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . 0.406 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.12 3.72 1.89 Allowed Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.795 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -83.73 70.28 10.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.197 0.999 . . . . 0.0 110.54 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -126.71 35.29 4.65 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.714 178.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.46 -41.15 89.48 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 112.713 -2.04 . . . . 0.0 108.765 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -137.61 85.81 2.14 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -116.98 127.23 53.99 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -177.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -98.91 107.8 20.33 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.49 101.92 5.14 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.58 148.76 5.78 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -96.08 12.13 31.72 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.305 1.05 . . . . 0.0 108.967 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -123.38 179.89 4.56 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.476 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.23 86.7 3.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.6 107.05 0.22 Allowed Pre-proline 0 C--O 1.247 0.946 0 C-N-CA 127.004 2.122 . . . . 0.0 116.141 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.37 152.42 60.76 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.093 2.529 . . . . 0.0 109.76 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.53 131.57 43.46 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.438 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.563 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.408 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.408 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.438 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.444 HG13 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.512 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.444 ' CD2' HG13 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.563 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.402 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.03 -67.32 3.73 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.455 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 61.28 83.71 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.776 1.231 . . . . 0.0 111.809 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.4 173.19 13.81 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -77.5 -76.32 0.18 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 117.945 0.339 . . . . 0.0 111.5 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -113.41 141.73 46.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -101.51 84.07 2.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.495 0.664 . . . . 0.0 111.605 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.21 127.47 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 60.48 18.4 8.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 125.337 1.455 . . . . 0.0 112.447 -173.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.88 -31.28 15.49 Favored Glycine 0 C--N 1.307 -1.083 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -158.22 162.86 37.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.8 mtt -73.7 163.24 28.24 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.74 0.781 . . . . 0.0 112.805 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.71 35.05 4.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.77 158.06 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.813 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.6 120.46 1.76 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 124.113 3.208 . . . . 0.0 112.583 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.86 131.85 43.59 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.56 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.511 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.441 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.511 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.245 0.858 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.51 142.16 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -114.8 96.49 5.75 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.78 100.42 0.2 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.699 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -119.31 3.86 11.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.519 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.02 95.23 9.45 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -94.34 122.74 37.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.146 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.35 107.28 12.0 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.366 0.603 . . . . 0.0 111.388 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.58 80.7 1.5 Allowed 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.71 -34.18 8.62 Favored Glycine 0 C--N 1.282 -2.43 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -71.34 103.83 2.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.422 ' C ' ' H ' ' A' ' 20' ' ' ALA . 65.2 mtt -125.28 -178.3 4.17 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.5 27.1 1.14 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.322 0.649 . . . . 0.0 109.608 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' H ' ' C ' ' A' ' 18' ' ' MET . . . 73.58 128.19 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.142 -173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 121.18 8.58 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.697 1.598 . . . . 0.0 110.92 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.1 50.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.584 ' SG ' HD13 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' HB3' HG23 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.405 HG23 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.431 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.584 HD13 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 68' ' ' VAL . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.562 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.409 HG22 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.98 12.92 34.49 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.179 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -101.86 82.39 2.25 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 117.225 0.512 . . . . 0.0 111.593 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 44.32 90.73 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 126.906 2.082 . . . . 0.0 115.333 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -125.91 4.97 7.3 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.585 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.53 125.9 43.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.262 0.553 . . . . 0.0 111.119 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.6 85.55 7.41 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.748 0.785 . . . . 0.0 109.221 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.62 149.57 28.59 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -88.62 81.7 7.03 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.368 1.08 . . . . 0.0 109.272 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.81 -139.52 14.47 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.287 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -167.07 123.13 1.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 55.2 ttm -132.39 120.83 22.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.9 14.97 10.75 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.101 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.27 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 125.676 1.59 . . . . 0.0 111.545 -178.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.22 -63.78 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 113.412 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 116.14 11.96 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.431 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.423 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.411 HD11 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.421 HG23 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.527 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.423 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.423 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.54 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.414 ' N ' HD21 ' A' ' 72' ' ' ASN . 0.7 OUTLIER -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.433 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.45 45.11 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.099 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -126.67 29.03 5.78 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.82 97.09 3.21 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.386 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.74 73.22 1.43 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.8 119.12 11.32 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -61.44 122.74 15.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.67 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -81.33 105.23 12.36 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-O 121.751 0.786 . . . . 0.0 109.934 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -82.66 69.25 9.4 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.79 1.281 . . . . 0.0 110.173 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.99 101.02 2.45 Favored Glycine 0 N--CA 1.413 -2.898 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -79.04 105.26 10.25 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 mmt -97.94 149.46 22.39 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.899 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.26 19.89 19.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.98 81.51 0.21 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 113.14 -1.845 . . . . 0.0 112.194 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 43.3 Cg_endo -72.26 -16.05 28.24 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.243 1.962 . . . . 0.0 110.367 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.94 135.47 32.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.579 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.445 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.486 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.541 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.541 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.45 HD11 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.487 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.45 ' HA ' HD11 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.508 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.445 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.01 47.11 3.78 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.252 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -122.3 83.97 2.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.41 140.04 38.0 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.229 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -168.0 96.72 0.44 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.612 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.7 97.4 8.53 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -90.14 62.82 5.63 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 60.27 -37.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 169.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -79.82 86.71 5.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.53 1.157 . . . . 0.0 108.99 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.54 16.2 8.31 Favored Glycine 0 C--N 1.278 -2.669 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.025 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -139.16 170.29 16.23 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.9 ttm -68.74 119.61 13.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.94 24.89 0.22 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -171.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.41 83.57 0.22 Allowed Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.58 1.152 . . . . 0.0 112.139 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.68 -16.77 10.19 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.086 1.857 . . . . 0.0 112.189 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.38 135.91 33.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.409 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.433 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.52 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.4 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.41 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.533 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.541 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.52 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.91 -113.41 0.48 Allowed Glycine 0 N--CA 1.423 -2.198 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.073 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -103.64 79.74 1.71 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -143.71 116.8 8.91 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.81 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -133.56 89.61 2.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.2 tp -58.24 113.72 2.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.131 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.01 141.95 31.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.892 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -111.21 95.25 5.42 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.31 110.72 8.5 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.35 33.74 0.05 OUTLIER Glycine 0 C--N 1.272 -3.021 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.503 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -159.82 177.61 10.64 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.2 mtt -123.58 129.15 50.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.94 53.67 1.83 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.44 153.52 0.14 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.814 1.645 . . . . 0.0 111.514 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.85 85.74 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.754 1.636 . . . . 0.0 110.606 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.64 151.66 43.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.713 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.404 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.484 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.476 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.523 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.887 0.375 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.05 -125.5 5.69 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -80.9 68.94 7.35 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -113.08 123.61 50.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -109.12 30.67 6.36 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.34 78.89 7.0 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.136 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 28.94 102.43 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 128.888 2.875 . . . . 0.0 116.14 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -65.07 95.26 0.16 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.441 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -161.29 125.02 3.32 Favored 'General case' 0 N--CA 1.379 -3.992 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.65 -16.38 77.8 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.928 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.9 t60 66.13 93.32 0.07 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.514 1.126 . . . . 0.0 110.069 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.556 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . 23.4 ttt -145.71 159.74 42.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -175.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.85 20.71 0.34 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 18' ' ' MET . . . 46.46 67.42 4.39 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 125.024 1.33 . . . . 0.0 113.995 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.1 -35.47 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 N-CA-C 108.443 -1.407 . . . . 0.0 108.443 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.81 119.23 25.07 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.758 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.478 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.464 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.478 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.406 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.498 HG13 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.556 ' OE1' ' HB3' ' A' ' 18' ' ' MET . 2.4 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.465 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.498 ' CD2' HG13 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.464 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.498 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.36 84.7 0.38 Allowed Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.425 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -133.33 97.25 3.92 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.41 105.63 3.11 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.867 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -92.83 5.54 50.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.588 1.185 . . . . 0.0 108.614 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.1 tp -122.47 88.61 2.96 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.012 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -89.58 144.44 26.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.65 116.48 32.41 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.292 0.567 . . . . 0.0 111.116 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -92.8 81.63 4.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.124 0.964 . . . . 0.0 108.519 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 178.97 56.25 0.08 OUTLIER Glycine 0 C--N 1.283 -2.364 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.369 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -124.63 144.55 50.12 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 120.858 0.361 . . . . 0.0 111.194 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.32 122.74 36.32 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.772 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.24 73.52 10.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.034 0.445 . . . . 0.0 109.903 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.04 90.29 0.09 OUTLIER Pre-proline 0 C--O 1.252 1.226 0 C-N-CA 125.263 1.425 . . . . 0.0 113.589 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.0 -55.51 1.28 Allowed 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.531 2.154 . . . . 0.0 109.222 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.36 121.09 24.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 171.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.412 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.431 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.412 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.431 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.402 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.567 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.426 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.411 ' HB3' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.411 HD23 ' HB3' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.28 -155.67 7.06 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.02 71.3 10.54 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.341 0.591 . . . . 0.0 111.115 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.43 130.59 43.54 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.187 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -150.94 106.86 3.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.97 107.65 0.28 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.356 1.035 . . . . 0.0 111.935 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -78.74 132.94 37.14 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -79.89 100.06 7.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -108.39 80.35 1.34 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.09 154.88 50.1 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -74.58 87.28 2.13 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.285 1.041 . . . . 0.0 109.721 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.3 mtt -113.37 -155.81 0.58 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.436 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.498 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -82.88 -10.97 58.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.501 0.667 . . . . 0.0 110.361 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.15 144.42 0.1 Allowed Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 127.433 2.293 . . . . 0.0 112.378 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 -16.67 47.89 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.4 2.734 . . . . 0.0 112.731 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.404 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . -135.71 128.8 31.63 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.504 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.504 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.522 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.433 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.688 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.415 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.522 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.415 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.688 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.404 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.15 -25.05 25.28 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.835 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.82 81.15 8.89 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.83 175.77 7.33 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -173.61 141.73 0.88 Allowed 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.43 88.65 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.838 0.828 . . . . 0.0 112.934 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -91.98 132.83 36.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -102.13 146.11 28.41 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.615 0.722 . . . . 0.0 111.759 -176.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -91.74 96.01 10.19 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.3 -141.39 0.03 OUTLIER Glycine 0 C--N 1.282 -2.468 0 CA-C-N 113.209 -1.814 . . . . 0.0 114.447 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -87.73 95.37 10.05 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.741 0.781 . . . . 0.0 109.262 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.1 mtt -139.49 175.1 9.85 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.752 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.97 68.81 0.73 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.84 138.53 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.099 1.36 . . . . 0.0 112.11 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.61 -17.59 53.02 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.878 2.385 . . . . 0.0 112.935 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 152.31 27.98 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.616 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.494 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.403 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.559 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.644 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.494 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.241 0.622 0 CA-C-O 120.697 0.284 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.39 11.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.382 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 9' ' ' ARG . 15.2 ptp180 -119.86 87.09 2.68 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 122.299 1.047 . . . . 0.0 110.565 -179.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.76 82.49 2.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.834 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.39 110.35 2.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.045 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.66 105.26 16.62 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.041 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -53.62 132.0 39.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.785 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -85.73 94.59 9.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.494 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 163.54 -33.3 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 126.856 2.063 . . . . 0.0 107.693 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.02 30.78 Favored Glycine 1 C--N 1.24 -4.762 0 CA-C-N 111.708 -2.496 . . . . 0.0 108.458 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -79.55 -25.43 41.65 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 117.865 0.833 . . . . 0.0 111.729 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 tpt -98.99 143.86 28.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 11.41 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.683 0.754 . . . . 0.0 112.307 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.563 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 57.36 70.01 1.46 Allowed Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 125.643 1.577 . . . . 0.0 114.435 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.492 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 61.1 Cg_endo -80.84 -16.65 10.05 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.715 1.61 . . . . 0.0 110.071 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 136.15 50.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.521 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.447 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.412 HD22 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.412 ' OG1' HD22 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.447 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.49 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.54 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.531 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.486 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' HB2' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.416 ' HD2' ' HB2' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.521 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.531 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.92 165.14 15.42 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -90.91 82.43 5.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 122.154 0.978 . . . . 0.0 110.103 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -88.36 132.02 34.6 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.835 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -133.18 93.06 3.11 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.505 0.669 . . . . 0.0 111.948 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.75 132.62 43.98 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -87.26 104.68 16.62 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -72.62 150.26 43.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -96.0 83.72 3.71 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.5 1.143 . . . . 0.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.55 66.96 2.3 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.692 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -95.6 140.49 30.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.359 0.664 . . . . 0.0 109.306 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.4 tpt -101.45 113.43 26.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.92 11.54 17.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.202 0.525 . . . . 0.0 111.882 -175.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.536 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 58.78 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 125.964 1.706 . . . . 0.0 113.386 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.6 -54.86 2.1 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 121.863 1.709 . . . . 0.0 109.468 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.91 115.27 13.16 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.572 ' SG ' ' HB2' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.47 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.2 p80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 71.9 m-70 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . 0.536 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 19.2 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.537 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.443 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.572 ' HB2' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.838 0.352 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.01 25.75 0.24 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -119.38 82.67 1.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.703 0.764 . . . . 0.0 108.956 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -114.52 156.97 23.62 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.057 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -124.8 46.03 2.41 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.23 120.11 12.13 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.75 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 71.83 93.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.884 1.274 . . . . 0.0 110.342 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.7 111.42 11.15 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.3 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.51 83.16 1.73 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.914 0.864 . . . . 0.0 108.868 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.9 -14.93 82.09 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.993 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -124.88 121.39 34.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.8 mtt -70.17 115.98 10.0 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.53 -0.77 48.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.945 1.355 . . . . 0.0 110.063 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.04 87.52 2.45 Favored Pre-proline 0 C--N 1.266 -3.048 0 CA-C-N 112.544 -2.116 . . . . 0.0 107.452 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.2 175.83 7.09 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 109.948 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.14 24.18 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.48 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.475 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.44 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.436 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.436 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.55 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.475 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.521 ' HB3' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.46 -177.37 20.79 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -125.03 87.37 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.92 93.91 7.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.23 -24.18 14.29 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.653 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.76 93.01 3.07 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.955 0.883 . . . . 0.0 112.789 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.57 132.33 55.71 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -77.0 119.57 20.91 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.421 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -91.05 75.77 6.25 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -40.58 89.92 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 112.946 -1.934 . . . . 0.0 115.417 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -60.22 -58.44 8.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.371 0.586 . . . . 0.0 111.486 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.0 ttt -166.37 136.71 3.34 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.74 67.86 4.58 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.652 0.595 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 22' ' ' ALA . . . 68.1 108.47 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.656 1.582 . . . . 0.0 112.69 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.0 -36.04 95.39 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.192 2.594 . . . . 0.0 110.768 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.485 ' O ' HD13 ' A' ' 44' ' ' ILE . . . -118.48 122.24 42.25 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 170.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.459 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.482 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.504 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ARG . . . . . 0.459 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.485 HD13 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.428 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.428 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.456 ' O ' ' HA ' ' A' ' 47' ' ' THR . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.4 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.541 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.414 ' HB2' ' HB2' ' A' ' 74' ' ' LYS . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' LYS . . . . . 0.414 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.482 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.543 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD23 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.479 ' OG1' HD23 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.693 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 ' HD2' ' A' ' 33' ' ' PRO . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 32' ' ' LEU . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.45 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 76' ' ' ALA . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 80' ' ' LEU . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 50' ' ' ILE . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.669 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 43' ' ' ARG . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.892 0 CA-C-O 121.233 0.54 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 85' ' ' TYR . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 76' ' ' ALA . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HB2' HG23 ' A' ' 26' ' ' VAL . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' HG22 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 32' ' ' LEU . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 44' ' ' ILE . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 CA-C-O 121.275 0.56 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 120.765 0.317 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.725 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' HA ' HD13 ' A' ' 44' ' ' ILE . 11.9 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HA ' HD13 ' A' ' 44' ' ' ILE . 4.2 pp0? -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB1' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 2.8 pp0? -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.656 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.656 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.659 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' HD12 ' A' ' 32' ' ' LEU . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 27.1 m80 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 59' ' ' VAL . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 48' ' ' ALA . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB1' ' A' ' 61' ' ' ALA . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG12 ' HG ' ' A' ' 70' ' ' LEU . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 76' ' ' ALA . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 76' ' ' ALA . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.33 -138.33 26.27 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.16 74.55 2.55 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 117.729 0.765 . . . . 0.0 112.726 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -104.44 108.8 20.4 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.02 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -86.74 76.26 9.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 111.978 -172.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.77 136.69 35.42 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.308 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -84.55 108.27 17.22 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.27 136.01 56.08 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.44 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.9 tt0 -162.01 110.29 1.43 Allowed 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 72.41 2.63 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -78.03 83.55 4.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 156.12 8.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.75 30.69 2.07 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.81 131.19 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 112.379 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.99 -18.28 16.79 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.305 2.003 . . . . 0.0 111.545 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.21 140.8 36.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.543 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD23 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.479 ' OG1' HD23 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.693 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.8 78.02 1.83 Allowed Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -118.87 16.25 13.45 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.474 0.654 . . . . 0.0 112.216 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.29 145.07 29.3 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.279 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -150.43 106.97 3.5 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 mp -87.0 92.3 8.99 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.736 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 71' ' ' THR . 14.3 m-85 -113.91 123.54 50.02 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 122.625 1.202 . . . . 0.0 113.361 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -139.64 -173.59 3.66 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -136.51 93.17 2.84 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.962 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.0 80.42 0.98 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.976 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.87 120.06 18.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.7 mtt -100.08 129.44 46.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.965 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.8 78.19 5.45 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.57 169.16 7.53 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.221 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.86 -39.99 82.24 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.283 1.989 . . . . 0.0 110.707 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.13 118.79 29.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 ' HD2' ' A' ' 33' ' ' PRO . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 32' ' ' LEU . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.448 ' HA ' ' OH ' ' A' ' 13' ' ' TYR . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.45 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.14 44.09 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.3 29.86 6.23 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -93.71 13.29 22.72 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.96 0.886 . . . . 0.0 112.071 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.8 -25.08 33.04 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.7 tp -87.52 108.09 18.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.795 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -69.88 117.79 11.91 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -53.92 132.19 41.53 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 124.048 0.842 . . . . 0.0 110.495 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.62 85.88 5.31 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.527 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.7 -172.41 31.28 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 113.167 -1.833 . . . . 0.0 111.492 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -74.77 106.77 6.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.3 tpp -78.54 100.53 6.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.103 -172.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.01 108.44 11.28 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 167.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.73 111.92 2.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.389 1.056 . . . . 0.0 112.636 -172.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.01 -18.18 13.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.147 1.898 . . . . 0.0 110.703 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.04 136.97 33.35 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.9 pp0? -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 76' ' ' ALA . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.33 86.03 0.74 Allowed Glycine 0 N--CA 1.415 -2.747 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -82.73 76.04 9.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.518 1.152 . . . . 0.0 108.163 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.79 96.96 10.47 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.348 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -148.45 106.22 3.69 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.4 mt -56.94 137.37 55.48 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.229 1.014 . . . . 0.0 113.338 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -101.77 174.93 5.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.554 -1.657 . . . . 0.0 106.661 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.84 91.25 0.83 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.48 0.657 . . . . 0.0 109.376 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -81.24 74.81 8.22 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.675 1.226 . . . . 0.0 112.47 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.17 99.43 0.14 Allowed Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.286 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -71.24 146.62 48.88 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 ttt -76.28 95.46 3.75 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.093 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 116.66 6.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 125.61 57.12 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 124.515 1.134 . . . . 0.0 112.41 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.54 -17.81 26.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.55 2.167 . . . . 0.0 109.996 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.91 139.35 30.54 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 80' ' ' LEU . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 50' ' ' ILE . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.34 94.11 2.29 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -103.89 24.79 10.76 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 123.097 1.427 . . . . 0.0 107.476 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.02 81.83 8.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.645 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -142.56 103.13 4.19 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.39 87.77 0.19 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -103.13 120.88 41.51 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.5 98.43 4.62 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.051 0.929 . . . . 0.0 109.806 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -78.17 87.1 4.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.879 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.61 50.86 1.81 Allowed Glycine 0 C--N 1.273 -2.932 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.274 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -83.43 -29.53 28.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 94.6 mtp -122.22 132.61 54.52 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.767 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.05 22.01 9.03 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.14 138.3 25.08 Favored Pre-proline 0 N--CA 1.418 -2.037 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.18 127.09 9.65 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.179 1.919 . . . . 0.0 109.559 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.58 151.14 26.51 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.033 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 43' ' ' ARG . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 27.9 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.12 3.72 1.89 Allowed Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.795 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -83.73 70.28 10.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.197 0.999 . . . . 0.0 110.54 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 12.6 pt-20 -126.71 35.29 4.65 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.714 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.46 -41.15 89.48 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 112.713 -2.04 . . . . 0.0 108.765 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -137.61 85.81 2.14 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' ' HA ' ' A' ' 10' ' ' GLU . 68.4 t80 -116.98 127.23 53.99 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -98.91 107.8 20.33 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.49 101.92 5.14 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.58 148.76 5.78 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -96.08 12.13 31.72 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.305 1.05 . . . . 0.0 108.967 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -123.38 179.89 4.56 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.476 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.23 86.7 3.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.6 107.05 0.22 Allowed Pre-proline 0 C--O 1.247 0.946 0 C-N-CA 127.004 2.122 . . . . 0.0 116.141 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.37 152.42 60.76 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.093 2.529 . . . . 0.0 109.76 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.53 131.57 43.46 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.03 -67.32 3.73 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.455 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 61.28 83.71 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.776 1.231 . . . . 0.0 111.809 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.4 173.19 13.81 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -77.5 -76.32 0.18 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 117.945 0.339 . . . . 0.0 111.5 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -113.41 141.73 46.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -101.51 84.07 2.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.495 0.664 . . . . 0.0 111.605 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.21 127.47 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 60.48 18.4 8.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 125.337 1.455 . . . . 0.0 112.447 -173.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.88 -31.28 15.49 Favored Glycine 0 C--N 1.307 -1.083 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -158.22 162.86 37.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.8 mtt -73.7 163.24 28.24 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.74 0.781 . . . . 0.0 112.805 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.71 35.05 4.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.77 158.06 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.813 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.6 120.46 1.76 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 124.113 3.208 . . . . 0.0 112.583 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.86 131.85 43.59 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.56 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 85' ' ' TYR . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 76' ' ' ALA . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HB2' HG23 ' A' ' 26' ' ' VAL . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.245 0.858 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.51 142.16 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -114.8 96.49 5.75 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.78 100.42 0.2 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.699 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -119.31 3.86 11.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.519 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.02 95.23 9.45 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -94.34 122.74 37.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.146 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.35 107.28 12.0 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.366 0.603 . . . . 0.0 111.388 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.58 80.7 1.5 Allowed 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.71 -34.18 8.62 Favored Glycine 0 C--N 1.282 -2.43 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -71.34 103.83 2.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.2 mtt -125.28 -178.3 4.17 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.5 27.1 1.14 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.322 0.649 . . . . 0.0 109.608 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 128.19 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.142 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 121.18 8.58 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.697 1.598 . . . . 0.0 110.92 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.1 50.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' HG22 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 32' ' ' LEU . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.98 12.92 34.49 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.179 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -101.86 82.39 2.25 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 117.225 0.512 . . . . 0.0 111.593 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 44.32 90.73 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 126.906 2.082 . . . . 0.0 115.333 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -125.91 4.97 7.3 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.585 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.53 125.9 43.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.262 0.553 . . . . 0.0 111.119 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.6 85.55 7.41 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.748 0.785 . . . . 0.0 109.221 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.62 149.57 28.59 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -88.62 81.7 7.03 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.368 1.08 . . . . 0.0 109.272 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.81 -139.52 14.47 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.287 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -167.07 123.13 1.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.48 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 55.2 ttm -132.39 120.83 22.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.9 14.97 10.75 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.101 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 18' ' ' MET . . . 65.27 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 125.676 1.59 . . . . 0.0 111.545 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.22 -63.78 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 113.412 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 116.14 11.96 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 44' ' ' ILE . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.45 45.11 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.099 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -126.67 29.03 5.78 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.82 97.09 3.21 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.386 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.74 73.22 1.43 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.8 119.12 11.32 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -61.44 122.74 15.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.67 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -81.33 105.23 12.36 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-O 121.751 0.786 . . . . 0.0 109.934 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -82.66 69.25 9.4 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.79 1.281 . . . . 0.0 110.173 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.99 101.02 2.45 Favored Glycine 0 N--CA 1.413 -2.898 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -79.04 105.26 10.25 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 mmt -97.94 149.46 22.39 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.899 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.26 19.89 19.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.98 81.51 0.21 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 113.14 -1.845 . . . . 0.0 112.194 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 43.3 Cg_endo -72.26 -16.05 28.24 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.243 1.962 . . . . 0.0 110.367 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.94 135.47 32.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.01 47.11 3.78 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.252 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -122.3 83.97 2.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.41 140.04 38.0 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.229 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -168.0 96.72 0.44 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.612 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.7 97.4 8.53 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -90.14 62.82 5.63 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 60.27 -37.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 169.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -79.82 86.71 5.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.53 1.157 . . . . 0.0 108.99 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.54 16.2 8.31 Favored Glycine 0 C--N 1.278 -2.669 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.025 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -139.16 170.29 16.23 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.9 ttm -68.74 119.61 13.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.94 24.89 0.22 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -171.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.41 83.57 0.22 Allowed Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.58 1.152 . . . . 0.0 112.139 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.68 -16.77 10.19 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.086 1.857 . . . . 0.0 112.189 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.38 135.91 33.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.409 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 51.1 p-80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.91 -113.41 0.48 Allowed Glycine 0 N--CA 1.423 -2.198 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.073 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -103.64 79.74 1.71 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -143.71 116.8 8.91 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.81 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -133.56 89.61 2.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.2 tp -58.24 113.72 2.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.131 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.01 141.95 31.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.892 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -111.21 95.25 5.42 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.31 110.72 8.5 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.35 33.74 0.05 OUTLIER Glycine 0 C--N 1.272 -3.021 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.503 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 33.5 p80 -159.82 177.61 10.64 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.2 mtt -123.58 129.15 50.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.94 53.67 1.83 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.44 153.52 0.14 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.814 1.645 . . . . 0.0 111.514 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.85 85.74 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.754 1.636 . . . . 0.0 110.606 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.64 151.66 43.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.713 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.887 0.375 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.05 -125.5 5.69 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -80.9 68.94 7.35 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -113.08 123.61 50.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -109.12 30.67 6.36 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.34 78.89 7.0 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.136 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 28.94 102.43 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 128.888 2.875 . . . . 0.0 116.14 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -65.07 95.26 0.16 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.441 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -161.29 125.02 3.32 Favored 'General case' 0 N--CA 1.379 -3.992 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.65 -16.38 77.8 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.928 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.9 t60 66.13 93.32 0.07 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.514 1.126 . . . . 0.0 110.069 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.713 ' HB3' ' NE2' ' A' ' 64' ' ' GLN . 23.4 ttt -145.71 159.74 42.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -175.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.85 20.71 0.34 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 46.46 67.42 4.39 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 125.024 1.33 . . . . 0.0 113.995 -179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.1 -35.47 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 N-CA-C 108.443 -1.407 . . . . 0.0 108.443 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.81 119.23 25.07 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.758 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.713 ' NE2' ' HB3' ' A' ' 18' ' ' MET . 11.9 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.36 84.7 0.38 Allowed Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.425 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -133.33 97.25 3.92 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.41 105.63 3.11 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.867 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -92.83 5.54 50.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.588 1.185 . . . . 0.0 108.614 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.1 tp -122.47 88.61 2.96 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.012 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -89.58 144.44 26.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.65 116.48 32.41 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.292 0.567 . . . . 0.0 111.116 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -92.8 81.63 4.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.124 0.964 . . . . 0.0 108.519 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 178.97 56.25 0.08 OUTLIER Glycine 0 C--N 1.283 -2.364 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.369 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -124.63 144.55 50.12 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 120.858 0.361 . . . . 0.0 111.194 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.32 122.74 36.32 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.772 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.24 73.52 10.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.034 0.445 . . . . 0.0 109.903 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.04 90.29 0.09 OUTLIER Pre-proline 0 C--O 1.252 1.226 0 C-N-CA 125.263 1.425 . . . . 0.0 113.589 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.0 -55.51 1.28 Allowed 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.531 2.154 . . . . 0.0 109.222 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.36 121.09 24.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 171.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HA ' HD13 ' A' ' 44' ' ' ILE . 4.2 pp0? -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB1' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.28 -155.67 7.06 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.02 71.3 10.54 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.341 0.591 . . . . 0.0 111.115 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.43 130.59 43.54 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.187 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -150.94 106.86 3.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.97 107.65 0.28 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.356 1.035 . . . . 0.0 111.935 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -78.74 132.94 37.14 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -79.89 100.06 7.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -108.39 80.35 1.34 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.09 154.88 50.1 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -74.58 87.28 2.13 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.285 1.041 . . . . 0.0 109.721 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.3 mtt -113.37 -155.81 0.58 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.436 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -82.88 -10.97 58.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.501 0.667 . . . . 0.0 110.361 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.15 144.42 0.1 Allowed Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 127.433 2.293 . . . . 0.0 112.378 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 -16.67 47.89 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.4 2.734 . . . . 0.0 112.731 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . -135.71 128.8 31.63 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.3 p-80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.656 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.656 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.15 -25.05 25.28 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.835 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.82 81.15 8.89 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.83 175.77 7.33 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -173.61 141.73 0.88 Allowed 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.43 88.65 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.838 0.828 . . . . 0.0 112.934 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -91.98 132.83 36.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -102.13 146.11 28.41 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.615 0.722 . . . . 0.0 111.759 -176.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -91.74 96.01 10.19 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.3 -141.39 0.03 OUTLIER Glycine 0 C--N 1.282 -2.468 0 CA-C-N 113.209 -1.814 . . . . 0.0 114.447 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -87.73 95.37 10.05 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.741 0.781 . . . . 0.0 109.262 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.1 mtt -139.49 175.1 9.85 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.752 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.97 68.81 0.73 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 44' ' ' ILE . . . 70.84 138.53 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.099 1.36 . . . . 0.0 112.11 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.61 -17.59 53.02 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.878 2.385 . . . . 0.0 112.935 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 152.31 27.98 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.659 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 19.9 p-80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 20' ' ' ALA . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.241 0.622 0 CA-C-O 120.697 0.284 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.39 11.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.382 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.86 87.09 2.68 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 122.299 1.047 . . . . 0.0 110.565 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.76 82.49 2.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.834 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.39 110.35 2.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.045 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.66 105.26 16.62 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.041 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -53.62 132.0 39.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.785 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -85.73 94.59 9.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.494 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 163.54 -33.3 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 126.856 2.063 . . . . 0.0 107.693 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.02 30.78 Favored Glycine 1 C--N 1.24 -4.762 0 CA-C-N 111.708 -2.496 . . . . 0.0 108.458 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -79.55 -25.43 41.65 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 117.865 0.833 . . . . 0.0 111.729 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 tpt -98.99 143.86 28.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 11.41 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.683 0.754 . . . . 0.0 112.307 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 57.36 70.01 1.46 Allowed Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 125.643 1.577 . . . . 0.0 114.435 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 61.1 Cg_endo -80.84 -16.65 10.05 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.715 1.61 . . . . 0.0 110.071 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 136.15 50.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 52.7 p-80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' HD12 ' A' ' 32' ' ' LEU . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.92 165.14 15.42 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -90.91 82.43 5.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 122.154 0.978 . . . . 0.0 110.103 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -88.36 132.02 34.6 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.835 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -133.18 93.06 3.11 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.505 0.669 . . . . 0.0 111.948 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.75 132.62 43.98 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -87.26 104.68 16.62 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -72.62 150.26 43.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -96.0 83.72 3.71 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.5 1.143 . . . . 0.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.55 66.96 2.3 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.692 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -95.6 140.49 30.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.359 0.664 . . . . 0.0 109.306 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.4 tpt -101.45 113.43 26.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.92 11.54 17.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.202 0.525 . . . . 0.0 111.882 -175.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 58.78 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 125.964 1.706 . . . . 0.0 113.386 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.6 -54.86 2.1 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 121.863 1.709 . . . . 0.0 109.468 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.91 115.27 13.16 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 34.4 p-80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 27.1 m80 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 19.2 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 59' ' ' VAL . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.838 0.352 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.01 25.75 0.24 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -119.38 82.67 1.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.703 0.764 . . . . 0.0 108.956 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -114.52 156.97 23.62 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.057 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -124.8 46.03 2.41 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.23 120.11 12.13 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.75 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 71.83 93.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.884 1.274 . . . . 0.0 110.342 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.7 111.42 11.15 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.3 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.51 83.16 1.73 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.914 0.864 . . . . 0.0 108.868 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.9 -14.93 82.09 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.993 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -124.88 121.39 34.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.8 mtt -70.17 115.98 10.0 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.53 -0.77 48.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.945 1.355 . . . . 0.0 110.063 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.04 87.52 2.45 Favored Pre-proline 0 C--N 1.266 -3.048 0 CA-C-N 112.544 -2.116 . . . . 0.0 107.452 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.2 175.83 7.09 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 109.948 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.14 24.18 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 48' ' ' ALA . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB1' ' A' ' 61' ' ' ALA . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 13.2 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.46 -177.37 20.79 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -125.03 87.37 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.92 93.91 7.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.23 -24.18 14.29 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.653 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.76 93.01 3.07 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.955 0.883 . . . . 0.0 112.789 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.57 132.33 55.71 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -77.0 119.57 20.91 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.421 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -91.05 75.77 6.25 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -40.58 89.92 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 112.946 -1.934 . . . . 0.0 115.417 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -60.22 -58.44 8.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.371 0.586 . . . . 0.0 111.486 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.0 ttt -166.37 136.71 3.34 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.74 67.86 4.58 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.652 0.595 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 22' ' ' ALA . . . 68.1 108.47 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.656 1.582 . . . . 0.0 112.69 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.0 -36.04 95.39 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.192 2.594 . . . . 0.0 110.768 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 44' ' ' ILE . . . -118.48 122.24 42.25 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 170.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG12 ' HG ' ' A' ' 70' ' ' LEU . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 76' ' ' ALA . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 76' ' ' ALA . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.249 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.543 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.479 HD23 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.479 ' OG1' HD23 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.693 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 ' HD2' ' A' ' 33' ' ' PRO . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 32' ' ' LEU . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.45 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 76' ' ' ALA . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 80' ' ' LEU . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 50' ' ' ILE . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.421 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.242 0.669 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 43' ' ' ARG . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.926 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.892 0 CA-C-O 121.233 0.54 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 85' ' ' TYR . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 76' ' ' ALA . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HB2' HG23 ' A' ' 26' ' ' VAL . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' HG22 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 32' ' ' LEU . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 44' ' ' ILE . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.191 0 CA-C-O 121.275 0.56 . . . . 0.0 110.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -0.925 0 CA-C-O 120.765 0.317 . . . . 0.0 111.713 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.424 -1.725 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.544 ' HA ' HD13 ' A' ' 44' ' ' ILE . 2.4 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB1' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . . . . . . 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.656 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.656 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.444 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.741 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.659 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' HD12 ' A' ' 32' ' ' LEU . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . 0.427 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.405 ' H ' ' CD2' ' A' ' 31' ' ' HIS . 7.2 p80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 71.9 m-70 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 59' ' ' VAL . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.905 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 48' ' ' ALA . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB1' ' A' ' 61' ' ' ALA . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 44' ' ' ILE . . . . . . . . 0 N--CA 1.422 -1.859 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.505 HG12 ' HG ' ' A' ' 70' ' ' LEU . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 76' ' ' ALA . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 76' ' ' ALA . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.6 p . . . . . 0 CA--C 1.542 0.654 0 N-CA-C 111.921 0.341 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.33 -138.33 26.27 Favored Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.185 -1.166 . . . . 0.0 110.185 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -97.16 74.55 2.55 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 117.729 0.765 . . . . 0.0 112.726 178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -104.44 108.8 20.4 Favored 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.02 172.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -86.74 76.26 9.51 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 122.112 0.958 . . . . 0.0 111.978 -172.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.0 tp -81.77 136.69 35.42 Favored 'General case' 0 C--N 1.299 -1.628 0 CA-C-N 114.276 -1.329 . . . . 0.0 108.308 174.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -84.55 108.27 17.22 Favored 'General case' 0 N--CA 1.424 -1.749 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 176.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -65.27 136.01 56.08 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.44 -175.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -162.01 110.29 1.43 Allowed 'General case' 0 N--CA 1.42 -1.962 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.18 72.41 2.63 Favored Glycine 0 C--N 1.299 -1.493 0 N-CA-C 110.57 -1.012 . . . . 0.0 110.57 177.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -78.03 83.55 4.33 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -168.14 156.12 8.55 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 105.491 -2.04 . . . . 0.0 105.491 174.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -139.75 30.69 2.07 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -177.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 72.81 131.19 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.479 0 C-N-CA 125.623 1.569 . . . . 0.0 112.379 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -75.99 -18.28 16.79 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.305 2.003 . . . . 0.0 111.545 178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.21 140.8 36.9 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 177.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.7 ttt180 -128.75 -16.09 4.28 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.519 0.676 . . . . 0.0 110.033 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 88.3 m-85 -130.33 171.2 13.18 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 108.833 -0.803 . . . . 0.0 108.833 174.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 95.8 m -131.5 135.36 47.01 Favored 'General case' 0 C--N 1.283 -2.302 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 173.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.556 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.7 t -102.38 116.85 46.8 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 -179.531 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.505 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 50.1 m-85 -96.52 143.19 27.75 Favored 'General case' 0 CA--C 1.495 -1.16 0 O-C-N 123.251 0.344 . . . . 0.0 110.596 178.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.543 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 52.0 m-85 -137.7 159.03 43.09 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.949 -179.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -95.65 108.5 20.78 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.2 153.55 10.41 Favored Glycine 0 N--CA 1.413 -2.867 0 N-CA-C 110.489 -1.044 . . . . 0.0 110.489 -178.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -105.73 -13.36 15.58 Favored 'General case' 0 C--N 1.292 -1.916 0 CA-C-O 120.726 0.298 . . . . 0.0 111.15 -177.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.479 HD23 ' OG1' ' A' ' 35' ' ' THR . 15.8 tp -81.95 124.81 78.77 Favored Pre-proline 0 N--CA 1.431 -1.38 0 N-CA-C 108.712 -0.848 . . . . 0.0 108.712 -175.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -56.17 -22.25 39.21 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.882 3.055 . . . . 0.0 115.854 -172.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.02 -40.94 9.39 Favored 'General case' 0 C--N 1.309 -1.193 0 C-N-CA 119.373 -0.931 . . . . 0.0 112.208 176.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.479 ' OG1' HD23 ' A' ' 32' ' ' LEU . 1.7 m -89.09 -5.94 57.45 Favored 'General case' 0 C--N 1.313 -1.012 0 N-CA-C 112.848 0.684 . . . . 0.0 112.848 -171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.543 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -71.3 126.08 28.66 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 119.9 -0.72 . . . . 0.0 111.634 -176.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 59.8 t -91.04 126.36 43.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 CA-C-N 115.87 -0.605 . . . . 0.0 109.953 -175.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 126.42 27.53 Favored 'General case' 0 C--N 1.316 -0.87 0 C-N-CA 122.827 0.451 . . . . 0.0 109.809 179.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 85.0 mt -101.16 -60.44 1.52 Allowed 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.76 177.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 14.8 ptp -175.54 165.66 3.19 Favored 'General case' 0 CA--C 1.501 -0.908 0 CA-C-O 121.107 0.479 . . . . 0.0 111.27 -179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 75.6 m-85 -103.29 137.72 41.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.994 179.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.7 t -125.88 137.96 56.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -78.17 124.79 28.47 Favored 'General case' 0 C--O 1.257 1.499 0 C-N-CA 123.447 0.699 . . . . 0.0 109.759 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 58.1 mt -64.98 123.58 18.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.12 -5.76 23.6 Favored Glycine 0 N--CA 1.416 -2.652 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -175.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 55.0 p -131.2 167.63 18.84 Favored 'General case' 0 C--O 1.258 1.517 0 CA-C-O 121.628 0.727 . . . . 0.0 111.879 178.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 38.6 p -99.28 158.31 15.79 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.388 175.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.35 148.45 26.77 Favored 'General case' 0 C--N 1.283 -2.283 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.872 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 5.6 m -97.04 113.09 24.61 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 177.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.1 mm -94.44 137.48 22.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 104.644 -2.354 . . . . 0.0 104.644 174.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.9 m -123.52 109.23 13.55 Favored 'General case' 0 C--N 1.261 -3.242 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -142.43 136.55 29.6 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.0 mtp180 63.29 26.64 15.17 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.857 0.863 . . . . 0.0 111.435 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.06 8.0 87.48 Favored Glycine 0 N--CA 1.437 -1.235 0 CA-C-N 114.962 -1.017 . . . . 0.0 113.116 -178.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 69.2 m-70 -109.91 140.59 43.72 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-N 117.161 0.481 . . . . 0.0 110.1 178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -100.25 128.54 46.3 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -120.63 109.33 15.1 Favored 'General case' 0 N--CA 1.421 -1.923 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 17.9 tp10 -87.79 107.28 18.58 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 31.1 m -114.48 155.43 15.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.951 -173.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -116.4 118.33 32.4 Favored 'General case' 0 C--N 1.282 -2.34 0 CA-C-N 116.088 -0.505 . . . . 0.0 109.911 176.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.95 88.4 7.44 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 16.7 ptpt -102.45 -20.79 14.4 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 114.822 1.416 . . . . 0.0 114.822 -172.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -123.79 151.54 43.2 Favored 'General case' 0 N--CA 1.425 -1.691 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.607 -169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.3 pt20 -69.03 -10.34 57.06 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 123.632 0.582 . . . . 0.0 111.55 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 38.7 m-80 -94.4 -1.93 52.85 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.693 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 84.2 m 60.11 37.15 21.1 Favored 'General case' 0 CA--C 1.5 -0.98 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.636 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.05 104.85 1.86 Allowed 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 173.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.436 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.6 p -81.42 109.7 15.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.1 mp -117.64 134.87 59.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 107.116 -1.438 . . . . 0.0 107.116 174.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.0 mp -85.15 161.47 19.62 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.0 p -63.18 -15.01 55.55 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 -170.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.585 ' OD1' ' HG2' ' A' ' 74' ' ' LYS . 8.0 p30 -104.35 4.45 33.52 Favored 'General case' 0 C--N 1.316 -0.89 0 O-C-N 121.288 -0.882 . . . . 0.0 110.615 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.62 10.58 46.74 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.305 178.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.585 ' HG2' ' OD1' ' A' ' 72' ' ' ASN . 32.5 mmtp -82.63 152.11 26.03 Favored 'General case' 0 CA--C 1.487 -1.476 0 CA-C-O 121.448 0.642 . . . . 0.0 111.745 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 23.9 mp0 -93.34 158.57 15.67 Favored 'General case' 0 N--CA 1.412 -2.339 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.37 155.91 71.49 Favored Pre-proline 0 C--N 1.282 -2.329 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.5 -176.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -54.58 158.01 11.16 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 123.213 2.609 . . . . 0.0 110.477 171.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -73.55 -26.72 60.97 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.388 0.613 . . . . 0.0 110.714 -177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.8 p-90 -81.62 -5.74 58.34 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.222 -0.899 . . . . 0.0 111.585 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.6 tp -96.96 108.67 21.43 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.505 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -104.76 152.07 23.0 Favored 'General case' 0 C--N 1.297 -1.695 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.186 -175.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.556 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -146.49 129.23 16.19 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.022 178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -118.89 137.11 24.66 Favored Pre-proline 0 C--N 1.302 -1.478 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.693 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 29.2 Cg_endo -62.71 124.73 14.64 Favored 'Trans proline' 0 C--O 1.247 0.968 0 C-N-CA 123.349 2.699 . . . . 0.0 112.082 178.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 58.9 t80 . . . . . 0 N--CA 1.422 -1.852 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 -178.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 43.3 p . . . . . 0 N--CA 1.442 -0.831 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -79.8 78.02 1.83 Allowed Glycine 0 N--CA 1.432 -1.602 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 18.2 mtp180 -118.87 16.25 13.45 Favored 'General case' 0 CA--C 1.49 -1.354 0 CA-C-O 121.474 0.654 . . . . 0.0 112.216 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -83.29 145.07 29.3 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.279 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -150.43 106.97 3.5 Favored 'General case' 0 C--N 1.279 -2.467 0 N-CA-C 106.451 -1.685 . . . . 0.0 106.451 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.0 mp -87.0 92.3 8.99 Favored 'General case' 0 C--N 1.282 -2.367 0 CA-C-N 115.083 -0.962 . . . . 0.0 110.736 -178.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.448 ' OH ' ' HA ' ' A' ' 71' ' ' THR . 14.3 m-85 -113.91 123.54 50.02 Favored 'General case' 0 N--CA 1.406 -2.657 0 CA-C-O 122.625 1.202 . . . . 0.0 113.361 -178.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -139.64 -173.59 3.66 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 104.929 -2.248 . . . . 0.0 104.929 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 60.4 tt0 -136.51 93.17 2.84 Favored 'General case' 0 C--N 1.289 -2.042 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.962 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -94.0 80.42 0.98 Allowed Glycine 0 C--N 1.3 -1.447 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.976 178.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -73.87 120.06 18.94 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -178.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.7 mtt -100.08 129.44 46.12 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.965 -178.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.8 78.19 5.45 Favored 'General case' 0 N--CA 1.423 -1.813 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.57 169.16 7.53 Favored Pre-proline 0 C--N 1.3 -1.565 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.221 -173.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -57.86 -39.99 82.24 Favored 'Trans proline' 0 C--N 1.361 1.227 0 C-N-CA 122.283 1.989 . . . . 0.0 110.707 173.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -90.13 118.79 29.93 Favored 'General case' 0 N--CA 1.431 -1.421 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 176.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 51.3 mtp180 -118.96 -3.21 10.72 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 121.168 0.508 . . . . 0.0 110.594 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.446 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 89.4 m-85 -138.76 162.07 35.64 Favored 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.099 175.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 72.6 m -122.01 133.41 54.81 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.687 -1.597 . . . . 0.0 106.687 169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.24 124.08 47.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 42.1 m-85 -102.89 137.93 40.44 Favored 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.013 0.435 . . . . 0.0 110.878 177.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 87.2 m-85 -131.89 151.16 51.88 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 115.374 -0.83 . . . . 0.0 109.596 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -97.29 109.37 22.14 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 105.985 -1.857 . . . . 0.0 105.985 173.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.47 153.72 6.16 Favored Glycine 0 C--N 1.286 -2.248 0 C-N-CA 119.799 -1.191 . . . . 0.0 112.128 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -112.67 -1.21 14.84 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.32 0.581 . . . . 0.0 109.991 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.491 HD12 ' HD2' ' A' ' 33' ' ' PRO . 22.9 tp -106.42 127.61 27.86 Favored Pre-proline 0 N--CA 1.418 -2.027 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.491 ' HD2' HD12 ' A' ' 32' ' ' LEU . 37.5 Cg_endo -65.51 -12.09 33.4 Favored 'Trans proline' 0 N--CA 1.475 0.428 0 C-N-CA 123.324 2.683 . . . . 0.0 114.001 -174.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.68 -43.17 8.4 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 16.8 p -106.84 12.5 28.89 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -66.33 129.13 38.79 Favored 'General case' 0 CA--C 1.547 0.865 0 CA-C-O 120.926 0.394 . . . . 0.0 110.799 -177.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -89.43 125.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 O-C-N 121.797 -0.565 . . . . 0.0 109.908 -174.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -65.45 122.22 16.68 Favored 'General case' 0 C--N 1.309 -1.166 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 93.2 mt -99.26 -60.39 1.54 Allowed 'General case' 0 C--N 1.308 -1.229 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.108 179.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 25.2 ptm -176.16 165.75 2.86 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-O 121.099 0.476 . . . . 0.0 111.729 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -107.12 133.87 51.08 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 114.478 -1.237 . . . . 0.0 108.489 178.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.446 ' O ' ' HA ' ' A' ' 24' ' ' PHE . 62.9 t -116.68 131.0 70.6 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.283 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 21.0 tpp180 -68.84 125.9 28.05 Favored 'General case' 0 C--O 1.245 0.82 0 C-N-CA 123.617 0.767 . . . . 0.0 111.286 -179.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.0 mm -57.73 117.59 1.64 Allowed 'Isoleucine or valine' 0 C--O 1.248 0.997 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.142 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.47 -1.17 30.84 Favored Glycine 0 N--CA 1.425 -2.059 0 CA-C-N 115.329 -0.851 . . . . 0.0 112.008 -177.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 70.9 p -131.59 164.01 26.81 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.977 -0.72 . . . . 0.0 110.814 179.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.2 p -99.33 157.34 16.47 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 114.98 -1.009 . . . . 0.0 108.391 174.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -153.98 151.44 29.4 Favored 'General case' 0 C--N 1.287 -2.151 0 O-C-N 123.527 0.517 . . . . 0.0 110.823 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 6.8 m -98.7 115.05 27.86 Favored 'General case' 0 N--CA 1.418 -2.053 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.127 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.4 mm -94.07 141.44 14.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 175.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 20.5 m -124.66 109.36 13.06 Favored 'General case' 0 C--N 1.269 -2.926 0 C-N-CA 120.238 -0.585 . . . . 0.0 109.65 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.94 137.31 31.18 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.52 -176.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 44.4 mtm180 59.59 26.14 15.12 Favored 'General case' 0 N--CA 1.485 1.298 0 C-N-CA 125.819 1.648 . . . . 0.0 109.954 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.82 4.65 88.36 Favored Glycine 0 C--N 1.304 -1.198 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.945 -177.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -103.77 141.86 35.36 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-N 117.369 0.584 . . . . 0.0 109.434 179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -100.49 120.79 40.53 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -109.3 108.39 18.95 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 -85.28 108.4 17.76 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 27.8 m -110.55 149.98 13.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.199 -174.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -110.0 119.38 39.13 Favored 'General case' 0 C--N 1.29 -1.999 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 176.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -84.5 86.26 7.31 Favored 'General case' 0 C--N 1.315 -0.933 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 174.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 22.2 mtpp -76.41 -57.19 4.01 Favored 'General case' 0 CA--C 1.501 -0.933 0 CA-C-N 114.592 -1.186 . . . . 0.0 112.227 -172.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -132.58 153.18 51.26 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-N 114.516 -1.22 . . . . 0.0 110.406 -173.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -59.56 -5.43 0.84 Allowed 'General case' 0 N--CA 1.478 0.949 0 C-N-CA 125.944 1.698 . . . . 0.0 114.414 -179.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -72.73 -26.24 61.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 173.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.495 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 96.1 m 65.56 31.87 9.72 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.552 -1.204 . . . . 0.0 113.81 177.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.43 103.51 2.46 Favored 'General case' 0 N--CA 1.398 -3.063 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 170.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.3 p -58.13 114.56 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 114.925 -1.034 . . . . 0.0 112.589 -178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 91.0 mt -128.98 123.97 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 176.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.489 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -91.45 161.63 14.9 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.424 -176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.448 ' HA ' ' OH ' ' A' ' 13' ' ' TYR . 40.2 p -67.56 -22.65 65.38 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.134 -1.393 . . . . 0.0 110.992 -178.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.0 m-80 -87.88 5.33 40.93 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.149 -0.932 . . . . 0.0 111.507 179.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.13 14.74 66.13 Favored Glycine 0 CA--C 1.492 -1.365 0 N-CA-C 111.251 -0.739 . . . . 0.0 111.251 175.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -98.18 150.24 21.7 Favored 'General case' 0 N--CA 1.42 -1.931 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 -177.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -107.88 26.31 10.49 Favored 'General case' 0 C--N 1.29 -1.993 0 CA-C-O 121.136 0.493 . . . . 0.0 111.865 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.79 153.37 0.15 Allowed Pre-proline 0 N--CA 1.472 0.632 0 C-N-CA 125.283 1.433 . . . . 0.0 113.706 174.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -64.14 159.44 43.03 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 123.342 2.695 . . . . 0.0 112.13 173.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.76 -6.27 30.89 Favored 'General case' 0 C--N 1.317 -0.834 0 C-N-CA 123.944 0.898 . . . . 0.0 112.571 -175.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -104.7 -10.07 17.74 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 120.748 0.309 . . . . 0.0 111.407 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.2 tp -94.3 116.29 28.65 Favored 'General case' 0 C--N 1.311 -1.088 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 178.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -112.84 145.26 40.97 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.978 -173.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.85 130.04 35.38 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.883 0.739 . . . . 0.0 109.452 178.094 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -130.34 140.3 38.25 Favored Pre-proline 0 C--N 1.312 -1.062 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.495 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 39.3 Cg_endo -63.91 126.18 16.82 Favored 'Trans proline' 0 C--O 1.249 1.067 0 C-N-CA 123.828 3.019 . . . . 0.0 114.042 -177.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.45 ' HB2' ' CG2' ' A' ' 26' ' ' VAL . 77.7 t80 . . . . . 0 N--CA 1.434 -1.27 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.111 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.9 t . . . . . 0 C--O 1.245 0.82 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.29 179.14 44.09 Favored Glycine 0 N--CA 1.435 -1.375 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 81.2 mtp180 -124.3 29.86 6.23 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.178 0.513 . . . . 0.0 111.612 -178.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -93.71 13.29 22.72 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.96 0.886 . . . . 0.0 112.071 -178.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -82.8 -25.08 33.04 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 106.452 -1.684 . . . . 0.0 106.452 174.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.7 tp -87.52 108.09 18.88 Favored 'General case' 0 N--CA 1.419 -1.998 0 CA-C-N 113.5 -1.682 . . . . 0.0 107.795 173.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -69.88 117.79 11.91 Favored 'General case' 0 N--CA 1.432 -1.365 0 N-CA-C 107.021 -1.474 . . . . 0.0 107.021 175.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -53.92 132.19 41.53 Favored 'General case' 0 C--O 1.248 0.98 0 O-C-N 124.048 0.842 . . . . 0.0 110.495 -177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -79.62 85.88 5.31 Favored 'General case' 0 N--CA 1.423 -1.81 0 CA-C-N 114.785 -1.098 . . . . 0.0 112.527 -171.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.7 -172.41 31.28 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 113.167 -1.833 . . . . 0.0 111.492 173.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.8 t-80 -74.77 106.77 6.47 Favored 'General case' 0 C--N 1.307 -1.258 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 45.3 tpp -78.54 100.53 6.97 Favored 'General case' 0 N--CA 1.424 -1.734 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.103 -172.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.01 108.44 11.28 Favored 'General case' 0 N--CA 1.411 -2.401 0 N-CA-C 103.446 -2.798 . . . . 0.0 103.446 167.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.73 111.92 2.56 Favored Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.389 1.056 . . . . 0.0 112.636 -172.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -78.01 -18.18 13.15 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.147 1.898 . . . . 0.0 110.703 178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -85.04 136.97 33.35 Favored 'General case' 0 N--CA 1.425 -1.698 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 177.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 53.5 mtm180 -95.98 -31.51 13.04 Favored 'General case' 0 C--N 1.291 -1.962 0 CA-C-O 121.632 0.729 . . . . 0.0 109.745 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -140.95 165.97 26.07 Favored 'General case' 0 N--CA 1.425 -1.682 0 CA-C-N 114.485 -1.234 . . . . 0.0 108.04 -177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 98.2 m -113.94 128.7 56.51 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 104.674 -2.343 . . . . 0.0 104.674 163.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 58.7 t -95.0 126.46 47.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 -177.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.571 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 41.0 m-85 -99.17 144.75 27.95 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 123.902 0.751 . . . . 0.0 112.29 -177.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -136.47 150.35 48.66 Favored 'General case' 0 N--CA 1.429 -1.504 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.8 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.442 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 6.3 t70 -89.69 106.26 18.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.499 -1.297 . . . . 0.0 107.499 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 127.69 143.53 5.73 Favored Glycine 0 C--N 1.294 -1.788 0 C-N-CA 121.248 -0.501 . . . . 0.0 112.175 178.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 29.7 t-80 -93.99 -8.03 41.11 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-O 121.5 0.667 . . . . 0.0 109.797 -177.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 10.9 mp -104.56 127.77 28.29 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.448 -0.797 . . . . 0.0 111.647 -176.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 31.1 Cg_endo -64.12 -18.17 62.48 Favored 'Trans proline' 0 CA--C 1.538 0.695 0 C-N-CA 123.364 2.709 . . . . 0.0 113.009 -178.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.8 -14.32 37.31 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 112.085 0.402 . . . . 0.0 112.085 179.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.5 m -121.72 -24.81 5.2 Favored 'General case' 0 C--N 1.311 -1.066 0 C-N-CA 119.711 -0.795 . . . . 0.0 112.942 -172.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.442 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 0.0 OUTLIER -53.67 131.01 38.3 Favored 'General case' 0 CA--C 1.544 0.73 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 -169.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.0 t -97.12 125.93 50.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.636 -177.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -59.8 125.53 23.99 Favored 'General case' 0 C--N 1.313 -0.989 0 C-N-CA 123.729 0.812 . . . . 0.0 109.29 177.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.52 -63.15 1.27 Allowed 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.316 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.2 ptp -174.87 163.71 3.37 Favored 'General case' 0 C--O 1.25 1.116 0 N-CA-C 112.368 0.507 . . . . 0.0 112.368 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 84.1 m-85 -94.93 121.91 37.03 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.454 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.4 t -108.69 120.67 60.48 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.107 0 C-N-CA 120.144 -0.622 . . . . 0.0 109.607 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.9 tpp180 -63.38 134.75 56.26 Favored 'General case' 0 C--O 1.245 0.866 0 C-N-CA 124.335 1.054 . . . . 0.0 110.615 -176.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 43.0 mm -62.54 115.6 2.13 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 CA-C-N 115.137 -0.938 . . . . 0.0 111.254 178.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.07 11.0 55.63 Favored Glycine 0 C--N 1.293 -1.807 0 CA-C-N 114.481 -1.236 . . . . 0.0 110.061 177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.3 m -126.5 169.41 13.05 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 121.754 0.788 . . . . 0.0 109.973 -177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 24.0 p -108.43 156.56 19.31 Favored 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 114.462 -1.245 . . . . 0.0 110.165 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.33 151.45 22.81 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.187 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -98.39 111.71 23.97 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 178.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.2 mm -93.72 146.86 6.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.511 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 32.5 m -132.59 112.53 12.14 Favored 'General case' 0 C--N 1.269 -2.914 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -141.47 131.96 25.33 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.5 mtm180 59.06 26.33 14.97 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.59 1.556 . . . . 0.0 110.404 -176.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.45 -5.68 83.96 Favored Glycine 0 C--N 1.307 -1.05 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.768 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.511 ' O ' ' HA ' ' A' ' 51' ' ' THR . 18.3 m-70 -85.48 130.51 34.56 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -105.38 113.31 26.82 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -109.29 118.09 35.78 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 -176.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -86.13 107.58 17.92 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 172.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.547 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 20.1 m -115.57 155.95 16.73 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 CA-C-O 121.149 0.499 . . . . 0.0 111.459 -172.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -115.53 111.28 20.49 Favored 'General case' 0 C--N 1.289 -2.057 0 CA-C-N 114.838 -1.074 . . . . 0.0 108.598 174.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -90.96 80.96 5.69 Favored 'General case' 0 CA--C 1.499 -1.011 0 N-CA-C 107.319 -1.363 . . . . 0.0 107.319 175.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.6 ptpt -66.19 -35.65 80.99 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 114.903 1.445 . . . . 0.0 114.903 -172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -148.03 164.24 34.41 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.135 -0.626 . . . . 0.0 110.966 -169.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.69 -10.82 39.87 Favored 'General case' 0 C--O 1.241 0.651 0 C-N-CA 124.723 1.209 . . . . 0.0 112.322 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -68.02 -18.76 64.79 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 173.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 75.6 m 56.92 35.35 26.24 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 112.441 176.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.622 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -83.66 96.14 8.59 Favored 'General case' 0 CA--C 1.485 -1.557 0 CA-C-O 122.229 1.014 . . . . 0.0 109.078 173.756 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.513 HG13 ' HB3' ' A' ' 76' ' ' ALA . 3.4 p -68.16 112.73 3.38 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.183 0 CA-C-N 112.352 -2.203 . . . . 0.0 112.265 -177.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 72.5 mt -127.28 135.09 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.06 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.6 mp -81.43 158.47 24.58 Favored 'General case' 0 C--N 1.282 -2.365 0 CA-C-O 121.348 0.594 . . . . 0.0 109.668 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.4 p -66.92 -21.72 65.98 Favored 'General case' 0 C--N 1.279 -2.465 0 CA-C-N 114.545 -1.207 . . . . 0.0 111.165 -177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 50.2 m-80 -78.85 -2.66 40.81 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.125 179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 86.31 22.17 49.0 Favored Glycine 0 CA--C 1.487 -1.705 0 N-CA-C 109.852 -1.299 . . . . 0.0 109.852 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -109.63 150.73 27.8 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 -178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -100.05 143.62 30.05 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.513 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -82.88 153.62 67.27 Favored Pre-proline 0 C--N 1.295 -1.773 0 CA-C-N 115.527 -0.761 . . . . 0.0 111.603 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -64.46 156.79 58.47 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.233 2.622 . . . . 0.0 113.185 -178.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.1 -30.67 71.21 Favored 'General case' 0 CA--C 1.497 -1.071 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.719 -175.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.7 p-90 -71.7 -13.6 61.78 Favored 'General case' 0 C--O 1.214 -0.808 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.251 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 48.3 tp -88.54 104.79 17.15 Favored 'General case' 0 N--CA 1.421 -1.916 0 N-CA-C 105.795 -1.928 . . . . 0.0 105.795 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.571 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.61 145.38 27.63 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.391 -172.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -137.22 129.7 29.88 Favored 'General case' 0 C--N 1.299 -1.617 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.873 178.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -120.04 136.85 25.26 Favored Pre-proline 0 C--N 1.302 -1.496 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 178.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -65.38 129.07 21.7 Favored 'Trans proline' 0 C--O 1.243 0.725 0 C-N-CA 122.971 2.448 . . . . 0.0 110.024 178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' HB2' HG23 ' A' ' 26' ' ' VAL . 22.2 t80 . . . . . 0 N--CA 1.413 -2.294 0 C-N-CA 120.068 -0.653 . . . . 0.0 110.632 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.4 m . . . . . 0 N--CA 1.439 -1.016 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.33 86.03 0.74 Allowed Glycine 0 N--CA 1.415 -2.747 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 69.2 mtt180 -82.73 76.04 9.59 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-O 122.518 1.152 . . . . 0.0 108.163 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -92.79 96.96 10.47 Favored 'General case' 0 C--N 1.29 -1.987 0 CA-C-N 112.858 -1.974 . . . . 0.0 110.348 -174.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -148.45 106.22 3.69 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 53.4 mt -56.94 137.37 55.48 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-O 122.229 1.014 . . . . 0.0 113.338 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -101.77 174.93 5.73 Favored 'General case' 0 C--N 1.284 -2.276 0 CA-C-N 113.554 -1.657 . . . . 0.0 106.661 178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -70.84 91.25 0.83 Allowed 'General case' 0 C--N 1.315 -0.913 0 CA-C-O 121.48 0.657 . . . . 0.0 109.376 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 8.6 pt20 -81.24 74.81 8.22 Favored 'General case' 0 N--CA 1.425 -1.678 0 CA-C-O 122.675 1.226 . . . . 0.0 112.47 -175.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -174.17 99.43 0.14 Allowed Glycine 0 N--CA 1.415 -2.758 0 CA-C-N 113.157 -1.838 . . . . 0.0 110.286 178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m-70 -71.24 146.62 48.88 Favored 'General case' 0 C--O 1.25 1.089 0 N-CA-C 107.043 -1.466 . . . . 0.0 107.043 178.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.8 ttt -76.28 95.46 3.75 Favored 'General case' 0 CA--C 1.498 -1.02 0 C-N-CA 119.636 -0.826 . . . . 0.0 110.093 -177.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.07 116.66 6.13 Favored 'General case' 0 N--CA 1.429 -1.515 0 N-CA-C 105.383 -2.08 . . . . 0.0 105.383 172.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.0 125.61 57.12 Favored Pre-proline 0 C--N 1.304 -1.406 0 O-C-N 124.515 1.134 . . . . 0.0 112.41 -172.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -72.54 -17.81 26.29 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.55 2.167 . . . . 0.0 109.996 175.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -88.91 139.35 30.54 Favored 'General case' 0 N--CA 1.429 -1.521 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 175.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -116.49 -28.53 6.42 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 -178.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.461 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 22.0 m-85 -129.19 169.57 14.63 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 73.1 m -124.76 136.56 53.96 Favored 'General case' 0 C--N 1.279 -2.481 0 N-CA-C 105.958 -1.868 . . . . 0.0 105.958 167.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.5 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 8.3 t -101.49 125.94 55.44 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.582 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 13.1 m-85 -101.55 139.85 36.65 Favored 'General case' 0 C--N 1.307 -1.264 0 O-C-N 123.652 0.595 . . . . 0.0 110.671 179.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 52.1 m-85 -133.76 149.14 51.44 Favored 'General case' 0 C--N 1.302 -1.475 0 CA-C-N 115.41 -0.814 . . . . 0.0 108.884 177.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.527 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 10.5 t70 -86.07 98.7 11.01 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 124.282 1.033 . . . . 0.0 108.248 174.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.69 147.97 8.84 Favored Glycine 0 C--N 1.292 -1.87 0 N-CA-C 110.45 -1.06 . . . . 0.0 110.45 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.3 p80 -101.67 0.63 36.47 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-O 121.32 0.581 . . . . 0.0 109.469 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 25.3 tp -100.46 119.76 57.99 Favored Pre-proline 0 N--CA 1.428 -1.544 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 -178.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -56.96 -36.7 99.32 Favored 'Trans proline' 0 N--CA 1.475 0.402 0 C-N-CA 123.385 2.724 . . . . 0.0 114.204 -171.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.76 -1.98 55.34 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 112.553 0.575 . . . . 0.0 112.553 -176.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 14.7 m -135.32 6.56 3.31 Favored 'General case' 0 C--N 1.306 -1.326 0 CA-C-O 121.538 0.685 . . . . 0.0 110.599 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 35.9 ptt180 -87.81 128.55 35.33 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 121.299 -0.875 . . . . 0.0 110.469 -176.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.451 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 57.4 t -96.69 129.22 47.05 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.847 -178.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -61.02 126.19 26.47 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.6 mt -105.43 -62.53 1.34 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 -179.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 20.8 ptp -172.23 163.6 5.82 Favored 'General case' 0 CA--C 1.502 -0.893 0 CA-C-O 121.046 0.451 . . . . 0.0 111.952 -175.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -109.44 131.89 54.64 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 114.454 -1.248 . . . . 0.0 107.942 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 65.3 t -127.13 141.82 45.22 Favored 'Isoleucine or valine' 0 C--O 1.199 -1.573 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.43 137.09 38.49 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 122.779 0.432 . . . . 0.0 111.614 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 27.3 mm -58.07 115.89 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.259 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.5 175.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 112.63 -15.07 24.55 Favored Glycine 0 C--N 1.287 -2.154 0 CA-C-N 115.544 -0.753 . . . . 0.0 112.333 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 74.3 p -102.21 162.9 12.56 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-O 121.487 0.661 . . . . 0.0 111.46 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.7 p -99.11 152.78 19.48 Favored 'General case' 0 C--N 1.286 -2.159 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 175.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -143.16 142.74 31.55 Favored 'General case' 0 C--N 1.272 -2.793 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -173.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.4 m -99.27 105.24 17.23 Favored 'General case' 0 N--CA 1.406 -2.655 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 174.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.422 HG21 HD11 ' A' ' 80' ' ' LEU . 16.3 mm -94.52 146.89 6.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.744 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.3 m -131.03 110.47 11.25 Favored 'General case' 0 C--N 1.273 -2.738 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -136.4 135.57 38.85 Favored 'General case' 0 C--N 1.306 -1.3 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.543 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 59.5 mtm180 59.79 25.61 14.68 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.932 1.693 . . . . 0.0 110.627 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.21 16.16 78.98 Favored Glycine 0 N--CA 1.439 -1.157 0 CA-C-N 114.831 -1.077 . . . . 0.0 112.617 -178.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.467 ' O ' ' HA ' ' A' ' 51' ' ' THR . 35.5 m-70 -114.39 141.25 47.88 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 178.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -93.17 134.32 35.46 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -128.98 114.63 16.66 Favored 'General case' 0 C--N 1.29 -2.021 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -92.9 108.09 19.72 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 107.578 -1.267 . . . . 0.0 107.578 177.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.607 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 34.4 m -117.54 163.64 14.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.945 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.869 -176.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.41 ' OE2' ' HD2' ' A' ' 62' ' ' LYS . 11.4 pt-20 -120.67 122.88 41.42 Favored 'General case' 0 N--CA 1.401 -2.915 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.408 175.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -89.43 68.86 7.95 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 107.273 -1.38 . . . . 0.0 107.273 177.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.41 ' HD2' ' OE2' ' A' ' 60' ' ' GLU . 21.8 ptmt -79.78 -20.23 46.74 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.692 -172.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -119.22 144.76 46.56 Favored 'General case' 0 N--CA 1.426 -1.66 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.81 -171.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -71.26 1.05 6.6 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 125.128 1.371 . . . . 0.0 112.78 -177.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -115.79 8.36 14.84 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.421 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 63.3 m 57.57 54.82 6.09 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.229 -1.35 . . . . 0.0 113.187 178.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.538 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -79.96 91.65 5.46 Favored 'General case' 0 CA--C 1.486 -1.502 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 172.098 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.14 108.07 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 CA-C-N 113.027 -1.897 . . . . 0.0 112.583 -175.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 93.4 mt -127.61 143.48 40.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.796 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.607 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 26.7 mt -75.28 160.09 30.75 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.2 p -73.73 -17.5 61.1 Favored 'General case' 0 C--N 1.27 -2.86 0 CA-C-O 122.204 1.002 . . . . 0.0 110.385 -176.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -76.58 -11.58 59.89 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.104 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.2 10.76 50.83 Favored Glycine 0 CA--C 1.494 -1.26 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -108.55 149.86 28.28 Favored 'General case' 0 N--CA 1.428 -1.525 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 -177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -72.48 139.95 47.95 Favored 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.75 158.1 88.43 Favored Pre-proline 0 C--N 1.288 -2.086 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.603 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -49.27 145.02 16.04 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.729 2.953 . . . . 0.0 112.797 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -62.5 -33.97 75.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.296 -179.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.7 p-90 -77.56 -13.59 59.87 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.076 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.422 HD11 HG21 ' A' ' 50' ' ' ILE . 52.3 tp -86.79 101.32 13.22 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 177.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.582 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.77 136.32 41.81 Favored 'General case' 0 C--N 1.294 -1.817 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.198 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -131.46 129.08 40.72 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -126.4 134.39 25.95 Favored Pre-proline 0 C--N 1.3 -1.563 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.176 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.421 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 15.1 Cg_endo -58.07 122.33 11.53 Favored 'Trans proline' 0 C--O 1.255 1.349 0 C-N-CA 124.011 3.141 . . . . 0.0 113.652 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 87.4 t80 . . . . . 0 N--CA 1.421 -1.904 0 CA-C-N 114.572 -1.194 . . . . 0.0 109.368 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.1 t . . . . . 0 C--O 1.242 0.659 0 CA-C-O 121.185 0.517 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 103.34 94.11 2.29 Favored Glycine 0 N--CA 1.418 -2.564 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 65.4 ttt180 -103.89 24.79 10.76 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-O 123.097 1.427 . . . . 0.0 107.476 176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 -83.02 81.83 8.51 Favored 'General case' 0 N--CA 1.422 -1.833 0 CA-C-N 114.403 -1.271 . . . . 0.0 110.645 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 t30 -142.56 103.13 4.19 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 103.777 -2.675 . . . . 0.0 103.777 175.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.4 mp -67.39 87.77 0.19 Allowed 'General case' 0 C--N 1.291 -1.975 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 -173.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.0 t80 -103.13 120.88 41.51 Favored 'General case' 0 N--CA 1.4 -2.946 0 N-CA-C 104.352 -2.462 . . . . 0.0 104.352 168.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -76.5 98.43 4.62 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 122.051 0.929 . . . . 0.0 109.806 -177.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.9 tt0 -78.17 87.1 4.28 Favored 'General case' 0 N--CA 1.399 -2.991 0 CA-C-N 113.583 -1.644 . . . . 0.0 108.879 -178.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.61 50.86 1.81 Allowed Glycine 0 C--N 1.273 -2.932 0 CA-C-N 114.356 -1.293 . . . . 0.0 112.274 176.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 25.4 t-80 -83.43 -29.53 28.02 Favored 'General case' 0 N--CA 1.445 -0.705 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 94.6 mtp -122.22 132.61 54.52 Favored 'General case' 0 CA--C 1.489 -1.381 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.767 172.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -97.05 22.01 9.03 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -137.14 138.3 25.08 Favored Pre-proline 0 N--CA 1.418 -2.037 0 CA-C-N 114.144 -1.389 . . . . 0.0 110.561 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -76.18 127.09 9.65 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.179 1.919 . . . . 0.0 109.559 172.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -82.58 151.14 26.51 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.033 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 64.0 mtt180 -119.15 -14.67 9.28 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.519 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 63.1 m-85 -136.76 168.27 19.85 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 176.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 85.0 m -129.1 137.21 51.1 Favored 'General case' 0 C--N 1.289 -2.065 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 21.9 t -97.4 116.62 40.29 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 -179.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.466 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 47.9 m-85 -97.76 142.95 28.9 Favored 'General case' 0 C--N 1.312 -1.046 0 CA-C-O 120.851 0.357 . . . . 0.0 111.623 -178.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -132.81 150.81 52.12 Favored 'General case' 0 C--N 1.309 -1.19 0 CA-C-N 115.272 -0.876 . . . . 0.0 110.73 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.487 ' O ' ' HA ' ' A' ' 36' ' ' ARG . 5.9 t70 -85.79 102.38 13.62 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 105.778 -1.934 . . . . 0.0 105.778 170.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 103.34 145.03 14.51 Favored Glycine 0 C--N 1.284 -2.335 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -176.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.3 p-80 -109.29 6.99 25.03 Favored 'General case' 0 C--N 1.289 -2.029 0 CA-C-O 121.414 0.626 . . . . 0.0 110.355 -176.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 22.8 tp -105.41 123.1 40.64 Favored Pre-proline 0 C--N 1.292 -1.917 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 -177.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -42.51 -43.62 8.31 Favored 'Trans proline' 0 C--N 1.357 0.977 0 C-N-CA 124.654 3.569 . . . . 0.0 115.59 -173.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.39 -35.69 63.49 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 112.619 0.6 . . . . 0.0 112.619 -178.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.1 m -96.78 -16.81 20.63 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -172.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.487 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 40.1 ptt180 -64.62 132.55 50.08 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 121.324 0.583 . . . . 0.0 111.386 -176.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 54.3 t -113.4 128.31 70.28 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.682 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 176.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.48 129.2 39.58 Favored 'General case' 0 C--N 1.309 -1.169 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -102.06 -62.73 1.23 Allowed 'General case' 0 N--CA 1.437 -1.119 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.342 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.3 ptp -175.93 166.14 3.0 Favored 'General case' 0 CA--C 1.501 -0.939 0 CA-C-O 120.924 0.392 . . . . 0.0 111.205 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -107.57 127.44 53.64 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.586 -1.188 . . . . 0.0 108.432 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 66.7 t -124.58 136.48 60.5 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.951 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 -178.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.404 ' O ' ' HB3' ' A' ' 61' ' ' ALA . 9.9 ttp180 -73.13 139.32 46.32 Favored 'General case' 0 N--CA 1.426 -1.665 0 CA-C-O 121.962 0.887 . . . . 0.0 113.134 -179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 73.1 mt -73.7 106.81 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.796 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 131.12 -16.24 5.26 Favored Glycine 0 N--CA 1.412 -2.912 0 CA-C-N 114.604 -1.18 . . . . 0.0 110.489 -175.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 42.1 p -121.57 164.21 17.63 Favored 'General case' 0 C--O 1.262 1.733 0 CA-C-O 122.146 0.974 . . . . 0.0 111.844 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.4 p -103.75 154.5 19.5 Favored 'General case' 0 N--CA 1.403 -2.813 0 CA-C-N 114.284 -1.326 . . . . 0.0 107.721 172.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.55 147.24 25.95 Favored 'General case' 0 C--N 1.283 -2.319 0 CA-C-O 120.891 0.377 . . . . 0.0 111.113 177.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.9 m -88.46 112.29 22.79 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.857 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 13.1 mm -93.79 146.09 7.02 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.702 0 N-CA-C 104.624 -2.362 . . . . 0.0 104.624 175.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.1 m -125.73 114.97 19.34 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 173.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.69 136.31 25.59 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -177.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 89.8 mtt180 58.67 26.98 15.21 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 124.443 1.097 . . . . 0.0 112.98 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.18 13.95 72.91 Favored Glycine 0 N--CA 1.443 -0.874 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.55 179.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -124.54 138.47 54.33 Favored 'General case' 0 CA--C 1.502 -0.885 0 O-C-N 122.303 -0.528 . . . . 0.0 111.279 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -93.75 131.09 39.44 Favored 'General case' 0 N--CA 1.428 -1.567 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -130.01 110.18 11.45 Favored 'General case' 0 N--CA 1.421 -1.891 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -85.41 108.8 18.03 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.309 -1.357 . . . . 0.0 108.171 172.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 25.8 m -103.44 147.93 9.12 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 115.306 -0.861 . . . . 0.0 109.447 -176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -106.51 112.59 25.66 Favored 'General case' 0 C--N 1.282 -2.359 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.404 ' HB3' ' O ' ' A' ' 43' ' ' ARG . . . -80.92 99.8 8.56 Favored 'General case' 0 C--N 1.311 -1.084 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -99.81 -26.9 13.87 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 116.299 1.963 . . . . 0.0 116.299 -171.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -150.59 159.66 44.34 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 118.886 0.766 . . . . 0.0 109.417 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -74.65 -0.53 18.26 Favored 'General case' 0 C--O 1.219 -0.517 0 N-CA-C 113.639 0.978 . . . . 0.0 113.639 -177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.7 m120 -91.62 2.05 56.73 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 171.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.8 m 47.91 62.11 2.64 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.136 1.774 . . . . 0.0 113.594 177.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -85.52 92.22 8.46 Favored 'General case' 0 CA--C 1.473 -1.985 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -64.14 106.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.418 -2.058 0 CA-C-N 112.337 -2.21 . . . . 0.0 111.311 -178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.46 HG12 ' HG3' ' A' ' 75' ' ' GLN . 92.5 mt -127.55 131.15 70.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.678 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 7.7 mp -86.06 163.21 18.05 Favored 'General case' 0 C--N 1.277 -2.546 0 CA-C-O 121.638 0.732 . . . . 0.0 111.129 -178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 11.6 p -75.46 -7.5 54.27 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 114.383 -1.28 . . . . 0.0 110.347 179.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 -87.56 -0.6 57.08 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.882 -1.054 . . . . 0.0 109.41 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.84 22.45 57.83 Favored Glycine 0 CA--C 1.492 -1.382 0 N-CA-C 110.17 -1.172 . . . . 0.0 110.17 178.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -112.26 137.85 49.79 Favored 'General case' 0 N--CA 1.421 -1.887 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . 0.46 ' HG3' HG12 ' A' ' 69' ' ' ILE . 42.8 tt0 -91.29 34.74 0.94 Allowed 'General case' 0 C--N 1.305 -1.357 0 CA-C-O 121.302 0.572 . . . . 0.0 111.278 -177.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 66.57 158.1 0.13 Allowed Pre-proline 0 C--O 1.242 0.667 0 N-CA-C 114.337 1.236 . . . . 0.0 114.337 174.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -64.29 155.35 66.06 Favored 'Trans proline' 0 N--CA 1.454 -0.832 0 C-N-CA 122.274 1.983 . . . . 0.0 109.322 168.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -66.56 -27.23 67.57 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.618 0.723 . . . . 0.0 111.348 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 63.2 p-90 -77.27 -9.65 58.94 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.499 -0.773 . . . . 0.0 112.393 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.3 tp -88.4 110.26 20.66 Favored 'General case' 0 N--CA 1.43 -1.438 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.54 150.31 28.36 Favored 'General case' 0 C--N 1.307 -1.256 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.457 -174.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.501 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -144.07 131.58 21.05 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 123.628 0.58 . . . . 0.0 110.788 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -119.61 141.09 30.36 Favored Pre-proline 0 C--N 1.312 -1.059 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 176.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -62.93 142.83 89.77 Favored 'Trans proline' 0 C--O 1.257 1.429 0 C-N-CA 123.17 2.58 . . . . 0.0 113.574 -179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 61.7 t80 . . . . . 0 N--CA 1.421 -1.896 0 CA-C-N 115.123 -0.944 . . . . 0.0 108.529 179.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.44 -0.953 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 138.12 3.72 1.89 Allowed Glycine 0 N--CA 1.437 -1.272 0 C-N-CA 119.772 -1.204 . . . . 0.0 112.795 -178.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -83.73 70.28 10.32 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 122.197 0.999 . . . . 0.0 110.54 177.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.494 ' HA ' ' HB2' ' A' ' 13' ' ' TYR . 12.6 pt-20 -126.71 35.29 4.65 Favored 'General case' 0 N--CA 1.412 -2.35 0 CA-C-N 114.039 -1.437 . . . . 0.0 107.714 178.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.3 t30 -66.46 -41.15 89.48 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 112.713 -2.04 . . . . 0.0 108.765 -179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 4.3 tt -137.61 85.81 2.14 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 104.77 -2.307 . . . . 0.0 104.77 173.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.494 ' HB2' ' HA ' ' A' ' 10' ' ' GLU . 68.4 t80 -116.98 127.23 53.99 Favored 'General case' 0 C--N 1.302 -1.476 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 -177.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -98.91 107.8 20.33 Favored 'General case' 0 N--CA 1.421 -1.909 0 CA-C-O 121.427 0.632 . . . . 0.0 109.692 -177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -134.49 101.92 5.14 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 177.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 167.58 148.76 5.78 Favored Glycine 0 C--N 1.269 -3.191 0 N-CA-C 109.923 -1.271 . . . . 0.0 109.923 178.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 64.8 m-70 -96.08 12.13 31.72 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-O 122.305 1.05 . . . . 0.0 108.967 -178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.3 mpt? -123.38 179.89 4.56 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.909 -1.496 . . . . 0.0 107.476 -179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.23 86.7 3.67 Favored 'General case' 0 N--CA 1.425 -1.676 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 168.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -28.6 107.05 0.22 Allowed Pre-proline 0 C--O 1.247 0.946 0 C-N-CA 127.004 2.122 . . . . 0.0 116.141 -172.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -71.37 152.42 60.76 Favored 'Trans proline' 0 N--CA 1.449 -1.096 0 C-N-CA 123.093 2.529 . . . . 0.0 109.76 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.53 131.57 43.46 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.437 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 1.1 mtm180 -97.6 -48.51 5.22 Favored 'General case' 0 C--N 1.294 -1.846 0 CA-C-O 121.735 0.779 . . . . 0.0 109.078 -177.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.1 m-85 -124.56 176.19 6.69 Favored 'General case' 0 C--N 1.288 -2.087 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.41 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 27.3 t -132.02 139.0 48.45 Favored 'General case' 0 C--N 1.268 -2.952 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 170.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.35 124.81 66.34 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 -175.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.572 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 79.6 m-85 -104.27 138.68 40.37 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.136 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.405 ' HB2' ' HB3' ' A' ' 81' ' ' ALA . 83.8 m-85 -131.7 154.42 49.01 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.038 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.42 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 7.4 t70 -87.87 112.23 22.28 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 173.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 110.51 140.72 8.6 Favored Glycine 0 N--CA 1.422 -2.261 0 N-CA-C 110.132 -1.187 . . . . 0.0 110.132 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -97.24 1.75 50.04 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-O 121.302 0.572 . . . . 0.0 110.6 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.405 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 33.7 tp -96.6 117.74 65.76 Favored Pre-proline 0 N--CA 1.423 -1.786 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 179.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -67.46 -5.9 15.16 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 123.212 2.608 . . . . 0.0 113.171 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -79.6 -60.88 2.18 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.313 178.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.6 p -110.68 15.89 21.73 Favored 'General case' 0 C--N 1.311 -1.098 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -171.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -66.23 149.12 50.82 Favored 'General case' 0 C--O 1.256 1.4 0 CA-C-O 121.034 0.445 . . . . 0.0 111.551 -179.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.6 t -105.83 129.61 58.64 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.071 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.83 -177.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -59.85 128.49 37.18 Favored 'General case' 0 C--N 1.315 -0.931 0 C-N-CA 122.675 0.39 . . . . 0.0 111.176 178.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.2 mt -107.11 -62.65 1.38 Allowed 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.516 177.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 4.6 mtp -162.39 166.24 25.38 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 121.51 0.672 . . . . 0.0 112.575 -176.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 73.0 m-85 -116.45 130.84 56.98 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-N 113.448 -1.706 . . . . 0.0 108.187 176.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 61.6 t -125.4 134.83 65.81 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 25.9 tpt180 -69.1 132.51 46.71 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 177.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 35.1 mm -62.21 117.72 3.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.418 0.627 . . . . 0.0 109.663 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.82 -11.27 18.22 Favored Glycine 0 N--CA 1.423 -2.199 0 CA-C-N 114.686 -1.143 . . . . 0.0 111.296 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.6 p -114.05 164.91 13.2 Favored 'General case' 0 C--O 1.26 1.628 0 CA-C-O 121.878 0.847 . . . . 0.0 112.169 -176.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 34.7 p -99.82 156.07 17.31 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-N 114.078 -1.419 . . . . 0.0 108.452 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.44 152.8 26.19 Favored 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.783 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 3.1 m -98.89 105.85 18.04 Favored 'General case' 0 N--CA 1.424 -1.73 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.767 -178.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.1 mm -94.41 143.66 11.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 177.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.7 m -123.65 113.5 18.73 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.04 134.82 21.19 Favored 'General case' 0 N--CA 1.429 -1.502 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.698 -178.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 59.53 26.49 15.49 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 124.765 1.226 . . . . 0.0 113.383 175.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 89.17 10.1 66.56 Favored Glycine 0 N--CA 1.437 -1.268 0 CA-C-N 114.968 -1.014 . . . . 0.0 112.431 178.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 40.9 m-70 -122.25 135.43 54.75 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 122.259 -0.553 . . . . 0.0 110.363 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -100.26 113.25 25.79 Favored 'General case' 0 C--N 1.31 -1.125 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 174.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.8 m-85 -102.64 114.52 28.83 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 -178.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -86.12 107.19 17.73 Favored 'General case' 0 N--CA 1.422 -1.858 0 N-CA-C 104.421 -2.437 . . . . 0.0 104.421 174.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.462 HG12 ' CD2' ' A' ' 70' ' ' LEU . 21.5 m -103.33 153.69 5.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.405 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.275 -172.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -118.24 105.94 12.29 Favored 'General case' 0 C--N 1.276 -2.594 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 175.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -91.5 79.42 5.53 Favored 'General case' 0 CA--C 1.502 -0.876 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.6 ptmt -85.08 -20.32 30.55 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 115.019 1.488 . . . . 0.0 115.019 -170.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -136.4 155.5 49.94 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 119.787 -0.765 . . . . 0.0 110.179 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -62.71 -14.09 40.17 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 112.12 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -71.04 -14.27 62.27 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 123.084 0.553 . . . . 0.0 109.73 176.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 45.0 m 67.34 33.16 5.5 Favored 'General case' 0 CA--C 1.492 -1.272 0 CA-C-N 115.169 -0.923 . . . . 0.0 109.065 -172.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.558 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -64.81 89.78 0.07 Allowed 'General case' 0 N--CA 1.412 -2.356 0 CA-C-N 113.627 -1.624 . . . . 0.0 107.433 174.776 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.5 p -91.14 110.32 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.289 0 CA-C-N 114.882 -1.054 . . . . 0.0 113.004 -174.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.2 mp -119.51 140.09 44.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.004 0 N-CA-C 103.82 -2.659 . . . . 0.0 103.82 171.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.462 ' CD2' HG12 ' A' ' 59' ' ' VAL . 33.4 mt -79.39 170.14 17.04 Favored 'General case' 0 C--N 1.291 -1.952 0 C-N-CA 119.375 -0.93 . . . . 0.0 109.683 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.9 p -66.67 -25.34 66.52 Favored 'General case' 0 C--N 1.276 -2.593 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.657 -176.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.4 m-80 -83.91 0.88 46.0 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.677 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.46 21.87 61.41 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -104.14 154.01 20.25 Favored 'General case' 0 N--CA 1.412 -2.347 0 CA-C-N 114.945 -0.627 . . . . 0.0 110.172 -175.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -73.38 152.57 40.79 Favored 'General case' 0 C--N 1.302 -1.468 0 CA-C-N 115.159 -0.928 . . . . 0.0 109.393 -179.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -88.12 145.24 35.77 Favored Pre-proline 0 C--N 1.281 -2.374 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.084 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -50.74 148.05 16.88 Favored 'Trans proline' 0 C--O 1.244 0.797 0 C-N-CA 123.725 2.95 . . . . 0.0 112.81 175.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -71.9 -28.76 63.71 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.252 0.548 . . . . 0.0 110.272 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -81.43 -7.68 59.62 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.598 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.2 tp -87.64 113.89 23.74 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.827 -1.545 . . . . 0.0 106.827 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.74 137.75 37.78 Favored 'General case' 0 C--N 1.292 -1.899 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 -177.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.41 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -130.0 129.88 44.29 Favored 'General case' 0 C--N 1.295 -1.768 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -132.27 132.65 23.06 Favored Pre-proline 0 C--N 1.303 -1.453 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 178.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -65.53 129.33 22.22 Favored 'Trans proline' 0 C--O 1.238 0.489 0 C-N-CA 123.165 2.577 . . . . 0.0 111.859 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.447 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 33.6 t80 . . . . . 0 C--N 1.295 -1.782 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 -179.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.2 m . . . . . 0 N--CA 1.436 -1.133 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 84.03 -67.32 3.73 Favored Glycine 0 N--CA 1.442 -0.948 0 C-N-CA 121.692 -0.29 . . . . 0.0 113.455 174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 61.28 83.71 0.14 Allowed 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 124.776 1.231 . . . . 0.0 111.809 -176.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.4 173.19 13.81 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 104.948 -2.241 . . . . 0.0 104.948 -179.864 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 33.9 m-80 -77.5 -76.32 0.18 Allowed 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 117.945 0.339 . . . . 0.0 111.5 -177.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -113.41 141.73 46.73 Favored 'General case' 0 C--N 1.31 -1.113 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 179.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -101.51 84.07 2.54 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.495 0.664 . . . . 0.0 111.605 -178.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -70.21 127.47 32.9 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.209 -179.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 25.5 mp0 60.48 18.4 8.19 Favored 'General case' 0 N--CA 1.425 -1.686 0 C-N-CA 125.337 1.455 . . . . 0.0 112.447 -173.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.88 -31.28 15.49 Favored Glycine 0 C--N 1.307 -1.083 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -158.22 162.86 37.89 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.485 -2.043 . . . . 0.0 105.485 176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 64.8 mtt -73.7 163.24 28.24 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 121.74 0.781 . . . . 0.0 112.805 -177.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -117.71 35.05 4.86 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.77 158.06 88.83 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.813 -178.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_exo -42.6 120.46 1.76 Allowed 'Trans proline' 0 C--N 1.365 1.431 0 C-N-CA 124.113 3.208 . . . . 0.0 112.583 176.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.86 131.85 43.59 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.56 -178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 50.3 mtp180 -102.38 -40.24 6.81 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 83.7 m-85 -118.9 176.58 5.22 Favored 'General case' 0 N--CA 1.418 -2.06 0 CA-C-N 114.709 -1.132 . . . . 0.0 108.153 177.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -139.91 140.75 36.49 Favored 'General case' 0 C--N 1.265 -3.108 0 N-CA-C 105.455 -2.054 . . . . 0.0 105.455 175.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.412 HG23 ' HB2' ' A' ' 85' ' ' TYR . 11.9 t -115.06 141.67 30.9 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.692 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 -175.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 89.7 m-85 -112.11 135.67 52.47 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 109.773 -0.454 . . . . 0.0 109.773 179.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -128.39 156.12 43.65 Favored 'General case' 0 C--N 1.293 -1.86 0 O-C-N 124.038 0.836 . . . . 0.0 110.27 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.445 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 19.7 t70 -89.94 103.55 16.2 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.77 147.02 12.17 Favored Glycine 0 C--N 1.287 -2.176 0 N-CA-C 110.632 -0.987 . . . . 0.0 110.632 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -91.06 -5.67 54.91 Favored 'General case' 0 C--N 1.296 -1.74 0 O-C-N 122.763 -0.257 . . . . 0.0 111.279 -177.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 tp -86.66 110.89 35.81 Favored Pre-proline 0 N--CA 1.434 -1.249 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 -174.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.449 ' HA ' ' CZ ' ' A' ' 36' ' ' ARG . 84.9 Cg_exo -38.48 -54.3 1.55 Allowed 'Trans proline' 0 N--CA 1.481 0.79 1 C-N-CA 125.638 4.225 . . . . 0.0 116.144 -172.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.17 -34.04 24.08 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.5 m -94.03 -2.69 52.58 Favored 'General case' 0 CA--C 1.555 1.155 0 CA-C-O 121.501 0.667 . . . . 0.0 112.442 -172.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.449 ' CZ ' ' HA ' ' A' ' 33' ' ' PRO . 36.0 ptt180 -77.64 148.01 35.27 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 121.089 0.471 . . . . 0.0 112.256 -178.489 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 23.8 t -94.36 143.22 12.12 Favored 'Isoleucine or valine' 0 C--O 1.208 -1.112 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.374 -177.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -73.06 129.41 38.01 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 81.6 mt -112.68 -62.64 1.55 Allowed 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 5.6 mtp -152.52 167.73 27.85 Favored 'General case' 0 CA--C 1.481 -1.675 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 -173.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -124.06 135.75 53.79 Favored 'General case' 0 C--N 1.296 -1.743 0 CA-C-N 113.655 -1.611 . . . . 0.0 108.286 176.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.5 t -142.0 140.43 29.92 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.074 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.414 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 50.2 ttp85 -79.37 143.96 34.6 Favored 'General case' 0 C--O 1.259 1.604 0 CA-C-O 121.499 0.666 . . . . 0.0 111.72 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 37.3 mm -64.62 125.21 21.0 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.57 -178.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.14 -23.3 23.49 Favored Glycine 0 N--CA 1.426 -2.027 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.818 -178.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.1 p -108.87 163.6 13.14 Favored 'General case' 0 N--CA 1.437 -1.114 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.7 p -99.28 158.78 15.46 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.956 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.27 153.48 25.64 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.533 178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.4 m -95.53 111.35 23.28 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.759 177.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.3 mm -94.71 146.42 6.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 43.2 m -135.25 112.45 10.44 Favored 'General case' 0 C--N 1.27 -2.859 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 176.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -143.23 133.32 24.32 Favored 'General case' 0 C--N 1.309 -1.194 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -178.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.6 mtm180 62.99 26.08 15.35 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 125.304 1.441 . . . . 0.0 110.0 -177.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.3 4.86 89.19 Favored Glycine 0 N--CA 1.438 -1.229 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.965 -178.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 55.2 m-70 -98.83 132.25 44.32 Favored 'General case' 0 CA--C 1.505 -0.764 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -98.83 113.76 26.02 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -105.87 113.81 27.59 Favored 'General case' 0 N--CA 1.42 -1.94 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -87.89 107.59 18.76 Favored 'General case' 0 N--CA 1.422 -1.85 0 N-CA-C 104.811 -2.292 . . . . 0.0 104.811 175.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 17.3 m -109.57 157.87 9.81 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.066 -172.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -121.21 121.54 38.01 Favored 'General case' 0 C--N 1.281 -2.402 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 173.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.79 89.66 3.44 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -60.11 -57.92 10.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.536 -1.211 . . . . 0.0 112.894 -169.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -152.72 168.58 25.2 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.153 -172.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.461 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 88.1 mt-30 -59.32 -19.98 50.86 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.641 1.176 . . . . 0.0 112.538 -176.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -69.42 -17.84 63.69 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 120.884 0.373 . . . . 0.0 111.217 177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 47.7 m 58.72 69.43 0.73 Allowed 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.661 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -107.19 119.32 39.07 Favored 'General case' 0 N--CA 1.393 -3.28 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 171.338 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.426 HG13 ' HB3' ' A' ' 76' ' ' ALA . 5.8 p -82.69 97.43 4.24 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-O 122.488 1.137 . . . . 0.0 113.489 -174.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.8 mp -110.62 136.0 47.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.557 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 174.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.526 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 32.2 mt -82.38 179.65 7.72 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-O 121.982 0.896 . . . . 0.0 110.106 -178.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.3 p -74.72 -18.01 60.57 Favored 'General case' 0 C--N 1.275 -2.646 0 CA-C-N 114.291 -1.322 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 45.3 m-80 -83.04 -3.33 57.15 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.234 178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.99 14.6 76.91 Favored Glycine 0 CA--C 1.49 -1.481 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -99.72 142.69 30.86 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.314 -0.943 . . . . 0.0 108.508 -177.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -81.3 136.35 35.77 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 106.834 -1.543 . . . . 0.0 106.834 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.426 ' HB3' HG13 ' A' ' 68' ' ' VAL . . . -67.96 162.43 59.23 Favored Pre-proline 0 C--N 1.29 -1.987 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.265 -177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -54.31 150.24 34.03 Favored 'Trans proline' 0 C--N 1.353 0.777 0 C-N-CA 123.333 2.688 . . . . 0.0 112.273 178.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -51.36 -37.13 46.45 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 124.916 1.286 . . . . 0.0 112.729 -177.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.3 p-90 -78.2 -12.96 60.03 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.47 -0.786 . . . . 0.0 112.726 -176.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 39.7 tp -88.22 100.5 13.03 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.6 125.51 45.43 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.448 -172.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -104.55 129.69 52.59 Favored 'General case' 0 C--N 1.308 -1.236 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -123.17 130.23 24.64 Favored Pre-proline 0 C--N 1.299 -1.605 0 C-N-CA 124.108 0.963 . . . . 0.0 110.79 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.461 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 49.3 Cg_endo -66.92 129.13 20.09 Favored 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.818 2.346 . . . . 0.0 111.499 179.292 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.412 ' HB2' HG23 ' A' ' 26' ' ' VAL . 68.9 t80 . . . . . 0 N--CA 1.423 -1.809 0 CA-C-O 117.655 -1.164 . . . . 0.0 110.157 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.3 t . . . . . 0 C--O 1.245 0.858 0 N-CA-C 107.701 -1.222 . . . . 0.0 107.701 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.51 142.16 40.12 Favored Glycine 0 N--CA 1.439 -1.148 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -179.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 77.5 mtt180 -114.8 96.49 5.75 Favored 'General case' 0 N--CA 1.419 -2.0 0 CA-C-O 121.214 0.531 . . . . 0.0 109.928 -177.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -62.78 100.42 0.2 Allowed 'General case' 0 C--N 1.283 -2.299 0 CA-C-N 114.054 -1.43 . . . . 0.0 109.699 174.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -119.31 3.86 11.29 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.519 -173.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 37.3 tp -86.02 95.23 9.45 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 86.7 m-85 -94.34 122.74 37.21 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.146 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -79.35 107.28 12.0 Favored 'General case' 0 C--N 1.297 -1.677 0 CA-C-O 121.366 0.603 . . . . 0.0 111.388 -177.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -106.58 80.7 1.5 Allowed 'General case' 0 N--CA 1.427 -1.603 0 N-CA-C 107.383 -1.34 . . . . 0.0 107.383 174.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -89.71 -34.18 8.62 Favored Glycine 0 C--N 1.282 -2.43 0 CA-C-N 114.79 -1.095 . . . . 0.0 110.547 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -71.34 103.83 2.99 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.2 mtt -125.28 -178.3 4.17 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -178.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.5 27.1 1.14 Allowed 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 123.322 0.649 . . . . 0.0 109.608 175.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 73.58 128.19 0.03 OUTLIER Pre-proline 0 C--O 1.24 0.591 0 C-N-CA 126.448 1.899 . . . . 0.0 110.142 -173.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -65.06 121.18 8.58 Favored 'Trans proline' 0 N--CA 1.448 -1.158 0 C-N-CA 121.697 1.598 . . . . 0.0 110.92 179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.44 141.1 50.27 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.433 -1.321 . . . . 0.0 107.433 177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.442 ' O ' ' HD3' ' A' ' 43' ' ' ARG . 97.4 mtt180 -95.72 -30.58 13.66 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-O 121.835 0.826 . . . . 0.0 109.396 -174.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -139.45 166.31 24.91 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.26 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.606 ' SG ' HD11 ' A' ' 44' ' ' ILE . 52.1 m -119.91 133.8 55.45 Favored 'General case' 0 C--N 1.28 -2.42 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 166.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.497 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.3 t -96.64 122.72 48.44 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.716 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.454 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.4 m-85 -102.8 141.53 35.46 Favored 'General case' 0 C--N 1.31 -1.134 0 O-C-N 123.584 0.552 . . . . 0.0 111.121 179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -131.19 148.53 52.72 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.129 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -91.46 99.46 12.4 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.568 -1.196 . . . . 0.0 108.985 174.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 146.91 129.06 1.94 Allowed Glycine 0 N--CA 1.416 -2.687 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.748 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -76.34 -5.89 49.15 Favored 'General case' 0 C--N 1.286 -2.165 0 CA-C-N 113.947 -1.126 . . . . 0.0 111.253 -177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.529 ' HB3' HG22 ' A' ' 35' ' ' THR . 19.0 tp -137.99 138.99 24.69 Favored Pre-proline 0 N--CA 1.411 -2.42 0 O-C-N 121.228 -0.92 . . . . 0.0 108.549 -173.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.487 ' HD2' HD12 ' A' ' 32' ' ' LEU . 24.6 Cg_endo -62.58 -8.19 12.53 Favored 'Trans proline' 0 N--CA 1.479 0.65 0 C-N-CA 123.54 2.827 . . . . 0.0 112.795 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.33 -7.59 41.35 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 178.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.529 HG22 ' HB3' ' A' ' 32' ' ' LEU . 13.2 t -135.58 8.48 3.34 Favored 'General case' 0 CA--C 1.546 0.824 0 CA-C-O 121.202 0.525 . . . . 0.0 110.887 -175.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -81.39 140.44 34.7 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 113.164 0.801 . . . . 0.0 113.164 -170.106 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 97.7 t -115.04 135.09 56.05 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.242 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -67.2 126.29 28.75 Favored 'General case' 0 C--N 1.31 -1.151 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -100.37 -63.1 1.16 Allowed 'General case' 0 N--CA 1.445 -0.692 0 C-N-CA 119.901 -0.72 . . . . 0.0 111.617 178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.6 ptm -178.43 167.09 1.86 Allowed 'General case' 0 CA--C 1.496 -1.097 0 CA-C-O 121.11 0.481 . . . . 0.0 110.662 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -104.54 139.46 39.4 Favored 'General case' 0 C--N 1.29 -2.021 0 CA-C-N 114.492 -1.231 . . . . 0.0 108.027 179.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 87.2 t -122.59 130.69 74.32 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 10.6 tpp180 -66.63 130.32 42.78 Favored 'General case' 0 C--O 1.25 1.09 0 C-N-CA 123.713 0.805 . . . . 0.0 110.705 -179.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.606 HD11 ' SG ' ' A' ' 25' ' ' CYS . 45.2 mm -63.54 116.35 3.18 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 CA-C-O 121.728 0.775 . . . . 0.0 110.564 177.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 114.85 -12.24 20.44 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.556 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -115.61 163.84 15.2 Favored 'General case' 0 C--O 1.261 1.692 0 CA-C-O 121.636 0.732 . . . . 0.0 112.078 -177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.3 p -99.86 153.64 18.99 Favored 'General case' 0 N--CA 1.414 -2.246 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 171.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.72 150.58 27.75 Favored 'General case' 0 C--N 1.276 -2.595 0 CA-C-O 121.01 0.433 . . . . 0.0 110.477 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.9 m -93.0 117.98 30.66 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.977 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 20.0 mm -93.76 144.68 9.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 104.046 -2.575 . . . . 0.0 104.046 173.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 24.2 m -132.49 109.6 9.91 Favored 'General case' 0 C--N 1.259 -3.347 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 -178.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -144.36 135.41 25.24 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 52.1 mtm180 63.23 26.15 15.06 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.292 1.437 . . . . 0.0 111.076 -178.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.4 2.6 84.6 Favored Glycine 0 C--N 1.304 -1.232 0 CA-C-N 115.349 -0.841 . . . . 0.0 111.845 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 43.5 m-70 -97.12 132.62 42.73 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -101.97 113.72 27.2 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -104.63 112.29 25.32 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.6 tp10 -87.1 107.46 18.45 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 106.753 -1.573 . . . . 0.0 106.753 176.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.46 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.1 m -107.91 141.07 24.08 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.74 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.855 -174.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -107.13 112.39 25.27 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 175.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -87.54 84.76 7.09 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 176.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 18.5 ptpt -83.65 -20.27 33.91 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 -172.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -142.21 146.41 35.18 Favored 'General case' 0 N--CA 1.431 -1.421 0 C-N-CA 119.222 -0.991 . . . . 0.0 110.537 -176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -1.1 2.33 Favored 'General case' 0 C--O 1.22 -0.488 0 N-CA-C 114.587 1.329 . . . . 0.0 114.587 -178.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -96.69 11.37 35.7 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 175.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 79.3 m 63.7 42.74 6.06 Favored 'General case' 0 CA--C 1.503 -0.852 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.392 177.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.586 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.5 OUTLIER -81.41 91.65 6.32 Favored 'General case' 0 CA--C 1.483 -1.608 0 CA-C-O 122.605 1.193 . . . . 0.0 108.465 172.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.45 HG23 ' HB ' ' A' ' 59' ' ' VAL . 3.6 p -89.47 110.06 21.18 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.401 0 CA-C-N 112.069 -2.332 . . . . 0.0 111.792 -176.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 mp -122.5 128.94 75.55 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 106.69 -1.596 . . . . 0.0 106.69 174.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.46 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.6 mp -81.7 157.91 24.42 Favored 'General case' 0 N--CA 1.423 -1.817 0 N-CA-C 109.406 -0.591 . . . . 0.0 109.406 -177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.2 p -65.84 -21.05 66.45 Favored 'General case' 0 C--N 1.284 -2.252 0 CA-C-N 115.236 -0.893 . . . . 0.0 112.415 -174.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 48.8 m-80 -89.81 4.68 49.05 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.698 179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 87.37 20.91 50.68 Favored Glycine 0 N--CA 1.435 -1.431 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.7 mmtp -93.31 139.94 30.09 Favored 'General case' 0 N--CA 1.418 -2.064 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 25.8 mt-30 -94.61 28.54 2.6 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.655 -175.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.48 139.71 0.07 OUTLIER Pre-proline 0 C--O 1.244 0.808 0 C-N-CA 125.612 1.565 . . . . 0.0 114.613 175.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -53.45 148.64 33.27 Favored 'Trans proline' 0 C--N 1.363 1.297 0 C-N-CA 123.604 2.87 . . . . 0.0 111.292 174.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 44.6 m-20 -70.63 -27.54 64.14 Favored 'General case' 0 C--N 1.306 -1.319 0 CA-C-O 121.301 0.572 . . . . 0.0 111.121 -176.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 62.2 p-90 -84.82 -9.44 58.16 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.214 179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.4 tp -87.55 106.64 18.14 Favored 'General case' 0 N--CA 1.43 -1.456 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.87 145.89 29.11 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -176.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -138.52 140.59 39.19 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.75 138.34 21.54 Favored Pre-proline 0 C--N 1.297 -1.7 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 176.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -64.63 134.4 40.87 Favored 'Trans proline' 0 C--O 1.242 0.712 0 C-N-CA 123.631 2.887 . . . . 0.0 113.38 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 t80 . . . . . 0 N--CA 1.417 -2.124 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 177.522 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 m . . . . . 0 CA--C 1.553 1.062 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -108.98 12.92 34.49 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 119.854 -1.165 . . . . 0.0 114.179 -176.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -101.86 82.39 2.25 Favored 'General case' 0 CA--C 1.495 -1.147 0 CA-C-N 117.225 0.512 . . . . 0.0 111.593 179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 44.32 90.73 0.01 OUTLIER 'General case' 0 C--N 1.311 -1.105 0 C-N-CA 126.906 2.082 . . . . 0.0 115.333 173.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 14.0 m120 -125.91 4.97 7.3 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.585 -177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.53 125.9 43.9 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 121.262 0.553 . . . . 0.0 111.119 -176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -85.6 85.55 7.41 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.748 0.785 . . . . 0.0 109.221 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -152.62 149.57 28.59 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 105.464 -2.051 . . . . 0.0 105.464 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -88.62 81.7 7.03 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 122.368 1.08 . . . . 0.0 109.272 -177.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.81 -139.52 14.47 Favored Glycine 0 N--CA 1.426 -1.999 0 CA-C-N 112.829 -1.987 . . . . 0.0 109.287 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -167.07 123.13 1.14 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 176.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.48 ' HG2' ' H ' ' A' ' 20' ' ' ALA . 55.2 ttm -132.39 120.83 22.56 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 -178.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -89.9 14.97 10.75 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.165 0.507 . . . . 0.0 111.101 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.48 ' H ' ' HG2' ' A' ' 18' ' ' MET . . . 65.27 98.82 0.04 OUTLIER Pre-proline 0 C--N 1.308 -1.232 0 C-N-CA 125.676 1.59 . . . . 0.0 111.545 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_exo -65.22 -63.78 0.06 OUTLIER 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.156 2.571 . . . . 0.0 113.412 -179.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.92 116.14 11.96 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 120.91 0.386 . . . . 0.0 110.728 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 76.7 mtt180 -121.32 4.56 10.26 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.782 -178.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.445 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 71.5 m-85 -139.49 154.87 47.8 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 176.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 78.9 m -126.2 143.95 50.95 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 176.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.0 t -106.06 125.26 61.65 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.316 0 N-CA-C 108.191 -1.04 . . . . 0.0 108.191 178.013 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 15.2 m-85 -99.2 138.04 36.86 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-O 120.903 0.383 . . . . 0.0 110.388 178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -131.31 148.56 52.69 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.686 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 13.4 t70 -89.15 105.24 17.66 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.208 -1.404 . . . . 0.0 107.208 173.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.69 144.61 7.09 Favored Glycine 0 C--N 1.283 -2.364 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -111.54 13.88 21.35 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-O 122.179 0.99 . . . . 0.0 109.11 -178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 32.1 tp -118.4 121.63 30.89 Favored Pre-proline 0 N--CA 1.423 -1.799 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -60.64 -18.29 54.21 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.217 2.611 . . . . 0.0 114.452 -174.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.59 -33.72 60.6 Favored 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.8 t -126.17 23.38 7.07 Favored 'General case' 0 C--N 1.32 -0.679 0 C-N-CA 120.056 -0.658 . . . . 0.0 111.969 -172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.17 123.47 25.32 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 42.1 t -99.67 127.15 52.78 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -62.72 122.38 15.75 Favored 'General case' 0 C--N 1.311 -1.071 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 94.6 mt -102.17 -62.75 1.22 Allowed 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 120.417 -0.513 . . . . 0.0 111.507 179.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.1 ptm -173.52 164.81 4.58 Favored 'General case' 0 CA--C 1.504 -0.793 0 CA-C-O 121.161 0.505 . . . . 0.0 111.868 -174.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -104.28 146.47 28.76 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-N 114.56 -1.2 . . . . 0.0 108.394 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 89.4 t -137.32 138.47 45.13 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.159 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 -179.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.437 ' HD3' ' CE2' ' A' ' 24' ' ' PHE . 12.8 tpt180 -80.06 128.12 33.11 Favored 'General case' 0 C--N 1.312 -1.038 0 C-N-CA 123.839 0.856 . . . . 0.0 109.082 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.491 HD13 ' HA ' ' A' ' 64' ' ' GLN . 60.0 mt -67.04 124.58 22.61 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.827 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.79 -8.18 31.8 Favored Glycine 0 N--CA 1.425 -2.04 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 -174.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 82.6 p -119.57 162.28 19.21 Favored 'General case' 0 C--O 1.257 1.468 0 CA-C-O 121.209 0.528 . . . . 0.0 110.382 177.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.461 HG22 ' HB3' ' A' ' 60' ' ' GLU . 32.2 p -100.74 152.92 19.91 Favored 'General case' 0 N--CA 1.414 -2.225 0 CA-C-N 115.1 -0.955 . . . . 0.0 108.534 173.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.82 145.19 22.06 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.083 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 91.3 m -92.6 115.47 28.13 Favored 'General case' 0 N--CA 1.418 -2.049 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.542 177.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.78 146.76 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.546 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 60.5 m -129.06 116.15 18.85 Favored 'General case' 0 C--N 1.275 -2.66 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.16 177.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -140.5 133.18 28.84 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 40.5 mtm180 60.09 25.57 14.87 Favored 'General case' 0 N--CA 1.482 1.161 0 C-N-CA 125.465 1.506 . . . . 0.0 110.226 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 79.67 9.69 86.56 Favored Glycine 0 C--N 1.301 -1.382 0 CA-C-N 114.943 -1.026 . . . . 0.0 113.139 -178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' THR . 21.3 m-70 -101.9 136.38 41.84 Favored 'General case' 0 C--O 1.242 0.666 0 CA-C-N 117.338 0.569 . . . . 0.0 109.516 179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -89.84 132.06 35.45 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 85.8 m-85 -124.64 110.65 14.67 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 107.817 -1.179 . . . . 0.0 107.817 175.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -85.8 108.14 17.96 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 106.489 -1.671 . . . . 0.0 106.489 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.4 m -106.45 151.88 8.27 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.915 0 CA-C-N 116.024 -0.534 . . . . 0.0 109.73 -175.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.47 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 12.0 pt-20 -118.48 115.07 23.86 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.402 ' CB ' ' HA ' ' A' ' 44' ' ' ILE . . . -76.54 113.06 13.74 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.496 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.47 ' HD3' ' HG3' ' A' ' 60' ' ' GLU . 30.6 mmmt -98.94 -58.42 1.95 Allowed 'General case' 0 CA--C 1.52 -0.208 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 -171.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -121.11 153.36 37.58 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.416 -167.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.491 ' HA ' HD13 ' A' ' 44' ' ' ILE . 11.1 pt20 -65.21 -8.72 18.64 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 124.39 1.076 . . . . 0.0 113.151 -177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 45.5 m-80 -96.54 10.75 37.45 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.826 0.822 . . . . 0.0 108.927 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 98.7 m 54.61 69.68 0.7 Allowed 'General case' 0 CA--C 1.492 -1.278 0 CA-C-N 113.932 -1.486 . . . . 0.0 114.075 178.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.517 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.2 OUTLIER -99.15 119.85 38.53 Favored 'General case' 0 N--CA 1.425 -1.701 0 CA-C-N 114.165 -1.379 . . . . 0.0 108.017 173.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.6 p -92.17 101.19 12.31 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 CA-C-N 113.971 -1.468 . . . . 0.0 112.846 -174.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.415 HG22 ' O ' ' A' ' 70' ' ' LEU . 3.4 mp -113.49 135.38 53.24 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.735 0 N-CA-C 106.31 -1.737 . . . . 0.0 106.31 174.338 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 24.7 mt -81.64 177.07 9.13 Favored 'General case' 0 N--CA 1.423 -1.776 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.9 p -73.49 -20.34 60.71 Favored 'General case' 0 C--N 1.275 -2.632 0 CA-C-N 114.15 -1.386 . . . . 0.0 109.021 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.456 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER -76.69 -11.52 59.86 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 113.749 -1.569 . . . . 0.0 109.209 -179.882 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.32 6.74 68.28 Favored Glycine 0 CA--C 1.495 -1.188 0 N-CA-C 110.223 -1.151 . . . . 0.0 110.223 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -109.39 152.19 25.66 Favored 'General case' 0 N--CA 1.428 -1.562 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 -176.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 99.3 mt-30 -85.9 172.31 10.82 Favored 'General case' 0 C--N 1.28 -2.42 0 CA-C-O 121.083 0.468 . . . . 0.0 111.266 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -82.66 152.41 66.52 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.318 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -58.87 157.41 28.73 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 123.473 2.782 . . . . 0.0 110.751 175.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -50.48 -42.51 54.68 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.214 1.005 . . . . 0.0 111.949 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -75.57 -21.64 57.68 Favored 'General case' 0 C--N 1.297 -1.692 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.017 -175.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.7 tp -90.24 110.61 21.65 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -120.88 147.02 45.98 Favored 'General case' 0 C--N 1.306 -1.307 0 C-N-CA 120.03 -0.668 . . . . 0.0 111.668 -172.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -134.97 129.34 34.06 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 177.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 84' ' ' PRO . 8.2 pt-20 -128.91 148.18 67.76 Favored Pre-proline 0 N--CA 1.422 -1.836 0 O-C-N 123.053 0.221 . . . . 0.0 110.712 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 82.8 Cg_exo -50.26 134.56 37.88 Favored 'Trans proline' 0 C--O 1.253 1.233 0 C-N-CA 124.773 3.649 . . . . 0.0 114.598 -178.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.445 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 81.4 t80 . . . . . 0 N--CA 1.424 -1.746 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 175.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.3 p . . . . . 0 N--CA 1.438 -1.07 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.45 45.11 0.02 OUTLIER Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.081 -1.057 . . . . 0.0 112.099 -178.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 31.7 ttp180 -126.67 29.03 5.78 Favored 'General case' 0 C--N 1.306 -1.287 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 175.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.82 97.09 3.21 Favored 'General case' 0 N--CA 1.415 -2.188 0 CA-C-N 113.777 -1.556 . . . . 0.0 109.386 -175.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -138.74 73.22 1.43 Allowed 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 106.761 -1.57 . . . . 0.0 106.761 174.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.9 tp -66.8 119.12 11.32 Favored 'General case' 0 N--CA 1.424 -1.744 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 175.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -61.44 122.74 15.95 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.67 -179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -81.33 105.23 12.36 Favored 'General case' 0 N--CA 1.414 -2.248 0 CA-C-O 121.751 0.786 . . . . 0.0 109.934 178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -82.66 69.25 9.4 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-O 122.79 1.281 . . . . 0.0 110.173 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -97.99 101.02 2.45 Favored Glycine 0 N--CA 1.413 -2.898 0 CA-C-N 113.511 -1.677 . . . . 0.0 110.815 -178.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -79.04 105.26 10.25 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 25.6 mmt -97.94 149.46 22.39 Favored 'General case' 0 C--N 1.291 -1.941 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.899 -170.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -104.26 19.89 19.37 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 173.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 65.98 81.51 0.21 Allowed Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 113.14 -1.845 . . . . 0.0 112.194 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 43.3 Cg_endo -72.26 -16.05 28.24 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 122.243 1.962 . . . . 0.0 110.367 175.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -139.94 135.47 32.83 Favored 'General case' 0 N--CA 1.433 -1.293 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 177.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 67.3 mtt180 -115.65 -28.97 6.59 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.482 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.439 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 54.6 m-85 -127.17 172.56 10.45 Favored 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.033 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 96.8 m -126.3 134.57 51.1 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 171.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 5.5 t -96.21 117.65 40.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 N-CA-C 107.829 -1.174 . . . . 0.0 107.829 -179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.438 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 39.2 m-85 -97.4 145.53 26.07 Favored 'General case' 0 C--O 1.249 1.066 0 O-C-N 123.439 0.462 . . . . 0.0 111.541 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.505 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 62.6 m-85 -138.04 158.46 44.29 Favored 'General case' 0 C--N 1.307 -1.267 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.1 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -96.85 113.97 25.55 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 106.445 -1.687 . . . . 0.0 106.445 172.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.68 149.11 5.32 Favored Glycine 0 N--CA 1.416 -2.649 0 C-N-CA 118.988 -1.577 . . . . 0.0 113.049 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -103.52 6.99 37.78 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 121.522 0.677 . . . . 0.0 110.244 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.534 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 10.6 mp -107.02 126.79 29.34 Favored Pre-proline 0 CA--C 1.498 -1.024 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 177.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -67.22 -10.75 29.69 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.495 2.13 . . . . 0.0 111.962 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.22 -62.18 1.35 Allowed 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.299 0.571 . . . . 0.0 111.769 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.81 16.54 3.98 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.686 0.795 . . . . 0.0 112.805 -169.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -73.85 135.79 43.43 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.463 -177.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.17 126.03 45.65 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 N-CA-C 109.764 -0.458 . . . . 0.0 109.764 -176.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -61.68 129.48 41.23 Favored 'General case' 0 C--N 1.314 -0.952 0 C-N-CA 123.029 0.532 . . . . 0.0 110.159 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 97.7 mt -108.93 -62.97 1.4 Allowed 'General case' 0 N--CA 1.444 -0.73 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.6 ptp -175.54 166.67 3.25 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 120.965 0.412 . . . . 0.0 111.124 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -101.64 139.77 36.84 Favored 'General case' 0 C--N 1.304 -1.384 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.884 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 67.6 t -125.01 133.01 70.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 176.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 23.2 tpt85 -72.38 121.74 20.02 Favored 'General case' 0 C--N 1.308 -1.224 0 C-N-CA 123.665 0.786 . . . . 0.0 110.685 -179.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.514 HD13 ' HA ' ' A' ' 64' ' ' GLN . 56.7 mt -61.13 125.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.57 177.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.97 -22.54 10.48 Favored Glycine 0 N--CA 1.418 -2.556 0 N-CA-C 109.694 -1.362 . . . . 0.0 109.694 -176.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 72.2 p -118.79 167.62 11.52 Favored 'General case' 0 C--O 1.263 1.79 0 CA-C-O 121.948 0.88 . . . . 0.0 111.756 -176.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 61.8 p -103.45 158.35 16.41 Favored 'General case' 0 N--CA 1.418 -2.031 0 CA-C-N 114.25 -1.341 . . . . 0.0 109.124 175.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -161.7 151.03 16.13 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 123.699 0.624 . . . . 0.0 110.523 178.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 38.9 m -93.25 119.13 32.06 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-O 121.312 0.577 . . . . 0.0 110.887 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mm -94.87 146.75 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.673 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 174.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.7 m -127.95 107.95 10.27 Favored 'General case' 0 C--N 1.263 -3.16 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.88 138.0 45.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.174 -176.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 38.6 mtm180 59.19 25.61 14.2 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.285 1.434 . . . . 0.0 110.25 -175.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.65 12.97 83.97 Favored Glycine 0 C--N 1.304 -1.219 0 CA-C-N 115.017 -0.992 . . . . 0.0 112.873 -178.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.502 ' O ' ' HA ' ' A' ' 51' ' ' THR . 66.6 m-70 -111.95 148.23 34.19 Favored 'General case' 0 CA--C 1.508 -0.649 0 N-CA-C 109.759 -0.459 . . . . 0.0 109.759 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -101.58 128.54 47.8 Favored 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.196 -178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -125.83 109.72 12.85 Favored 'General case' 0 N--CA 1.425 -1.687 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -83.1 107.73 15.88 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 105.167 -2.16 . . . . 0.0 105.167 174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.6 m -106.95 156.22 7.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.889 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 -174.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 45.6 tt0 -115.63 114.09 24.43 Favored 'General case' 0 C--N 1.278 -2.537 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.373 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -86.84 79.64 8.74 Favored 'General case' 0 C--O 1.209 -1.04 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 177.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 20.0 ptmt -93.42 -20.92 19.86 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -173.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' H ' ' A' ' 67' ' ' LYS . 19.5 t70 -118.87 142.42 47.76 Favored 'General case' 0 C--N 1.296 -1.755 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.239 -169.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.514 ' HA ' HD13 ' A' ' 44' ' ' ILE . 79.6 mt-30 -78.62 9.68 3.86 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 -175.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.405 ' HB3' ' OD2' ' A' ' 63' ' ' ASP . 54.6 t30 -119.52 4.64 11.13 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 106.464 -1.68 . . . . 0.0 106.464 174.004 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.9 m 64.34 59.81 0.99 Allowed 'General case' 0 N--CA 1.44 -0.949 0 CA-C-N 113.117 -1.856 . . . . 0.0 113.398 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.542 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -71.06 104.04 2.9 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 171.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.1 p -81.44 92.52 2.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 CA-C-O 122.778 1.275 . . . . 0.0 112.827 -175.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 69.5 mt -119.05 144.53 27.12 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 106.388 -1.708 . . . . 0.0 106.388 177.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 31.4 mt -88.76 -176.75 5.34 Favored 'General case' 0 C--N 1.284 -2.266 0 CA-C-O 121.977 0.894 . . . . 0.0 110.95 -176.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.3 p -76.33 -26.31 55.64 Favored 'General case' 0 C--N 1.287 -2.135 0 CA-C-N 114.174 -1.376 . . . . 0.0 112.172 -177.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -80.03 -5.67 56.23 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.809 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 91.42 9.29 63.33 Favored Glycine 0 N--CA 1.43 -1.755 0 N-CA-C 111.21 -0.756 . . . . 0.0 111.21 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.8 mmtp -101.15 149.23 24.19 Favored 'General case' 0 N--CA 1.418 -2.048 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.488 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 2.3 mp0 -73.35 139.19 45.83 Favored 'General case' 0 C--N 1.297 -1.699 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -73.63 162.85 72.29 Favored Pre-proline 0 N--CA 1.416 -2.149 0 CA-C-N 114.912 -1.04 . . . . 0.0 109.937 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 77.4 Cg_exo -52.1 148.96 22.66 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.374 2.716 . . . . 0.0 111.871 178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -74.34 -20.33 60.14 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-O 121.355 0.597 . . . . 0.0 111.334 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 55.4 p-90 -82.7 -4.49 57.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.312 177.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.2 tp -91.9 123.37 35.22 Favored 'General case' 0 N--CA 1.432 -1.358 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 176.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.91 152.0 31.42 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 120.505 -0.478 . . . . 0.0 110.499 -174.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.591 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -152.66 129.68 11.07 Favored 'General case' 0 C--N 1.309 -1.187 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.269 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -127.7 143.81 48.91 Favored Pre-proline 0 N--CA 1.436 -1.166 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -60.32 136.16 66.42 Favored 'Trans proline' 0 C--O 1.253 1.263 0 C-N-CA 123.605 2.87 . . . . 0.0 113.456 -178.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.439 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 80.8 t80 . . . . . 0 C--O 1.274 2.361 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.336 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.43 -1.436 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -84.01 47.11 3.78 Favored Glycine 0 C--O 1.222 -0.632 0 C-N-CA 121.128 -0.558 . . . . 0.0 113.252 -177.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 83.4 mtp180 -122.3 83.97 2.19 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 177.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -103.41 140.04 38.0 Favored 'General case' 0 C--N 1.288 -2.081 0 CA-C-N 115.439 -0.801 . . . . 0.0 112.229 -174.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 49.0 t30 -168.0 96.72 0.44 Allowed 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.242 -1.345 . . . . 0.0 107.612 174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.3 mp -82.7 97.4 8.53 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 56.5 t80 -90.14 62.82 5.63 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -169.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 60.27 -37.37 0.09 Allowed 'General case' 0 N--CA 1.499 1.977 0 N-CA-C 117.097 2.258 . . . . 0.0 117.097 169.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.5 tt0 -79.82 86.71 5.35 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-O 122.53 1.157 . . . . 0.0 108.99 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 113.54 16.2 8.31 Favored Glycine 0 C--N 1.278 -2.669 0 CA-C-N 112.58 -2.1 . . . . 0.0 110.025 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -139.16 170.29 16.23 Favored 'General case' 0 C--N 1.314 -0.95 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -178.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 40.9 ttm -68.74 119.61 13.4 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 177.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.94 24.89 0.22 Allowed 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 114.544 1.312 . . . . 0.0 114.544 -171.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.41 83.57 0.22 Allowed Pre-proline 0 C--N 1.312 -1.063 0 C-N-CA 124.58 1.152 . . . . 0.0 112.139 -176.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.68 -16.77 10.19 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.086 1.857 . . . . 0.0 112.189 -179.064 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -87.38 135.91 33.14 Favored 'General case' 0 N--CA 1.435 -1.191 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.409 -177.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.434 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 0.1 OUTLIER -94.84 -48.9 5.82 Favored 'General case' 0 C--N 1.293 -1.873 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.743 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -135.19 170.54 15.76 Favored 'General case' 0 N--CA 1.425 -1.687 0 CA-C-N 114.355 -1.293 . . . . 0.0 108.115 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.7 m -116.28 133.66 55.78 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 165.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 6.0 t -91.19 119.04 37.68 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.91 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 87.5 m-85 -102.1 139.91 37.08 Favored 'General case' 0 C--N 1.306 -1.296 0 CA-C-O 121.061 0.457 . . . . 0.0 111.325 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 51.9 m-85 -130.9 146.74 52.41 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 115.097 -0.956 . . . . 0.0 109.317 178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.599 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 50.9 t0 -88.23 102.23 14.61 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 172.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.59 131.85 5.22 Favored Glycine 0 N--CA 1.408 -3.204 0 N-CA-C 110.186 -1.166 . . . . 0.0 110.186 -177.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -94.39 2.68 55.77 Favored 'General case' 0 C--N 1.269 -2.927 0 CA-C-N 114.279 -0.96 . . . . 0.0 110.267 -176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 20.0 tp -97.94 116.17 65.7 Favored Pre-proline 0 N--CA 1.422 -1.865 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -175.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -58.9 -18.26 41.4 Favored 'Trans proline' 0 N--CA 1.479 0.626 0 C-N-CA 124.056 3.171 . . . . 0.0 116.146 -169.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.12 -16.24 23.95 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 13.1 t -135.3 23.22 3.47 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 119.349 -0.94 . . . . 0.0 111.85 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.94 127.62 33.37 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 115.553 -0.749 . . . . 0.0 110.399 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.599 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 43.3 t -90.06 116.96 32.41 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 O-C-N 121.047 -1.033 . . . . 0.0 108.754 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -61.18 121.97 13.87 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 91.0 mt -99.81 -63.05 1.16 Allowed 'General case' 0 C--N 1.304 -1.375 0 C-N-CA 120.574 -0.451 . . . . 0.0 111.846 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.3 ptp -176.42 165.52 2.7 Favored 'General case' 0 CA--C 1.501 -0.934 0 CA-C-O 121.019 0.438 . . . . 0.0 111.184 -176.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -104.04 122.03 44.41 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 114.5 -1.227 . . . . 0.0 108.645 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 49.1 t -109.62 126.05 66.76 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.434 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 15.5 tpt180 -63.99 131.95 49.18 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 123.68 0.612 . . . . 0.0 109.921 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 46.9 mm -55.17 118.89 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.79 177.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.04 -22.54 25.2 Favored Glycine 0 C--N 1.294 -1.758 0 CA-C-N 115.228 -0.896 . . . . 0.0 112.752 179.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.3 p -99.42 164.27 12.18 Favored 'General case' 0 C--O 1.258 1.536 0 CA-C-O 121.455 0.645 . . . . 0.0 111.804 -174.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 36.7 p -98.88 153.6 18.68 Favored 'General case' 0 N--CA 1.42 -1.94 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.133 176.335 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.4 150.84 30.1 Favored 'General case' 0 C--N 1.28 -2.429 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.523 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 m -95.44 111.7 23.55 Favored 'General case' 0 N--CA 1.41 -2.429 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 176.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 24.9 mm -93.5 146.46 6.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 105.413 -2.069 . . . . 0.0 105.413 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 35.5 m -131.17 112.49 12.89 Favored 'General case' 0 C--N 1.264 -3.139 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 177.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.91 132.95 31.22 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.577 -178.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 48.1 mtm105 59.9 26.42 15.66 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.476 1.11 . . . . 0.0 111.463 -178.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.86 -4.46 84.9 Favored Glycine 0 C--N 1.302 -1.327 0 CA-C-N 114.881 -1.054 . . . . 0.0 113.175 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.415 ' O ' ' HA ' ' A' ' 51' ' ' THR . 49.0 m-70 -103.45 139.62 38.57 Favored 'General case' 0 CA--C 1.496 -1.127 0 CA-C-N 117.519 0.66 . . . . 0.0 110.581 -179.112 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -97.15 130.22 44.43 Favored 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 177.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 86.8 m-85 -122.5 116.82 24.58 Favored 'General case' 0 N--CA 1.424 -1.738 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -86.41 108.6 18.55 Favored 'General case' 0 C--N 1.299 -1.601 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 7.9 m -115.73 159.27 15.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.345 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.782 -174.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.421 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 33.2 tt0 -123.36 126.11 46.23 Favored 'General case' 0 C--N 1.285 -2.205 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 170.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.96 88.47 3.51 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 174.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -65.28 -57.98 7.09 Favored 'General case' 0 CA--C 1.502 -0.898 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.109 -171.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 67' ' ' LYS . 26.1 t70 -123.34 151.88 42.04 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.053 -170.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.458 HE21 ' C ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -67.88 2.4 2.03 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -179.043 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -100.65 15.9 26.66 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 172.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.5 m 64.27 59.88 1.0 Allowed 'General case' 0 CA--C 1.494 -1.175 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.805 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.555 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.4 OUTLIER -93.43 102.02 14.24 Favored 'General case' 0 CA--C 1.465 -2.311 0 CA-C-N 114.086 -1.416 . . . . 0.0 108.355 174.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.0 p -96.4 99.93 9.94 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.005 0 CA-C-N 113.748 -1.569 . . . . 0.0 111.334 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.63 137.77 51.5 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.877 0 N-CA-C 105.769 -1.937 . . . . 0.0 105.769 175.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.4 mt -75.11 176.27 7.44 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-O 121.968 0.889 . . . . 0.0 109.796 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -77.15 -18.24 58.0 Favored 'General case' 0 C--N 1.271 -2.812 0 CA-C-N 114.08 -1.418 . . . . 0.0 109.314 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 44.7 m-80 -79.7 -11.62 59.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.274 -1.33 . . . . 0.0 109.862 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.65 12.25 61.11 Favored Glycine 0 N--CA 1.433 -1.527 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 178.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 32.2 mmtp -103.21 149.41 24.7 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 -176.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -84.32 155.34 22.42 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 121.528 0.68 . . . . 0.0 111.05 -179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.94 152.4 95.94 Favored Pre-proline 0 C--N 1.299 -1.611 0 CA-C-N 114.419 -1.264 . . . . 0.0 112.23 -177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -67.14 154.22 75.06 Favored 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 123.284 2.656 . . . . 0.0 112.533 175.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -56.72 -39.26 73.58 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 124.886 1.275 . . . . 0.0 112.263 -176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 68.8 p-90 -73.27 -17.9 61.28 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 115.102 -0.953 . . . . 0.0 112.424 -176.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.3 tp -84.18 109.11 17.49 Favored 'General case' 0 N--CA 1.436 -1.17 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 178.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.89 135.11 41.81 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.187 -173.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -126.03 128.62 47.71 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 177.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 7.2 mm-40 -122.57 130.38 24.68 Favored Pre-proline 0 C--N 1.305 -1.331 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.78 126.52 16.82 Favored 'Trans proline' 0 C--O 1.242 0.709 0 C-N-CA 122.734 2.289 . . . . 0.0 112.596 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.2 t80 . . . . . 0 C--O 1.262 1.735 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.481 179.878 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.445 -0.695 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 171.91 -113.41 0.48 Allowed Glycine 0 N--CA 1.423 -2.198 0 C-N-CA 120.606 -0.806 . . . . 0.0 112.073 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -103.64 79.74 1.71 Allowed 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -176.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -143.71 116.8 8.91 Favored 'General case' 0 C--N 1.295 -1.8 0 CA-C-N 114.6 -1.182 . . . . 0.0 110.81 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -133.56 89.61 2.61 Favored 'General case' 0 C--N 1.286 -2.172 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 172.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 33.2 tp -58.24 113.72 2.07 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.131 -179.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -83.01 141.95 31.7 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.892 -179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 52.9 m-85 -111.21 95.25 5.42 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 105.019 -2.215 . . . . 0.0 105.019 175.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 53.4 tt0 -136.31 110.72 8.5 Favored 'General case' 0 N--CA 1.408 -2.575 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -169.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 148.35 33.74 0.05 OUTLIER Glycine 0 C--N 1.272 -3.021 0 CA-C-N 114.56 -1.2 . . . . 0.0 111.503 177.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.1 p-80 -159.82 177.61 10.64 Favored 'General case' 0 N--CA 1.403 -2.791 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.2 mtt -123.58 129.15 50.74 Favored 'General case' 0 C--N 1.288 -2.07 0 N-CA-C 107.025 -1.472 . . . . 0.0 107.025 169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.94 53.67 1.83 Allowed 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 175.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 70.44 153.52 0.14 Allowed Pre-proline 0 CA--C 1.548 0.88 0 C-N-CA 125.814 1.645 . . . . 0.0 111.514 -174.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -74.85 85.74 1.47 Allowed 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 121.754 1.636 . . . . 0.0 110.606 175.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.64 151.66 43.53 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.328 -1.305 . . . . 0.0 111.713 -177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 69.5 mtp180 -115.19 -1.96 12.84 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 121.524 0.678 . . . . 0.0 109.45 178.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 93.1 m-85 -137.53 162.59 33.33 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 177.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 84.8 m -128.3 142.22 51.21 Favored 'General case' 0 C--N 1.287 -2.132 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 2.4 m -103.59 120.84 54.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 123.389 0.431 . . . . 0.0 109.88 175.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 34.1 m-85 -98.97 141.5 31.65 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.717 178.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -128.29 146.38 50.77 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.635 -178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.441 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.1 t0 -85.67 104.21 15.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 171.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 107.22 143.49 11.05 Favored Glycine 0 N--CA 1.424 -2.102 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 -176.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 10.1 p80 -108.91 6.52 25.4 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.541 0.686 . . . . 0.0 110.787 -176.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.92 121.51 65.68 Favored Pre-proline 0 N--CA 1.424 -1.774 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -46.46 -37.84 20.24 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.146 3.23 . . . . 0.0 115.217 -172.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.09 -52.7 5.76 Favored 'General case' 0 C--N 1.306 -1.287 0 C-N-CA 120.175 -0.61 . . . . 0.0 112.263 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 5.9 m -82.46 4.38 24.48 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -172.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 41.3 ptt180 -75.29 142.59 43.26 Favored 'General case' 0 C--N 1.309 -1.182 0 O-C-N 121.817 -0.552 . . . . 0.0 110.097 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.441 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.2 t -111.78 119.19 59.4 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -65.28 121.69 15.4 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -92.9 -62.36 1.4 Allowed 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.928 -177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 26.5 ptm -167.73 167.12 13.43 Favored 'General case' 0 C--O 1.254 1.338 0 CA-C-O 120.98 0.419 . . . . 0.0 111.488 -175.757 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -95.23 146.85 24.05 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.289 177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 84.7 t -134.85 125.43 45.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 177.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 13.9 tpt180 -66.16 121.89 16.19 Favored 'General case' 0 C--N 1.307 -1.27 0 C-N-CA 123.269 0.628 . . . . 0.0 110.481 176.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.0 mt -66.37 122.36 17.21 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.311 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 117.9 -17.77 11.76 Favored Glycine 0 N--CA 1.421 -2.328 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 -176.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.6 p -119.57 170.54 9.08 Favored 'General case' 0 C--O 1.265 1.883 0 CA-C-O 121.65 0.738 . . . . 0.0 111.662 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 49.2 p -99.93 155.99 17.39 Favored 'General case' 0 N--CA 1.412 -2.351 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.992 173.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.89 148.83 27.6 Favored 'General case' 0 C--N 1.281 -2.383 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.629 178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.7 m -97.28 116.11 28.88 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.7 mm -93.83 146.55 6.43 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 105.785 -1.931 . . . . 0.0 105.785 178.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 15.4 m -133.87 109.4 9.04 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -129.62 131.41 46.45 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 55.91 27.87 11.71 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.607 1.163 . . . . 0.0 110.436 -176.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.6 -9.18 72.14 Favored Glycine 0 N--CA 1.44 -1.058 0 CA-C-N 115.349 -0.841 . . . . 0.0 113.218 -178.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.49 ' O ' ' HA ' ' A' ' 51' ' ' THR . 73.1 m-70 -83.72 130.2 34.95 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -99.89 124.09 44.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-O 121.031 0.443 . . . . 0.0 110.459 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.8 m-85 -118.76 107.14 13.29 Favored 'General case' 0 N--CA 1.423 -1.821 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 -179.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -80.82 107.26 13.48 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 174.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 19.5 m -114.79 148.58 17.44 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 120.899 0.38 . . . . 0.0 111.132 -172.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.17 120.77 43.01 Favored 'General case' 0 C--N 1.29 -1.992 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 172.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -96.76 108.44 21.09 Favored 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 175.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -99.2 -40.27 8.05 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 115.957 1.836 . . . . 0.0 115.957 -173.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.72 179.92 5.93 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 119.085 0.857 . . . . 0.0 111.223 -176.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.477 ' O ' ' HB3' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -79.95 -0.19 34.12 Favored 'General case' 0 C--O 1.218 -0.556 0 N-CA-C 115.458 1.651 . . . . 0.0 115.458 -174.619 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 49.1 m-80 -87.88 -8.0 56.41 Favored 'General case' 0 CA--C 1.497 -1.082 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 169.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 74.9 m 64.34 49.09 2.61 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.23 -1.35 . . . . 0.0 110.622 -178.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.566 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.1 107.25 1.85 Allowed 'General case' 0 N--CA 1.411 -2.422 0 CA-C-N 114.132 -1.394 . . . . 0.0 107.605 174.904 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 3.7 p -89.53 114.31 27.29 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.068 0 CA-C-O 121.68 0.752 . . . . 0.0 111.965 -176.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 4.3 mp -123.09 121.27 62.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.179 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 174.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 9.4 mp -78.96 166.4 22.41 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-O 121.005 0.431 . . . . 0.0 109.979 177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 8.6 p -68.12 -7.5 30.31 Favored 'General case' 0 C--N 1.289 -2.022 0 C-N-CA 124.654 1.182 . . . . 0.0 112.264 -178.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 87.5 m-20 -96.52 0.99 50.99 Favored 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.404 177.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.66 16.23 75.99 Favored Glycine 0 CA--C 1.487 -1.656 0 N-CA-C 110.181 -1.168 . . . . 0.0 110.181 179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 33.9 mmtp -104.89 135.42 46.28 Favored 'General case' 0 N--CA 1.414 -2.23 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 -175.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 -92.25 41.91 1.09 Allowed 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 -172.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 68.95 156.59 0.15 Allowed Pre-proline 0 N--CA 1.482 1.16 0 C-N-CA 124.986 1.314 . . . . 0.0 114.546 173.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -65.61 152.28 82.22 Favored 'Trans proline' 0 N--CA 1.457 -0.644 0 C-N-CA 122.384 2.056 . . . . 0.0 110.978 171.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -69.91 -13.34 62.2 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 115.79 -0.641 . . . . 0.0 112.151 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.2 p-90 -93.73 -9.0 39.16 Favored 'General case' 0 N--CA 1.436 -1.165 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.64 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 60.1 tp -89.85 126.69 35.79 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 178.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -117.53 149.62 40.31 Favored 'General case' 0 C--N 1.294 -1.837 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.293 -176.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -140.76 129.85 23.43 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 123.534 0.521 . . . . 0.0 110.232 178.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -120.96 145.65 42.08 Favored Pre-proline 0 N--CA 1.437 -1.104 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.477 ' HB3' ' O ' ' A' ' 64' ' ' GLN . 28.6 Cg_endo -64.7 129.52 23.78 Favored 'Trans proline' 0 C--N 1.315 -1.204 0 C-N-CA 123.071 2.514 . . . . 0.0 111.324 175.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 62.3 t80 . . . . . 0 C--N 1.3 -1.583 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.621 -178.701 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.6 m . . . . . 0 N--CA 1.448 -0.555 0 CA-C-O 120.887 0.375 . . . . 0.0 110.213 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.05 -125.5 5.69 Favored Glycine 0 N--CA 1.434 -1.498 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 -179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -80.9 68.94 7.35 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -175.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -113.08 123.61 50.68 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -109.12 30.67 6.36 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 174.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 6.6 mp -80.34 78.89 7.0 Favored 'General case' 0 CA--C 1.494 -1.189 0 CA-C-N 114.656 -1.156 . . . . 0.0 108.136 174.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 28.94 102.43 0.0 OUTLIER 'General case' 0 N--CA 1.438 -1.073 0 C-N-CA 128.888 2.875 . . . . 0.0 116.14 179.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -65.07 95.26 0.16 Allowed 'General case' 0 CA--C 1.517 -0.312 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.441 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -161.29 125.02 3.32 Favored 'General case' 0 N--CA 1.379 -3.992 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 178.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -72.65 -16.38 77.8 Favored Glycine 0 C--N 1.281 -2.473 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.928 178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 66.9 t60 66.13 93.32 0.07 Allowed 'General case' 0 C--O 1.238 0.489 0 C-N-CA 124.514 1.126 . . . . 0.0 110.069 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.563 ' HB3' ' OE1' ' A' ' 64' ' ' GLN . 23.4 ttt -145.71 159.74 42.72 Favored 'General case' 0 C--N 1.287 -2.148 0 N-CA-C 106.175 -1.787 . . . . 0.0 106.175 -175.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.85 20.71 0.34 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.434 ' HB2' HE22 ' A' ' 64' ' ' GLN . . . 46.46 67.42 4.39 Favored Pre-proline 0 C--N 1.309 -1.164 0 C-N-CA 125.024 1.33 . . . . 0.0 113.995 -179.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_exo -71.1 -35.47 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 N-CA-C 108.443 -1.407 . . . . 0.0 108.443 174.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -84.81 119.23 25.07 Favored 'General case' 0 N--CA 1.424 -1.725 0 CA-C-N 114.259 -1.337 . . . . 0.0 108.758 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.48 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 43.2 mtp85 -119.09 -12.5 9.48 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 122.019 0.914 . . . . 0.0 109.148 177.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -133.99 162.99 30.56 Favored 'General case' 0 N--CA 1.425 -1.675 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 93.2 m -126.91 136.89 52.92 Favored 'General case' 0 C--N 1.281 -2.388 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 173.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 11.8 t -97.88 118.85 45.07 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 -179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.461 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.9 m-85 -94.93 143.16 26.69 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.119 0.485 . . . . 0.0 111.216 -179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -133.94 152.74 51.96 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.255 -178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -97.28 112.16 24.09 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 154.44 143.9 3.79 Favored Glycine 0 N--CA 1.415 -2.747 0 C-N-CA 118.401 -1.857 . . . . 0.0 113.722 174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 11.6 t-80 -92.69 -6.38 49.34 Favored 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.493 -0.853 . . . . 0.0 109.462 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 14.0 tp -117.45 114.24 38.32 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -58.41 -23.55 64.21 Favored 'Trans proline' 0 N--CA 1.476 0.443 0 C-N-CA 123.674 2.916 . . . . 0.0 115.579 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.13 -14.7 25.41 Favored 'General case' 0 C--N 1.3 -1.577 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.157 179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 6.2 m -123.59 14.98 9.51 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 121.427 0.632 . . . . 0.0 111.525 -171.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -79.45 154.94 28.55 Favored 'General case' 0 CA--C 1.55 0.98 0 O-C-N 121.604 -0.685 . . . . 0.0 111.492 -176.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.0 t -101.53 132.84 46.59 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.859 0 C-N-CA 122.856 0.462 . . . . 0.0 110.87 -175.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -64.82 123.11 18.52 Favored 'General case' 0 C--N 1.319 -0.734 0 C-N-CA 123.576 0.75 . . . . 0.0 109.67 178.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.5 mt -103.98 -63.78 1.16 Allowed 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 120.215 -0.594 . . . . 0.0 112.511 179.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.8 ptp -170.88 164.75 7.81 Favored 'General case' 0 CA--C 1.505 -0.765 0 CA-C-O 121.025 0.441 . . . . 0.0 111.85 -173.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -106.13 134.11 49.77 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.448 -178.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 95.0 t -128.75 137.75 56.44 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.094 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 11.6 tpt180 -73.52 127.19 32.05 Favored 'General case' 0 C--O 1.253 1.281 0 C-N-CA 123.471 0.708 . . . . 0.0 110.761 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.544 HD13 ' HA ' ' A' ' 64' ' ' GLN . 83.1 mt -64.13 124.96 19.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 176.247 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 110.94 -17.43 27.3 Favored Glycine 0 N--CA 1.426 -1.981 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 -176.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 81.1 p -110.01 163.67 13.34 Favored 'General case' 0 N--CA 1.435 -1.216 0 CA-C-O 121.536 0.684 . . . . 0.0 111.325 -178.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.8 p -99.07 151.7 20.66 Favored 'General case' 0 C--N 1.283 -2.303 0 CA-C-N 114.594 -1.184 . . . . 0.0 107.906 173.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -151.62 155.64 38.82 Favored 'General case' 0 C--N 1.277 -2.546 0 O-C-N 123.366 0.416 . . . . 0.0 110.946 -178.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.5 m -105.53 110.38 22.68 Favored 'General case' 0 N--CA 1.413 -2.278 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 178.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.4 mm -93.98 146.44 6.61 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 179.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 45.7 m -130.36 113.44 14.36 Favored 'General case' 0 C--N 1.266 -3.044 0 N-CA-C 108.976 -0.749 . . . . 0.0 108.976 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -146.96 133.93 20.28 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.072 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 50.9 mtt180 62.94 25.88 15.27 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 124.607 1.163 . . . . 0.0 111.98 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.7 -4.02 85.96 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.199 -0.91 . . . . 0.0 112.947 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 -100.62 135.35 42.2 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -104.46 113.39 26.93 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 61.2 m-85 -103.04 121.18 42.05 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 -176.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -91.23 108.31 19.79 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 173.641 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.524 HG12 ' CD2' ' A' ' 70' ' ' LEU . 16.8 m -102.71 154.76 5.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 CA-C-N 114.845 -1.07 . . . . 0.0 109.021 -175.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -123.16 111.31 16.35 Favored 'General case' 0 C--N 1.278 -2.521 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 172.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.22 106.75 8.01 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 -179.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.5 mmpt? -93.17 -58.05 2.43 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -171.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -120.86 162.21 20.21 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.785 -0.766 . . . . 0.0 111.068 -171.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.563 ' OE1' ' HB3' ' A' ' 18' ' ' MET . 2.4 pt20 -79.91 4.99 15.04 Favored 'General case' 0 C--N 1.319 -0.748 0 C-N-CA 123.925 0.89 . . . . 0.0 112.756 -177.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -93.13 3.38 55.8 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.453 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.9 m 65.7 31.09 9.97 Favored 'General case' 0 CA--C 1.497 -1.08 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.06 179.296 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.471 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -68.12 103.78 1.62 Allowed 'General case' 0 N--CA 1.403 -2.81 0 CA-C-N 114.362 -1.29 . . . . 0.0 107.847 173.539 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.416 ' CG2' ' HB ' ' A' ' 59' ' ' VAL . 5.4 p -97.04 124.21 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.951 0 CA-C-O 121.689 0.757 . . . . 0.0 111.607 -178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.0 mp -118.4 132.51 68.06 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.882 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 173.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 59' ' ' VAL . 26.8 mt -83.44 164.36 19.96 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 -179.019 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 36.9 p -76.27 -17.28 59.54 Favored 'General case' 0 C--N 1.259 -3.347 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.827 -176.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -71.53 -9.82 58.8 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.538 -1.21 . . . . 0.0 109.931 176.743 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 90.98 22.37 33.14 Favored Glycine 0 CA--C 1.492 -1.386 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 178.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -114.79 146.9 40.5 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 -177.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -87.93 30.23 0.86 Allowed 'General case' 0 C--N 1.294 -1.817 0 CA-C-O 121.223 0.535 . . . . 0.0 112.024 -177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 71.4 151.76 0.14 Allowed Pre-proline 0 C--O 1.247 0.925 0 C-N-CA 125.936 1.694 . . . . 0.0 114.471 174.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -58.96 145.0 98.87 Favored 'Trans proline' 0 C--N 1.36 1.164 0 C-N-CA 122.858 2.372 . . . . 0.0 110.161 171.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -75.87 -18.51 59.4 Favored 'General case' 0 C--N 1.29 -2.008 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.368 -174.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.1 p-90 -88.15 -3.22 58.91 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.513 0.673 . . . . 0.0 110.513 176.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 57.6 tp -93.8 110.54 22.18 Favored 'General case' 0 N--CA 1.428 -1.545 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 175.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -109.11 150.97 27.05 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.177 -173.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -139.53 129.69 25.21 Favored 'General case' 0 C--N 1.298 -1.659 0 O-C-N 123.593 0.558 . . . . 0.0 110.088 178.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -115.97 135.93 22.84 Favored Pre-proline 0 C--N 1.304 -1.4 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.453 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 31.3 Cg_endo -61.85 125.47 16.66 Favored 'Trans proline' 0 C--O 1.241 0.647 0 C-N-CA 123.778 2.985 . . . . 0.0 112.772 -177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 73.2 t80 . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.775 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.6 m . . . . . 0 N--CA 1.436 -1.156 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -119.36 84.7 0.38 Allowed Glycine 0 N--CA 1.426 -1.987 0 C-N-CA 120.34 -0.933 . . . . 0.0 111.425 -178.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 87.3 mtt180 -133.33 97.25 3.92 Favored 'General case' 0 N--CA 1.426 -1.628 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -70.41 105.63 3.11 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 114.786 -1.097 . . . . 0.0 110.867 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -92.83 5.54 50.9 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-O 122.588 1.185 . . . . 0.0 108.614 176.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 40.1 tp -122.47 88.61 2.96 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 113.741 -1.572 . . . . 0.0 107.012 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 74.5 t80 -89.58 144.44 26.01 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 -179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -103.65 116.48 32.41 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.292 0.567 . . . . 0.0 111.116 -176.446 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -92.8 81.63 4.69 Favored 'General case' 0 N--CA 1.428 -1.562 0 CA-C-O 122.124 0.964 . . . . 0.0 108.519 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 178.97 56.25 0.08 OUTLIER Glycine 0 C--N 1.283 -2.364 0 CA-C-N 113.728 -1.578 . . . . 0.0 110.369 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.0 p80 -124.63 144.55 50.12 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-O 120.858 0.361 . . . . 0.0 111.194 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 67.5 mtt -126.32 122.74 36.32 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.772 178.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.24 73.52 10.43 Favored 'General case' 0 N--CA 1.437 -1.077 0 CA-C-O 121.034 0.445 . . . . 0.0 109.903 179.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 55.04 90.29 0.09 OUTLIER Pre-proline 0 C--O 1.252 1.226 0 C-N-CA 125.263 1.425 . . . . 0.0 113.589 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -61.0 -55.51 1.28 Allowed 'Trans proline' 0 C--N 1.357 0.978 0 C-N-CA 122.531 2.154 . . . . 0.0 109.222 176.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.36 121.09 24.02 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 105.719 -1.956 . . . . 0.0 105.719 171.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -127.51 -2.18 6.16 Favored 'General case' 0 C--N 1.301 -1.507 0 C-N-CA 119.563 -0.855 . . . . 0.0 111.994 -172.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.411 ' HB2' ' HB3' ' A' ' 85' ' ' TYR . 89.5 m-85 -124.74 172.25 9.45 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.658 -0.817 . . . . 0.0 108.947 174.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' O ' ' HA ' ' A' ' 41' ' ' TYR . 9.1 t -139.55 147.39 41.14 Favored 'General case' 0 C--N 1.274 -2.685 0 N-CA-C 107.369 -1.345 . . . . 0.0 107.369 178.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 6.1 t -116.72 124.76 73.19 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.095 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.516 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 49.3 m-85 -108.14 144.39 35.6 Favored 'General case' 0 C--O 1.25 1.128 0 O-C-N 123.64 0.588 . . . . 0.0 110.947 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 15.4 m-85 -139.64 156.55 46.78 Favored 'General case' 0 C--N 1.309 -1.171 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 -179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -96.44 113.84 25.45 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 104.926 -2.249 . . . . 0.0 104.926 168.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 152.88 148.51 4.89 Favored Glycine 0 C--N 1.288 -2.13 0 C-N-CA 119.071 -1.538 . . . . 0.0 113.413 177.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 9.4 p80 -91.59 -12.37 34.52 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.653 -0.774 . . . . 0.0 109.684 178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.465 ' O ' ' HB3' ' A' ' 36' ' ' ARG . 30.4 tp -128.91 128.89 23.43 Favored Pre-proline 0 N--CA 1.427 -1.576 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 -173.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 32' ' ' LEU . 73.7 Cg_endo -72.96 1.48 6.47 Favored 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.23 2.62 . . . . 0.0 112.93 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.01 -43.44 8.53 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.621 178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 19.8 p -110.74 12.42 22.5 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -174.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -71.29 162.55 29.25 Favored 'General case' 0 C--N 1.312 -1.055 0 N-CA-C 112.154 0.427 . . . . 0.0 112.154 -174.569 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 55.8 t -107.87 119.55 57.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 176.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.8 126.1 26.91 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 92.5 mt -102.24 -62.77 1.22 Allowed 'General case' 0 N--CA 1.44 -0.94 0 C-N-CA 120.169 -0.613 . . . . 0.0 112.057 -179.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.9 ptp -172.11 164.08 6.05 Favored 'General case' 0 CA--C 1.499 -0.995 0 CA-C-O 121.022 0.439 . . . . 0.0 111.82 -176.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' CYS . 59.6 m-85 -103.63 137.22 41.98 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 114.16 -1.382 . . . . 0.0 108.029 177.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.31 139.33 48.81 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.482 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.421 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 11.6 tpp85 -78.63 112.67 15.95 Favored 'General case' 0 C--O 1.254 1.308 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.829 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.549 HD13 ' HA ' ' A' ' 64' ' ' GLN . 40.1 mt -65.28 125.11 21.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.159 0.504 . . . . 0.0 110.244 -179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 118.76 -22.93 9.05 Favored Glycine 0 N--CA 1.418 -2.559 0 N-CA-C 110.605 -0.998 . . . . 0.0 110.605 -175.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.421 ' OG1' ' HB3' ' A' ' 43' ' ' ARG . 82.6 p -112.42 175.08 5.58 Favored 'General case' 0 C--O 1.257 1.448 0 CA-C-O 121.586 0.707 . . . . 0.0 111.855 -177.695 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.0 p -99.18 152.87 19.41 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-N 114.205 -1.361 . . . . 0.0 109.082 175.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -148.48 155.07 40.7 Favored 'General case' 0 C--N 1.282 -2.337 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.151 -179.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.5 m -108.99 108.97 19.9 Favored 'General case' 0 C--N 1.29 -2.006 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 14.5 mm -93.8 142.1 13.82 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 28.1 m -128.49 113.43 15.49 Favored 'General case' 0 C--N 1.273 -2.75 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -147.12 133.74 19.89 Favored 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 60.88 26.35 16.24 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.667 1.187 . . . . 0.0 111.685 179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.21 0.99 89.63 Favored Glycine 0 C--N 1.313 -0.746 0 CA-C-N 115.122 -0.945 . . . . 0.0 112.916 -178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 49.6 m-70 -102.5 128.09 49.27 Favored 'General case' 0 C--N 1.312 -1.05 0 O-C-N 122.033 -0.687 . . . . 0.0 109.267 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -100.24 113.49 26.22 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -102.41 116.84 33.45 Favored 'General case' 0 C--N 1.278 -2.531 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -87.07 106.8 18.11 Favored 'General case' 0 N--CA 1.42 -1.935 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 173.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 18.8 m -107.57 153.51 8.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.646 -174.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -121.0 117.99 28.68 Favored 'General case' 0 C--N 1.272 -2.773 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 171.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 44' ' ' ILE . . . -76.76 93.65 3.72 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.896 -1.15 . . . . 0.0 107.896 178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -73.39 -58.44 3.31 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.243 -0.89 . . . . 0.0 112.811 -172.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -121.67 157.73 30.24 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.466 -171.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.549 ' HA ' HD13 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -64.13 -7.24 8.28 Favored 'General case' 0 C--O 1.214 -0.774 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 -177.804 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -95.76 4.06 53.26 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 122.254 1.026 . . . . 0.0 108.525 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 94.3 m 68.67 61.76 0.35 Allowed 'General case' 0 CA--C 1.489 -1.385 0 CA-C-N 114.429 -1.259 . . . . 0.0 112.263 -176.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.649 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -81.47 94.24 6.8 Favored 'General case' 0 N--CA 1.395 -3.213 0 N-CA-C 105.613 -1.995 . . . . 0.0 105.613 172.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 4.0 p -80.43 96.87 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 CA-C-O 122.557 1.17 . . . . 0.0 111.279 -176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.3 mt -124.09 126.24 72.03 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.212 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 178.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 16.5 mt -74.31 178.33 5.25 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-O 122.302 1.048 . . . . 0.0 109.486 -177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.7 p -78.28 -15.46 58.74 Favored 'General case' 0 C--N 1.267 -3.019 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.6 177.26 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -75.86 -13.7 60.27 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 113.426 -1.715 . . . . 0.0 108.792 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.07 19.22 65.49 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 109.209 -1.556 . . . . 0.0 109.209 -177.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.418 ' O ' ' HG ' ' A' ' 70' ' ' LEU . 34.1 mmtp -113.91 156.52 23.83 Favored 'General case' 0 N--CA 1.418 -2.068 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.373 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -84.82 176.46 8.5 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 123.714 0.634 . . . . 0.0 110.485 177.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.495 ' HB1' HD23 ' A' ' 80' ' ' LEU . . . -96.21 151.77 38.38 Favored Pre-proline 0 C--N 1.294 -1.827 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -177.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -49.47 153.52 5.02 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 124.461 3.44 . . . . 0.0 113.14 175.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -67.22 -31.73 72.29 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.122 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 64.4 p-90 -78.97 -15.27 58.51 Favored 'General case' 0 C--N 1.306 -1.293 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.666 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD23 ' HB1' ' A' ' 76' ' ' ALA . 44.4 tp -90.14 112.01 23.35 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 178.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -99.87 144.36 29.02 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.982 -173.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -141.87 137.05 31.12 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 123.781 0.676 . . . . 0.0 109.491 179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -140.54 140.0 21.59 Favored Pre-proline 0 C--N 1.303 -1.448 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -68.0 139.01 45.74 Favored 'Trans proline' 0 C--O 1.254 1.298 0 C-N-CA 122.523 2.149 . . . . 0.0 112.771 179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 24' ' ' PHE . 88.4 t80 . . . . . 0 C--N 1.29 -2.012 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.446 -0.639 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.28 -155.67 7.06 Favored Glycine 0 N--CA 1.435 -1.419 0 N-CA-C 110.003 -1.239 . . . . 0.0 110.003 -179.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -84.02 71.3 10.54 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.341 0.591 . . . . 0.0 111.115 179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -96.43 130.59 43.54 Favored 'General case' 0 N--CA 1.413 -2.325 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.187 175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -150.94 106.86 3.42 Favored 'General case' 0 C--N 1.283 -2.284 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -177.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 31.3 tp -53.97 107.65 0.28 Allowed 'General case' 0 C--N 1.305 -1.336 0 O-C-N 124.356 1.035 . . . . 0.0 111.935 -178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 65.6 m-85 -78.74 132.94 37.14 Favored 'General case' 0 N--CA 1.426 -1.625 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 174.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -79.89 100.06 7.86 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 -170.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -108.39 80.35 1.34 Allowed 'General case' 0 N--CA 1.422 -1.834 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 173.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -73.09 154.88 50.1 Favored Glycine 0 N--CA 1.429 -1.825 0 N-CA-C 110.518 -1.033 . . . . 0.0 110.518 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.8 t-80 -74.58 87.28 2.13 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-O 122.285 1.041 . . . . 0.0 109.721 179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 63.3 mtt -113.37 -155.81 0.58 Allowed 'General case' 0 C--N 1.293 -1.857 0 CA-C-N 113.923 -1.49 . . . . 0.0 107.436 -179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 23' ' ' ARG . . . -82.88 -10.97 58.57 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.501 0.667 . . . . 0.0 110.361 175.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . 74.15 144.42 0.1 Allowed Pre-proline 0 C--N 1.302 -1.481 0 C-N-CA 127.433 2.293 . . . . 0.0 112.378 179.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 -16.67 47.89 Favored 'Trans proline' 0 C--N 1.366 1.454 0 C-N-CA 123.4 2.734 . . . . 0.0 112.731 179.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.444 ' HA ' ' OXT' ' A' ' 85' ' ' TYR . . . -135.71 128.8 31.63 Favored 'General case' 0 N--CA 1.435 -1.191 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 175.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 19' ' ' ALA . 74.2 mtp180 -114.52 -26.14 8.05 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-O 121.318 0.58 . . . . 0.0 110.017 -177.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -127.3 154.79 44.48 Favored 'General case' 0 N--CA 1.421 -1.894 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 80.7 m -120.16 135.62 54.9 Favored 'General case' 0 C--N 1.268 -2.955 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 170.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 t -102.94 115.42 44.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 -177.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 37.1 m-85 -94.08 140.13 30.12 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-O 120.933 0.397 . . . . 0.0 111.592 -179.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.432 ' CD1' ' HG2' ' A' ' 36' ' ' ARG . 93.0 m-85 -130.11 143.72 50.95 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.777 179.563 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.4 t70 -88.25 107.32 18.74 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 173.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.24 146.38 7.08 Favored Glycine 0 N--CA 1.417 -2.597 0 C-N-CA 120.099 -1.048 . . . . 0.0 111.512 178.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.0 p80 -109.5 -0.85 18.65 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 114.961 -0.62 . . . . 0.0 110.548 -176.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.4 tp -96.66 120.3 62.22 Favored Pre-proline 0 N--CA 1.425 -1.677 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 -178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -54.59 -31.02 68.23 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 123.264 2.643 . . . . 0.0 114.818 -173.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.76 -2.36 51.14 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 10.2 m -134.4 18.42 3.66 Favored 'General case' 0 CA--C 1.553 1.081 0 CA-C-O 121.719 0.771 . . . . 0.0 111.414 -176.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.432 ' HG2' ' CD1' ' A' ' 28' ' ' TYR . 0.0 OUTLIER -81.77 144.53 31.03 Favored 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 119.584 -0.846 . . . . 0.0 109.497 179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 40.6 t -113.87 128.16 70.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 O-C-N 121.601 -0.687 . . . . 0.0 110.622 -176.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -61.92 127.76 32.94 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 110.041 -0.355 . . . . 0.0 110.041 178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.6 mt -105.2 -62.64 1.32 Allowed 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.52 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 22.4 ptp -170.15 164.06 9.15 Favored 'General case' 0 CA--C 1.499 -1.016 0 CA-C-O 120.991 0.424 . . . . 0.0 111.568 -176.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -106.92 133.07 52.12 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-N 114.427 -1.26 . . . . 0.0 108.445 -178.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.1 t -124.6 138.71 53.11 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.226 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -177.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.61 134.38 36.45 Favored 'General case' 0 C--O 1.251 1.137 0 C-N-CA 123.707 0.803 . . . . 0.0 111.1 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 33.7 mm -58.82 117.6 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.804 173.247 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 116.15 -17.65 14.63 Favored Glycine 0 N--CA 1.426 -2.012 0 CA-C-N 114.971 -1.013 . . . . 0.0 111.887 -179.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 77.9 p -110.92 163.84 13.4 Favored 'General case' 0 C--O 1.256 1.441 0 CA-C-O 121.735 0.778 . . . . 0.0 112.534 -174.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 23.8 p -98.66 157.6 16.15 Favored 'General case' 0 N--CA 1.415 -2.206 0 CA-C-N 114.097 -1.411 . . . . 0.0 107.87 175.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.81 135.77 13.77 Favored 'General case' 0 C--N 1.278 -2.509 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.532 178.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 58' ' ' GLU . 19.6 m -88.46 112.15 22.62 Favored 'General case' 0 N--CA 1.408 -2.547 0 N-CA-C 107.839 -1.171 . . . . 0.0 107.839 176.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.8 mm -93.88 146.24 6.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.382 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 33.6 m -129.4 112.29 13.67 Favored 'General case' 0 C--N 1.272 -2.779 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.29 132.89 30.45 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.133 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mtm180 58.61 26.18 14.13 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 125.454 1.502 . . . . 0.0 110.785 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.86 1.66 88.82 Favored Glycine 0 N--CA 1.441 -0.995 0 CA-C-N 114.647 -1.16 . . . . 0.0 112.701 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 51' ' ' THR . 39.3 m-70 -99.19 137.87 37.09 Favored 'General case' 0 C--N 1.31 -1.144 0 O-C-N 122.274 -0.544 . . . . 0.0 110.076 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 49.6 mt-10 -100.25 113.32 25.91 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -108.88 110.74 22.15 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 49' ' ' THR . 29.5 tt0 -89.92 108.87 19.97 Favored 'General case' 0 C--N 1.293 -1.856 0 C-N-CA 119.419 -0.913 . . . . 0.0 108.554 -179.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.569 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 14.3 m -106.25 161.04 5.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.094 -174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.6 tt0 -123.04 124.31 42.83 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 168.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -85.26 79.71 9.43 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 105.694 -1.965 . . . . 0.0 105.694 173.008 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.424 ' HB3' ' NZ ' ' A' ' 62' ' ' LYS . 3.0 mtpm? -66.84 -57.88 6.13 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.64 -169.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -125.61 162.76 24.24 Favored 'General case' 0 C--N 1.292 -1.933 0 CA-C-N 114.846 -1.07 . . . . 0.0 110.253 -174.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.83 -5.0 1.12 Allowed 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -174.109 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -74.29 -20.25 60.2 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 120.744 0.307 . . . . 0.0 110.182 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.656 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 99.3 m 69.38 30.08 4.26 Favored 'General case' 0 CA--C 1.502 -0.866 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.613 -173.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -59.49 98.85 0.05 Allowed 'General case' 0 N--CA 1.412 -2.345 0 CA-C-N 113.66 -1.609 . . . . 0.0 107.954 174.086 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -75.78 92.22 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.6 0 CA-C-O 122.773 1.273 . . . . 0.0 112.676 -176.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -112.37 131.07 64.89 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.5 mt -83.32 170.83 14.17 Favored 'General case' 0 C--N 1.288 -2.104 0 CA-C-O 121.869 0.842 . . . . 0.0 109.724 -178.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.8 p -72.02 -20.7 61.66 Favored 'General case' 0 C--N 1.269 -2.922 0 CA-C-N 113.55 -1.659 . . . . 0.0 110.064 -178.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -83.57 -4.9 58.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.992 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.71 18.36 60.12 Favored Glycine 0 CA--C 1.494 -1.24 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 178.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.6 mmtp -112.77 164.36 13.47 Favored 'General case' 0 N--CA 1.421 -1.882 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -178.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -100.46 167.46 10.36 Favored 'General case' 0 C--N 1.276 -2.629 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 174.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.1 156.48 76.69 Favored Pre-proline 0 C--N 1.291 -1.972 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.691 -177.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_exo -53.81 155.44 14.25 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 123.844 3.029 . . . . 0.0 111.767 172.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -60.69 -30.0 69.66 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.0 p-90 -85.65 -9.99 56.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.543 -177.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 51.9 tp -97.75 110.58 23.12 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -113.27 147.8 36.85 Favored 'General case' 0 C--N 1.297 -1.682 0 C-N-CA 120.701 -0.4 . . . . 0.0 111.264 -171.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -125.3 127.51 46.79 Favored 'General case' 0 N--CA 1.435 -1.187 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 176.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 22.9 mm-40 -110.1 119.86 46.06 Favored Pre-proline 0 C--N 1.291 -1.941 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.264 -177.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.656 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 76.7 Cg_exo -53.51 126.64 22.41 Favored 'Trans proline' 0 C--O 1.249 1.068 0 C-N-CA 124.143 3.229 . . . . 0.0 112.461 176.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.444 ' OXT' ' HA ' ' A' ' 22' ' ' ALA . 51.3 t80 . . . . . 0 N--CA 1.414 -2.249 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 174.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.9 m . . . . . 0 N--CA 1.438 -1.073 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -91.15 -25.05 25.28 Favored Glycine 0 N--CA 1.445 -0.767 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.835 -179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -83.82 81.15 8.89 Favored 'General case' 0 N--CA 1.435 -1.189 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -88.83 175.77 7.33 Favored 'General case' 0 C--N 1.279 -2.475 0 CA-C-N 113.313 -1.767 . . . . 0.0 111.486 -179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -173.61 141.73 0.88 Allowed 'General case' 0 N--CA 1.414 -2.248 0 N-CA-C 101.732 -3.433 . . . . 0.0 101.732 -178.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 8.5 mp -62.43 88.65 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.359 0 CA-C-O 121.838 0.828 . . . . 0.0 112.934 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 83.8 t80 -91.98 132.83 36.23 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 177.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -102.13 146.11 28.41 Favored 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.615 0.722 . . . . 0.0 111.759 -176.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -91.74 96.01 10.19 Favored 'General case' 0 N--CA 1.407 -2.581 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -176.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -65.3 -141.39 0.03 OUTLIER Glycine 0 C--N 1.282 -2.468 0 CA-C-N 113.209 -1.814 . . . . 0.0 114.447 178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -87.73 95.37 10.05 Favored 'General case' 0 C--N 1.29 -1.981 0 CA-C-O 121.741 0.781 . . . . 0.0 109.262 -176.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 66.1 mtt -139.49 175.1 9.85 Favored 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 114.684 -1.144 . . . . 0.0 108.752 -179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -115.97 68.81 0.73 Allowed 'General case' 0 N--CA 1.418 -2.056 0 N-CA-C 107.134 -1.432 . . . . 0.0 107.134 171.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.4 ' HB3' HG21 ' A' ' 44' ' ' ILE . . . 70.84 138.53 0.06 OUTLIER Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 125.099 1.36 . . . . 0.0 112.11 -176.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -66.61 -17.59 53.02 Favored 'Trans proline' 0 N--CA 1.487 1.098 0 C-N-CA 122.878 2.385 . . . . 0.0 112.935 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.03 152.31 27.98 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.659 ' NE ' ' HA ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -112.07 -33.33 6.29 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.136 -1.026 . . . . 0.0 110.049 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -136.49 167.62 21.02 Favored 'General case' 0 C--N 1.304 -1.371 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 178.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 92.2 m -123.38 135.93 54.39 Favored 'General case' 0 C--N 1.275 -2.672 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 t -100.43 122.53 52.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 -178.69 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.484 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 86.2 m-85 -101.64 141.77 34.0 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-O 120.815 0.34 . . . . 0.0 111.438 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -132.83 149.47 52.26 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.531 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.452 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 9.4 t70 -90.24 100.44 13.27 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 140.04 150.51 5.49 Favored Glycine 0 N--CA 1.415 -2.76 0 C-N-CA 118.801 -1.666 . . . . 0.0 114.405 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -105.42 -0.23 26.24 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 114.267 -0.966 . . . . 0.0 109.469 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 38.1 tp -113.97 106.94 52.88 Favored Pre-proline 0 N--CA 1.422 -1.828 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 -178.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -49.07 -39.77 41.26 Favored 'Trans proline' 0 N--CA 1.476 0.493 0 C-N-CA 124.434 3.423 . . . . 0.0 113.553 -175.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.44 -15.33 62.81 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -176.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 2.4 t -135.84 7.45 3.22 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 118.03 -1.468 . . . . 0.0 112.189 -178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.5 ptt180 -71.54 134.53 46.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.038 0.447 . . . . 0.0 111.233 -176.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.452 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 45.8 t -89.17 138.82 18.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.102 -173.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -72.12 131.0 42.23 Favored 'General case' 0 C--N 1.308 -1.216 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.2 mt -105.86 -63.16 1.28 Allowed 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 112.302 0.482 . . . . 0.0 112.302 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 18.9 ptp -173.76 166.98 4.48 Favored 'General case' 0 CA--C 1.501 -0.915 0 CA-C-O 121.01 0.433 . . . . 0.0 111.024 -177.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -109.0 131.32 55.18 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-N 114.429 -1.259 . . . . 0.0 108.17 178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 60.3 t -126.64 134.38 66.44 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -73.75 142.75 46.26 Favored 'General case' 0 C--O 1.254 1.294 0 CA-C-O 121.691 0.758 . . . . 0.0 113.024 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.4 HG21 ' HB3' ' A' ' 20' ' ' ALA . 25.8 mm -57.13 124.45 11.0 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.194 0 CA-C-N 113.85 -1.523 . . . . 0.0 109.531 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 93.54 0.73 66.8 Favored Glycine 0 N--CA 1.429 -1.822 0 CA-C-N 115.524 -0.762 . . . . 0.0 113.261 177.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.7 p -121.46 157.05 31.44 Favored 'General case' 0 C--O 1.248 1.007 0 CA-C-N 117.853 0.826 . . . . 0.0 110.654 178.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 60' ' ' GLU . 60.3 p -99.21 154.11 18.41 Favored 'General case' 0 N--CA 1.42 -1.965 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.726 178.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.1 154.62 27.81 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 124.142 0.901 . . . . 0.0 110.585 176.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.8 m -92.08 115.39 28.03 Favored 'General case' 0 N--CA 1.426 -1.645 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.016 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.411 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 18.1 mm -94.09 146.54 6.51 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 176.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 31.2 m -137.47 109.37 7.14 Favored 'General case' 0 C--N 1.271 -2.835 0 O-C-N 121.922 -0.487 . . . . 0.0 110.688 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -135.26 132.77 38.2 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.109 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 26.2 mtm180 59.72 26.45 15.57 Favored 'General case' 0 N--CA 1.485 1.291 0 C-N-CA 125.267 1.427 . . . . 0.0 110.569 -177.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.54 4.55 90.12 Favored Glycine 0 C--N 1.304 -1.2 0 CA-C-N 115.318 -0.855 . . . . 0.0 112.283 -177.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.493 ' O ' ' HA ' ' A' ' 51' ' ' THR . 19.5 m-70 -93.43 120.89 34.25 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 52.7 mt-10 -95.88 123.82 39.63 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 176.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 42.5 m-85 -115.36 119.41 36.17 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 -179.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -90.09 107.42 19.11 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 105.69 -1.967 . . . . 0.0 105.69 176.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 33.2 m -127.06 164.95 26.65 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.988 0 CA-C-O 121.104 0.478 . . . . 0.0 110.555 -174.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 47' ' ' THR . 35.1 tt0 -116.04 132.96 56.5 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -76.18 97.15 4.05 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -73.78 -58.9 2.99 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 114.207 1.188 . . . . 0.0 114.207 -168.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -144.18 -171.85 3.65 Favored 'General case' 0 C--N 1.292 -1.901 0 C-N-CA 119.67 -0.812 . . . . 0.0 112.757 -168.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.408 ' HG3' ' H ' ' A' ' 64' ' ' GLN . 0.0 OUTLIER -75.4 -9.59 58.7 Favored 'General case' 0 C--O 1.213 -0.857 0 N-CA-C 114.125 1.157 . . . . 0.0 114.125 -178.206 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -92.33 -11.28 35.51 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 107.18 -1.415 . . . . 0.0 107.18 171.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.604 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 92.1 m 60.26 51.98 5.19 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 114.393 -1.276 . . . . 0.0 111.007 -178.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.589 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -65.0 111.6 2.94 Favored 'General case' 0 N--CA 1.425 -1.692 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 177.673 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 8.0 p -79.19 94.47 1.81 Allowed 'Isoleucine or valine' 0 C--O 1.254 1.314 0 CA-C-O 122.815 1.293 . . . . 0.0 112.025 -175.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.3 mt -117.49 132.77 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.757 0 CA-C-N 113.957 -1.474 . . . . 0.0 109.128 -178.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.604 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 22.7 mt -70.73 172.39 8.83 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.928 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 15.3 p -68.73 -24.14 64.43 Favored 'General case' 0 C--N 1.274 -2.702 0 CA-C-N 114.725 -1.125 . . . . 0.0 110.848 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 51.0 m-80 -80.43 -0.69 38.25 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.334 -0.848 . . . . 0.0 111.002 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.84 20.59 65.24 Favored Glycine 0 CA--C 1.483 -1.932 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 178.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 31.4 mmtp -113.86 150.91 32.91 Favored 'General case' 0 N--CA 1.411 -2.418 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 -175.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 89.8 mt-30 -73.37 142.48 47.01 Favored 'General case' 0 C--N 1.291 -1.935 0 CA-C-O 121.604 0.716 . . . . 0.0 110.813 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -82.78 165.73 40.02 Favored Pre-proline 0 N--CA 1.406 -2.638 0 CA-C-N 114.418 -1.264 . . . . 0.0 108.092 175.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 55.4 Cg_exo -45.52 152.38 0.89 Allowed 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 124.484 3.456 . . . . 0.0 115.077 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -71.83 -22.08 61.6 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.704 -175.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 65.5 p-90 -90.52 -5.37 56.07 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.709 179.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 47.8 tp -88.47 110.7 21.06 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 177.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -102.62 142.69 33.37 Favored 'General case' 0 C--N 1.292 -1.896 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.523 -172.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -132.37 128.84 38.48 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 176.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -115.97 135.22 22.71 Favored Pre-proline 0 C--N 1.299 -1.596 0 N-CA-C 108.127 -1.064 . . . . 0.0 108.127 -178.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.604 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 56.7 Cg_endo -68.95 119.17 6.18 Favored 'Trans proline' 0 C--O 1.244 0.781 0 C-N-CA 123.237 2.624 . . . . 0.0 113.077 -179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 74.0 t80 . . . . . 0 N--CA 1.426 -1.637 0 CA-C-O 118.182 -0.913 . . . . 0.0 109.514 179.923 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.1 p . . . . . 0 C--O 1.241 0.622 0 CA-C-O 120.697 0.284 . . . . 0.0 110.517 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.39 11.63 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.516 -0.849 . . . . 0.0 112.382 177.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.2 ptp180 -119.86 87.09 2.68 Favored 'General case' 0 N--CA 1.416 -2.129 0 CA-C-O 122.299 1.047 . . . . 0.0 110.565 -179.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -126.76 82.49 2.09 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 114.781 -1.1 . . . . 0.0 108.834 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -159.39 110.35 2.01 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.045 -178.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.5 mp -100.66 105.26 16.62 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.041 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 63.5 t80 -53.62 132.0 39.84 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.785 -178.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -85.73 94.59 9.15 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.494 -177.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.7 tt0 163.54 -33.3 0.0 OUTLIER 'General case' 0 CA--C 1.491 -1.299 0 C-N-CA 126.856 2.063 . . . . 0.0 107.693 -178.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 151.84 -175.02 30.78 Favored Glycine 1 C--N 1.24 -4.762 0 CA-C-N 111.708 -2.496 . . . . 0.0 108.458 -178.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 14.9 m-70 -79.55 -25.43 41.65 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 117.865 0.833 . . . . 0.0 111.729 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 10.8 tpt -98.99 143.86 28.8 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 178.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -83.79 11.41 7.56 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.683 0.754 . . . . 0.0 112.307 -176.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 57.36 70.01 1.46 Allowed Pre-proline 0 C--N 1.296 -1.719 0 C-N-CA 125.643 1.577 . . . . 0.0 114.435 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.501 ' HD2' ' OE1' ' A' ' 64' ' ' GLN . 61.1 Cg_endo -80.84 -16.65 10.05 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 121.715 1.61 . . . . 0.0 110.071 173.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -110.68 136.15 50.2 Favored 'General case' 0 N--CA 1.437 -1.106 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 179.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 36.8 ttm-85 -120.53 -23.27 6.14 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-O 121.598 0.713 . . . . 0.0 110.187 -176.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 43' ' ' ARG . 89.3 m-85 -132.74 166.5 22.09 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.65 128.97 53.5 Favored 'General case' 0 C--N 1.276 -2.597 0 N-CA-C 106.2 -1.778 . . . . 0.0 106.2 169.608 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 3.6 t -95.65 128.88 46.46 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.526 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 19.5 m-85 -105.9 138.09 42.68 Favored 'General case' 0 C--N 1.307 -1.257 0 O-C-N 123.594 0.559 . . . . 0.0 110.689 178.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.464 ' CD2' ' HG2' ' A' ' 36' ' ' ARG . 30.5 m-85 -132.44 155.85 47.77 Favored 'General case' 0 C--N 1.3 -1.569 0 CA-C-N 115.369 -0.832 . . . . 0.0 109.959 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -92.79 100.69 13.13 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 172.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 139.31 138.88 3.71 Favored Glycine 0 N--CA 1.423 -2.187 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.349 178.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -83.79 -19.07 35.68 Favored 'General case' 0 C--N 1.286 -2.164 0 CA-C-N 114.275 -0.962 . . . . 0.0 110.757 -178.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.42 HD23 ' OG1' ' A' ' 35' ' ' THR . 17.8 tp -100.74 125.91 37.16 Favored Pre-proline 0 N--CA 1.424 -1.732 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -170.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD2' HD12 ' A' ' 32' ' ' LEU . 22.0 Cg_endo -60.14 -21.51 66.2 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 123.598 2.865 . . . . 0.0 114.409 -175.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.06 -5.85 43.44 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 122.125 -0.359 . . . . 0.0 111.904 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.42 ' OG1' HD23 ' A' ' 32' ' ' LEU . 4.1 m -134.22 14.95 3.83 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-O 121.516 0.674 . . . . 0.0 110.86 -173.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.464 ' HG2' ' CD2' ' A' ' 28' ' ' TYR . 0.3 OUTLIER -88.0 121.42 30.39 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.474 -0.766 . . . . 0.0 109.96 -176.237 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 44.3 t -90.75 129.13 42.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 122.145 -0.347 . . . . 0.0 110.278 -174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.88 126.97 29.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 120.981 0.42 . . . . 0.0 111.393 -178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 79.9 mt -106.14 -63.26 1.28 Allowed 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.705 175.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 23.6 ptm -169.85 166.91 9.43 Favored 'General case' 0 CA--C 1.498 -1.042 0 O-C-N 121.914 -0.491 . . . . 0.0 111.704 -175.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -108.04 137.51 45.9 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.077 -0.965 . . . . 0.0 109.858 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' HB3' ' A' ' 48' ' ' ALA . 44.0 t -123.65 116.4 48.1 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.142 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 176.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.442 ' HA ' ' HA ' ' A' ' 24' ' ' PHE . 39.4 ttp180 -70.33 142.38 52.2 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 -177.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 38.8 mm -59.12 123.47 11.45 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.102 -1.408 . . . . 0.0 110.444 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 98.92 -9.71 61.87 Favored Glycine 0 C--N 1.296 -1.644 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.559 178.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p -119.56 158.17 26.89 Favored 'General case' 0 C--O 1.256 1.404 0 CA-C-O 121.08 0.467 . . . . 0.0 111.214 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 68.3 p -101.2 154.75 18.48 Favored 'General case' 0 N--CA 1.411 -2.378 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.078 176.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.449 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -145.32 149.93 35.7 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.272 177.043 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.0 m -93.79 113.11 25.09 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.52 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 14.8 mm -93.47 135.03 29.23 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 N-CA-C 104.617 -2.364 . . . . 0.0 104.617 176.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 6.9 m -125.72 109.65 12.83 Favored 'General case' 0 C--N 1.259 -3.354 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.85 132.45 28.8 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 67.7 mtm180 60.39 25.63 15.17 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 125.58 1.552 . . . . 0.0 111.233 -179.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.26 9.4 82.06 Favored Glycine 0 C--N 1.301 -1.405 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.382 -179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 71.4 m-70 -112.59 129.09 56.49 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.52 ' HA ' ' O ' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -105.92 125.56 51.14 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 122.121 0.963 . . . . 0.0 111.683 179.958 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 36.2 m-85 -114.95 112.36 22.57 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.6 tp10 -82.67 106.15 14.29 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.202 -2.148 . . . . 0.0 105.202 175.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 70' ' ' LEU . 21.1 m -113.21 148.79 15.91 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.147 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -172.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -110.7 126.35 54.44 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 177.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -80.62 80.97 6.99 Favored 'General case' 0 C--N 1.31 -1.135 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 172.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -70.17 -56.96 5.51 Favored 'General case' 0 CA--C 1.501 -0.94 0 CA-C-N 114.637 -1.165 . . . . 0.0 111.131 -172.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -125.15 155.5 39.85 Favored 'General case' 0 C--N 1.29 -1.985 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.47 -175.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.574 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 70.3 mt-30 -70.67 2.45 4.1 Favored 'General case' 0 C--N 1.319 -0.719 0 C-N-CA 124.235 1.014 . . . . 0.0 112.473 -178.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 47.7 t-20 -74.03 -26.21 60.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 171.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.486 ' SG ' ' HA ' ' A' ' 84' ' ' PRO . 83.4 m 59.64 65.8 1.09 Allowed 'General case' 0 N--CA 1.443 -0.818 0 CA-C-N 114.335 -1.302 . . . . 0.0 113.379 178.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.485 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.3 OUTLIER -102.14 140.31 36.59 Favored 'General case' 0 CA--C 1.468 -2.193 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 171.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.5 p -86.59 91.25 3.35 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.081 0 CA-C-O 122.513 1.149 . . . . 0.0 113.485 -174.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.2 mp -111.95 124.52 68.75 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.081 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.081 176.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.572 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 8.2 mp -80.44 157.02 26.34 Favored 'General case' 0 N--CA 1.421 -1.908 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.247 175.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 12.0 p -74.76 0.04 16.65 Favored 'General case' 0 C--N 1.279 -2.464 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.924 -176.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -95.18 -4.52 45.83 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.522 174.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.21 21.98 39.67 Favored Glycine 0 CA--C 1.5 -0.854 0 N-CA-C 110.169 -1.172 . . . . 0.0 110.169 -179.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -111.16 142.46 43.32 Favored 'General case' 0 N--CA 1.426 -1.654 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 -175.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -98.86 139.66 34.19 Favored 'General case' 0 C--N 1.292 -1.916 0 N-CA-C 107.386 -1.338 . . . . 0.0 107.386 175.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.445 ' HB1' ' HD2' ' A' ' 77' ' ' PRO . . . -81.45 166.87 35.47 Favored Pre-proline 0 C--N 1.297 -1.696 0 C-N-CA 122.603 0.361 . . . . 0.0 110.25 -177.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.445 ' HD2' ' HB1' ' A' ' 76' ' ' ALA . 71.3 Cg_exo -51.96 152.45 13.96 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.773 2.982 . . . . 0.0 113.501 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -67.38 -28.03 67.59 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.441 -177.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -74.75 -15.58 60.76 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.375 178.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.9 tp -87.07 100.79 12.89 Favored 'General case' 0 N--CA 1.431 -1.413 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -101.81 134.35 45.12 Favored 'General case' 0 C--N 1.289 -2.054 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.609 -170.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.61 ' HA ' ' O ' ' A' ' 26' ' ' VAL . . . -119.12 135.71 54.52 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 123.7 0.625 . . . . 0.0 110.118 177.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 138.66 33.37 Favored Pre-proline 0 C--O 1.246 0.87 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 177.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.486 ' HA ' ' SG ' ' A' ' 66' ' ' CYS . 32.7 Cg_endo -63.1 125.61 16.19 Favored 'Trans proline' 0 C--O 1.241 0.631 0 C-N-CA 123.404 2.736 . . . . 0.0 110.744 176.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 C--N 1.296 -1.728 0 CA-C-O 119.049 -0.501 . . . . 0.0 110.129 -175.913 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.444 -0.751 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.92 165.14 15.42 Favored Glycine 0 N--CA 1.428 -1.867 0 N-CA-C 110.479 -1.048 . . . . 0.0 110.479 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -90.91 82.43 5.65 Favored 'General case' 0 N--CA 1.436 -1.171 0 CA-C-O 122.154 0.978 . . . . 0.0 110.103 -178.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -88.36 132.02 34.6 Favored 'General case' 0 C--N 1.273 -2.719 0 CA-C-N 113.727 -1.579 . . . . 0.0 108.835 178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -133.18 93.06 3.11 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.505 0.669 . . . . 0.0 111.948 -176.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 9.5 mp -98.75 132.62 43.98 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 106.812 -1.551 . . . . 0.0 106.812 168.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 20.8 t80 -87.26 104.68 16.62 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -72.62 150.26 43.21 Favored 'General case' 0 C--N 1.301 -1.532 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.892 -176.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -96.0 83.72 3.71 Favored 'General case' 0 N--CA 1.416 -2.132 0 CA-C-O 122.5 1.143 . . . . 0.0 111.131 -179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -75.55 66.96 2.3 Favored Glycine 0 C--N 1.301 -1.367 0 CA-C-N 114.074 -1.421 . . . . 0.0 110.692 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -95.6 140.49 30.35 Favored 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 123.359 0.664 . . . . 0.0 109.306 -177.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.4 tpt -101.45 113.43 26.52 Favored 'General case' 0 N--CA 1.429 -1.499 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 178.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -88.92 11.54 17.81 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-O 121.202 0.525 . . . . 0.0 111.882 -175.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.54 ' HA ' ' OE1' ' A' ' 64' ' ' GLN . . . 58.78 90.98 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 125.964 1.706 . . . . 0.0 113.386 179.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -59.6 -54.86 2.1 Favored 'Trans proline' 0 C--O 1.241 0.655 0 C-N-CA 121.863 1.709 . . . . 0.0 109.468 173.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.91 115.27 13.16 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.455 -0.942 . . . . 0.0 108.455 174.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 38.5 mtp180 -93.37 -39.56 10.87 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.796 0.808 . . . . 0.0 109.418 -177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -137.82 -179.65 5.88 Favored 'General case' 0 N--CA 1.419 -1.999 0 CA-C-N 115.472 -0.785 . . . . 0.0 110.471 176.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.58 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 34.3 t -134.78 146.9 49.78 Favored 'General case' 0 C--N 1.275 -2.651 0 N-CA-C 106.716 -1.587 . . . . 0.0 106.716 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 21.6 t -115.13 123.93 71.25 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 31.8 m-85 -99.94 141.13 33.16 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.853 -178.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -131.88 150.28 52.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.823 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.511 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 6.5 t70 -85.02 101.94 12.8 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 105.764 -1.939 . . . . 0.0 105.764 172.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 121.41 132.73 4.22 Favored Glycine 0 N--CA 1.419 -2.476 0 N-CA-C 111.034 -0.827 . . . . 0.0 111.034 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.405 ' H ' ' CD2' ' A' ' 31' ' ' HIS . 7.2 p80 -97.25 15.33 23.12 Favored 'General case' 0 C--N 1.281 -2.412 0 CA-C-N 114.421 -0.889 . . . . 0.0 110.502 -175.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 24.2 tp -133.75 127.48 19.45 Favored Pre-proline 0 C--N 1.289 -2.032 0 N-CA-C 107.392 -1.336 . . . . 0.0 107.392 -174.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.32 -24.83 53.56 Favored 'Trans proline' 0 C--N 1.349 0.601 0 C-N-CA 123.269 2.646 . . . . 0.0 113.829 -177.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -78.46 -20.95 49.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 178.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 4.2 m -132.26 25.48 4.52 Favored 'General case' 0 CA--C 1.56 1.361 0 CA-C-O 121.41 0.624 . . . . 0.0 110.492 -172.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HA ' ' O ' ' A' ' 29' ' ' ASP . 34.5 ptt180 -97.44 119.46 36.02 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-O 121.39 0.614 . . . . 0.0 111.451 -177.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.511 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 85.4 t -100.36 134.47 39.95 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 177.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -66.2 125.58 25.98 Favored 'General case' 0 C--N 1.315 -0.926 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 -178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 80.6 mt -108.0 -62.91 1.38 Allowed 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 9.6 mtp -163.03 167.25 22.67 Favored 'General case' 0 CA--C 1.485 -1.531 0 N-CA-C 113.38 0.882 . . . . 0.0 113.38 -174.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -113.51 128.25 56.38 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 113.355 -1.748 . . . . 0.0 108.771 178.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.5 t -127.14 127.37 69.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.131 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -69.93 134.91 48.89 Favored 'General case' 0 C--O 1.251 1.182 0 C-N-CA 123.073 0.549 . . . . 0.0 109.797 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 42.9 mm -62.38 117.41 3.45 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 CA-C-O 121.595 0.712 . . . . 0.0 110.097 178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.02 -22.13 12.71 Favored Glycine 0 N--CA 1.426 -2.028 0 CA-C-N 114.577 -1.192 . . . . 0.0 112.046 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 71.1 p -106.38 169.21 8.65 Favored 'General case' 0 C--O 1.251 1.143 0 CA-C-O 121.594 0.712 . . . . 0.0 112.485 -174.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.3 p -99.19 156.69 16.83 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.167 -1.379 . . . . 0.0 108.889 174.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.43 147.11 24.24 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.98 175.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 19.7 m -102.6 111.66 24.08 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.213 0.53 . . . . 0.0 110.111 178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 11.9 mm -93.76 146.75 6.15 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 19.0 m -131.96 107.51 8.75 Favored 'General case' 0 C--N 1.266 -3.042 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 176.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -134.97 132.31 38.24 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 42.8 mtm180 60.84 26.62 16.46 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.66 1.184 . . . . 0.0 110.503 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 85.74 -1.27 88.12 Favored Glycine 0 N--CA 1.433 -1.529 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.774 -179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.464 ' HB2' ' CE2' ' A' ' 57' ' ' PHE . 71.9 m-70 -99.43 134.4 42.35 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 117.524 0.662 . . . . 0.0 109.538 -178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -90.34 121.37 32.28 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.464 ' CE2' ' HB2' ' A' ' 55' ' ' HIS . 84.7 m-85 -117.15 105.2 11.99 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 177.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -90.51 107.7 19.32 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 175.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG12 ' HG ' ' A' ' 70' ' ' LEU . 33.5 m -104.94 147.78 10.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-N 114.576 -1.193 . . . . 0.0 109.966 -172.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -117.76 116.04 26.21 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 172.467 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -78.7 94.61 5.11 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 177.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -71.92 -58.23 3.63 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -174.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -120.04 161.15 21.44 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.835 -171.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . 0.54 ' OE1' ' HA ' ' A' ' 20' ' ' ALA . 19.2 mt-30 -56.17 -21.2 21.43 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.038 1.735 . . . . 0.0 112.021 179.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -86.48 13.3 8.57 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.612 0.244 . . . . 0.0 110.881 -179.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 92.6 m 63.25 41.09 8.15 Favored 'General case' 0 CA--C 1.493 -1.215 0 CA-C-O 121.836 0.827 . . . . 0.0 110.791 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.613 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -67.89 93.92 0.44 Allowed 'General case' 0 N--CA 1.412 -2.352 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 174.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.404 HG23 ' HB ' ' A' ' 59' ' ' VAL . 2.9 p -94.69 107.84 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.791 0 CA-C-O 122.153 0.978 . . . . 0.0 112.981 -173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 2.7 mp -117.39 123.16 71.42 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 N-CA-C 106.865 -1.531 . . . . 0.0 106.865 173.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.438 ' HG ' HG12 ' A' ' 59' ' ' VAL . 7.5 mp -82.67 158.42 22.97 Favored 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 121.198 0.523 . . . . 0.0 110.303 -178.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 43.2 p -75.99 -20.86 57.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 72' ' ' ASN . 0.8 OUTLIER -74.93 -7.82 54.67 Favored 'General case' 0 N--CA 1.444 -0.767 0 CA-C-N 113.321 -1.763 . . . . 0.0 109.847 178.118 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 98.3 -1.85 59.1 Favored Glycine 0 CA--C 1.491 -1.412 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.635 176.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.9 mmtp -88.75 151.73 22.23 Favored 'General case' 0 N--CA 1.424 -1.731 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.477 -174.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -103.05 26.84 7.72 Favored 'General case' 0 C--N 1.289 -2.041 0 CA-C-O 121.517 0.675 . . . . 0.0 109.294 178.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 77.15 134.36 0.04 OUTLIER Pre-proline 0 C--O 1.237 0.404 0 C-N-CA 126.391 1.876 . . . . 0.0 113.088 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -62.87 150.93 86.83 Favored 'Trans proline' 0 C--O 1.242 0.714 0 C-N-CA 122.643 2.228 . . . . 0.0 110.726 175.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -55.1 -36.46 65.7 Favored 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 124.12 0.968 . . . . 0.0 112.936 -176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 70.0 p-90 -76.05 -17.11 59.78 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-N 115.86 -0.609 . . . . 0.0 112.403 -177.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 62.6 tp -84.77 119.32 25.16 Favored 'General case' 0 C--N 1.312 -1.045 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -110.9 141.15 44.7 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.58 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -127.68 129.25 46.85 Favored 'General case' 0 C--N 1.293 -1.88 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 178.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -127.12 122.14 23.0 Favored Pre-proline 0 C--N 1.298 -1.672 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -66.71 139.99 54.59 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.906 2.404 . . . . 0.0 112.551 -175.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 47.9 t80 . . . . . 0 N--CA 1.4 -2.971 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 175.767 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.438 -1.031 0 CA-C-O 120.838 0.352 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.01 25.75 0.24 Allowed Glycine 0 N--CA 1.436 -1.351 0 N-CA-C 111.568 -0.613 . . . . 0.0 111.568 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 57.7 mtp180 -119.38 82.67 1.91 Allowed 'General case' 0 C--N 1.304 -1.387 0 CA-C-O 121.703 0.764 . . . . 0.0 108.956 -179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -114.52 156.97 23.62 Favored 'General case' 0 N--CA 1.416 -2.167 0 CA-C-N 114.805 -1.089 . . . . 0.0 109.057 -177.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 46.4 m-80 -124.8 46.03 2.41 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 39.0 tp -65.23 120.11 12.13 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 114.252 -1.34 . . . . 0.0 109.75 -179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 66.0 t80 71.83 93.2 0.08 Allowed 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 124.884 1.274 . . . . 0.0 110.342 -174.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -132.7 111.42 11.15 Favored 'General case' 0 C--N 1.288 -2.082 0 CA-C-N 114.487 -1.233 . . . . 0.0 108.3 179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 35.4 tt0 -111.51 83.16 1.73 Allowed 'General case' 0 N--CA 1.412 -2.366 0 CA-C-O 121.914 0.864 . . . . 0.0 108.868 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -76.9 -14.93 82.09 Favored Glycine 0 C--N 1.308 -1.022 0 CA-C-N 114.294 -1.321 . . . . 0.0 111.993 -178.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -124.88 121.39 34.36 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 62.8 mtt -70.17 115.98 10.0 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 177.314 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.53 -0.77 48.2 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-O 122.945 1.355 . . . . 0.0 110.063 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -158.04 87.52 2.45 Favored Pre-proline 0 C--N 1.266 -3.048 0 CA-C-N 112.544 -2.116 . . . . 0.0 107.452 174.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -84.2 175.83 7.09 Favored 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.034 1.823 . . . . 0.0 109.948 178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.81 124.14 24.18 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 176.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -100.98 -38.03 8.37 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 106.717 -1.586 . . . . 0.0 106.717 -178.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -132.68 176.87 8.07 Favored 'General case' 0 N--CA 1.425 -1.695 0 N-CA-C 107.06 -1.459 . . . . 0.0 107.06 173.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.536 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 8.2 t -137.87 141.13 40.7 Favored 'General case' 0 C--N 1.27 -2.889 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 174.53 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.498 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 14.8 t -102.1 120.36 51.68 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.09 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.48 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 27.7 m-85 -102.88 144.31 31.35 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.95 0.405 . . . . 0.0 111.653 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -132.35 148.67 52.43 Favored 'General case' 0 C--N 1.31 -1.146 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.025 -179.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -87.09 106.07 17.61 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 171.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.68 144.72 7.56 Favored Glycine 0 N--CA 1.418 -2.543 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 -179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -105.06 -0.64 26.53 Favored 'General case' 0 C--N 1.288 -2.077 0 CA-C-O 121.005 0.431 . . . . 0.0 110.873 -177.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.5 mp -95.4 125.94 47.86 Favored Pre-proline 0 CA--C 1.497 -1.089 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -53.89 -29.2 52.36 Favored 'Trans proline' 0 CA--C 1.533 0.464 0 C-N-CA 123.204 2.603 . . . . 0.0 114.118 -175.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -81.93 -59.86 2.43 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 -178.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 7.1 p -85.61 1.14 50.39 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.8 ptt180 -68.71 138.98 55.36 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.587 -0.524 . . . . 0.0 109.587 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 58.6 t -107.21 127.12 63.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.746 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 -177.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -59.75 126.52 27.92 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 99.0 mt -104.64 -62.84 1.28 Allowed 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.845 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 19.0 ptp -173.82 167.01 4.44 Favored 'General case' 0 CA--C 1.5 -0.967 0 CA-C-O 121.181 0.515 . . . . 0.0 111.919 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -100.15 127.02 46.47 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.21 -1.359 . . . . 0.0 109.547 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.423 HG22 ' HB3' ' A' ' 48' ' ' ALA . 82.7 t -112.62 131.36 64.37 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.896 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . . . . . . . . . 33.6 ttt180 -79.88 140.48 36.74 Favored 'General case' 0 N--CA 1.424 -1.745 0 CA-C-O 121.849 0.833 . . . . 0.0 111.543 -177.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.449 HD13 ' HB1' ' A' ' 61' ' ' ALA . 32.5 mm -74.52 117.87 19.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.024 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 106.88 -1.24 35.91 Favored Glycine 0 C--N 1.292 -1.881 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 47' ' ' THR . 1.4 m -125.45 173.96 8.53 Favored 'General case' 0 N--CA 1.423 -1.808 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 -178.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.529 HG22 ' HA ' ' A' ' 60' ' ' GLU . 41.0 p -115.3 159.77 20.63 Favored 'General case' 0 C--N 1.276 -2.593 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.423 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . -154.68 149.76 26.91 Favored 'General case' 0 C--N 1.292 -1.895 0 O-C-N 123.513 0.508 . . . . 0.0 111.091 177.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 9.8 m -94.32 111.27 23.0 Favored 'General case' 0 N--CA 1.427 -1.584 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.623 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 22.1 mm -94.81 145.02 8.66 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 13.1 m -138.57 107.19 5.88 Favored 'General case' 0 C--N 1.274 -2.687 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 177.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -133.7 132.74 40.99 Favored 'General case' 0 C--N 1.307 -1.27 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 58.5 mtm180 58.33 25.52 12.88 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 124.085 0.954 . . . . 0.0 111.364 -174.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.37 -3.35 86.5 Favored Glycine 0 C--N 1.308 -0.995 0 CA-C-N 114.747 -1.115 . . . . 0.0 112.444 179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 51' ' ' THR . 83.4 m-70 -91.04 130.46 36.95 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -97.24 120.75 38.17 Favored 'General case' 0 C--N 1.3 -1.552 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.822 -178.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -116.71 105.67 12.66 Favored 'General case' 0 N--CA 1.404 -2.739 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 178.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.2 tp10 -84.41 107.57 16.75 Favored 'General case' 0 C--N 1.296 -1.749 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 174.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.4 m -95.34 137.37 23.71 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.098 -176.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.529 ' HA ' HG22 ' A' ' 47' ' ' THR . 44.2 tt0 -109.42 104.55 13.65 Favored 'General case' 0 C--N 1.267 -3.006 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 -177.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.449 ' HB1' HD13 ' A' ' 44' ' ' ILE . . . -83.8 92.46 7.76 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.087 -178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.6 mmtp -82.44 -58.07 3.08 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-N 115.149 -0.932 . . . . 0.0 112.787 -178.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -106.67 139.8 40.54 Favored 'General case' 0 N--CA 1.415 -2.208 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.175 -170.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 3.9 pt20 -70.22 12.87 0.19 Allowed 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.474 1.11 . . . . 0.0 113.644 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 44.9 m-80 -105.52 5.99 31.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 171.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 62.3 m 71.86 39.53 0.83 Allowed 'General case' 0 CA--C 1.492 -1.263 0 CA-C-N 115.157 -0.929 . . . . 0.0 111.238 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.607 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.0 OUTLIER -66.79 100.03 0.67 Allowed 'General case' 0 N--CA 1.42 -1.975 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 173.395 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 7.3 p -79.79 107.8 12.59 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.591 0 CA-C-O 122.289 1.043 . . . . 0.0 112.176 -173.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 84.6 mt -124.27 135.91 62.18 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.117 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 178.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 8.9 mp -103.4 170.31 8.02 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.246 0.546 . . . . 0.0 109.848 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 21.5 p -78.19 -11.33 59.92 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.266 -175.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 39.2 p-10 -88.06 -4.29 58.79 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.793 176.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 92.54 6.24 64.34 Favored Glycine 0 N--CA 1.424 -2.122 0 CA-C-N 115.039 -0.982 . . . . 0.0 111.935 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . . . . . . . . . 34.2 mmtp -101.87 154.0 19.33 Favored 'General case' 0 N--CA 1.426 -1.627 0 C-N-CA 119.823 -0.751 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -89.7 33.2 0.85 Allowed 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 115.546 -0.752 . . . . 0.0 112.885 -177.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 72.12 151.25 0.14 Allowed Pre-proline 0 N--CA 1.479 1.009 0 N-CA-C 114.871 1.434 . . . . 0.0 114.871 176.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -57.95 148.86 74.03 Favored 'Trans proline' 0 C--N 1.353 0.792 0 C-N-CA 122.835 2.357 . . . . 0.0 110.426 170.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -65.24 -21.16 66.71 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 112.216 0.45 . . . . 0.0 112.216 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -91.48 -2.55 57.19 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.849 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.8 tp -92.69 117.52 30.07 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.74 149.73 28.59 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 116.55 -0.296 . . . . 0.0 110.726 -174.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.536 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -140.81 134.96 30.92 Favored 'General case' 0 C--N 1.312 -1.033 0 O-C-N 123.866 0.729 . . . . 0.0 110.844 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -127.44 132.74 24.48 Favored Pre-proline 0 C--N 1.317 -0.843 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.8 128.09 20.15 Favored 'Trans proline' 0 C--O 1.24 0.581 0 C-N-CA 123.206 2.604 . . . . 0.0 112.712 -178.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.3 t80 . . . . . 0 C--N 1.304 -1.399 0 CA-C-O 118.151 -0.928 . . . . 0.0 109.315 -179.349 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.8 m . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 140.46 -177.37 20.79 Favored Glycine 0 N--CA 1.433 -1.524 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -125.03 87.37 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 44.0 tt0 -81.92 93.91 7.01 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 4.3 t-20 -101.23 -24.18 14.29 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.653 -179.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 30.5 tp -75.76 93.01 3.07 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 121.955 0.883 . . . . 0.0 112.789 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -119.57 132.33 55.71 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 106.765 -1.568 . . . . 0.0 106.765 172.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -77.0 119.57 20.91 Favored 'General case' 0 C--N 1.313 -1.014 0 C-N-CA 119.754 -0.778 . . . . 0.0 110.421 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -91.05 75.77 6.25 Favored 'General case' 0 N--CA 1.426 -1.665 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.82 -40.58 89.92 Favored Glycine 0 C--N 1.313 -0.708 0 CA-C-N 112.946 -1.934 . . . . 0.0 115.417 -173.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 m80 -60.22 -58.44 8.49 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 117.371 0.586 . . . . 0.0 111.486 -177.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 27.0 ttt -166.37 136.71 3.34 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 106.414 -1.698 . . . . 0.0 106.414 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.74 67.86 4.58 Favored 'General case' 0 C--N 1.313 -1.001 0 O-C-N 123.652 0.595 . . . . 0.0 110.911 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.486 ' HB1' ' O ' ' A' ' 22' ' ' ALA . . . 68.1 108.47 0.03 OUTLIER Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.656 1.582 . . . . 0.0 112.69 179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -56.0 -36.04 95.39 Favored 'Trans proline' 0 C--N 1.365 1.422 0 C-N-CA 123.192 2.594 . . . . 0.0 110.768 176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.492 ' O ' HD12 ' A' ' 44' ' ' ILE . . . -118.48 122.24 42.25 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 102.346 -3.205 . . . . 0.0 102.346 170.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.464 ' O ' ' HD2' ' A' ' 43' ' ' ARG . 52.3 mtt-85 -86.12 -19.85 29.54 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 119.081 -1.048 . . . . 0.0 112.304 -171.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -129.78 173.85 10.27 Favored 'General case' 0 C--N 1.303 -1.448 0 CA-C-O 121.361 0.6 . . . . 0.0 109.74 177.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.499 ' SG ' ' HB1' ' A' ' 82' ' ' ALA . 32.9 t -138.6 144.36 39.74 Favored 'General case' 0 C--N 1.278 -2.532 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 174.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 4.7 t -109.48 126.06 66.61 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.159 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.447 ' HA ' ' O ' ' A' ' 81' ' ' ALA . 78.9 m-85 -106.06 143.39 34.26 Favored 'General case' 0 C--N 1.308 -1.196 0 O-C-N 123.418 0.449 . . . . 0.0 111.084 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -134.55 152.25 51.66 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.59 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' HB ' ' A' ' 37' ' ' VAL . 8.3 t70 -93.98 110.29 21.98 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 173.542 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.06 144.89 8.52 Favored Glycine 0 C--N 1.279 -2.585 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 -178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 25.5 p-80 -91.66 -19.94 22.13 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-O 120.824 0.345 . . . . 0.0 110.825 -174.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 39.4 tp -100.73 113.69 65.68 Favored Pre-proline 0 N--CA 1.428 -1.571 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.932 -171.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.528 ' HA ' ' CD ' ' A' ' 36' ' ' ARG . 78.4 Cg_exo -43.66 -46.21 10.4 Favored 'Trans proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.986 3.791 . . . . 0.0 114.215 -178.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.34 -20.56 63.1 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 11.7 t -135.5 9.55 3.41 Favored 'General case' 0 C--O 1.243 0.723 0 C-N-CA 119.454 -0.898 . . . . 0.0 111.951 -176.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.528 ' CD ' ' HA ' ' A' ' 33' ' ' PRO . 40.8 ptt180 -81.41 150.38 28.4 Favored 'General case' 0 C--N 1.306 -1.29 0 O-C-N 122.101 -0.375 . . . . 0.0 110.095 -176.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.409 ' HB ' ' HB3' ' A' ' 29' ' ' ASP . 48.2 t -105.92 132.84 51.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 -178.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -69.78 125.33 26.4 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.2 mt -100.22 -63.78 1.1 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.873 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' MET . . . . . . . . . . . . . 21.6 ptp -173.56 165.71 4.6 Favored 'General case' 0 CA--C 1.5 -0.945 0 CA-C-O 121.142 0.496 . . . . 0.0 111.959 -176.356 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -106.49 132.61 52.3 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.571 179.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 97.2 t -123.89 138.39 53.75 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.233 0 N-CA-C 110.332 -0.247 . . . . 0.0 110.332 -178.46 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ARG . . . . . 0.464 ' HD2' ' O ' ' A' ' 23' ' ' ARG . 10.1 tpt180 -71.66 122.62 20.91 Favored 'General case' 0 C--O 1.257 1.461 0 C-N-CA 123.459 0.704 . . . . 0.0 111.006 178.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.492 HD12 ' O ' ' A' ' 22' ' ' ALA . 45.9 mt -66.78 123.4 19.74 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 CA-C-O 121.81 0.815 . . . . 0.0 109.879 176.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 120.4 -20.84 8.84 Favored Glycine 0 N--CA 1.424 -2.12 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 -174.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 40.8 p -121.65 165.76 15.27 Favored 'General case' 0 C--O 1.257 1.46 0 CA-C-O 121.75 0.786 . . . . 0.0 112.282 -177.443 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 59' ' ' VAL . 58.2 p -99.61 157.57 16.37 Favored 'General case' 0 N--CA 1.414 -2.237 0 CA-C-N 114.416 -1.265 . . . . 0.0 108.674 175.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -150.99 153.18 34.68 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 178.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 8.8 m -95.49 110.86 22.87 Favored 'General case' 0 N--CA 1.418 -2.055 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 21.3 mm -92.63 145.3 7.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.484 0 N-CA-C 104.347 -2.464 . . . . 0.0 104.347 178.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 26.3 m -131.22 107.66 9.15 Favored 'General case' 0 C--N 1.267 -2.981 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.636 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -139.5 133.53 31.0 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 115.345 -0.843 . . . . 0.0 108.981 -176.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 73.4 mtt180 62.07 26.49 15.96 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 124.769 1.228 . . . . 0.0 111.459 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 86.36 -1.33 87.41 Favored Glycine 0 N--CA 1.439 -1.126 0 CA-C-N 114.736 -1.12 . . . . 0.0 113.016 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' THR . 28.7 m-70 -103.51 139.09 39.32 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.89 0.376 . . . . 0.0 110.653 -177.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -104.4 120.27 40.84 Favored 'General case' 0 N--CA 1.425 -1.718 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.018 178.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.0 116.1 28.66 Favored 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.511 -0.768 . . . . 0.0 109.507 -177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -86.74 107.01 18.05 Favored 'General case' 0 C--N 1.31 -1.148 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 173.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.505 HG12 ' HG ' ' A' ' 70' ' ' LEU . 31.8 m -111.13 144.87 18.2 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.697 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -175.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.408 ' OE2' ' HB3' ' A' ' 62' ' ' LYS . 34.9 tt0 -102.26 117.21 34.26 Favored 'General case' 0 C--N 1.284 -2.252 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -81.18 88.1 6.04 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 106.126 -1.805 . . . . 0.0 106.126 174.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.408 ' HB3' ' OE2' ' A' ' 60' ' ' GLU . 0.8 OUTLIER -104.36 -20.34 13.77 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -168.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -131.21 148.47 52.71 Favored 'General case' 0 N--CA 1.426 -1.636 0 C-N-CA 119.028 -1.069 . . . . 0.0 109.96 -170.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -67.87 -9.97 49.24 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 123.727 0.811 . . . . 0.0 112.813 -178.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -103.64 3.83 34.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.5 m 62.1 70.16 0.59 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 114.2 -1.364 . . . . 0.0 113.477 -177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.557 ' HE3' ' HA ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -93.27 89.58 6.46 Favored 'General case' 0 CA--C 1.473 -1.981 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 172.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.41 HG22 ' HB2' ' A' ' 76' ' ' ALA . 2.4 p -69.25 101.3 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.422 -1.868 0 CA-C-N 112.578 -2.101 . . . . 0.0 110.729 -177.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 85.7 mt -124.67 133.49 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.141 0 CA-C-N 114.653 -1.158 . . . . 0.0 107.905 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.505 ' HG ' HG12 ' A' ' 59' ' ' VAL . 6.1 mp -93.26 159.52 15.24 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.037 -0.983 . . . . 0.0 110.286 -174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 40.0 p -66.05 -24.29 66.7 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 114.542 -1.208 . . . . 0.0 111.921 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -85.93 2.04 47.66 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.485 -178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 99.41 3.29 56.5 Favored Glycine 0 N--CA 1.43 -1.729 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.698 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' LYS . . . . . 0.456 ' HB2' ' HB2' ' A' ' 70' ' ' LEU . 35.6 mmtp -80.79 136.67 36.16 Favored 'General case' 0 N--CA 1.431 -1.394 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 -177.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -98.1 27.03 4.82 Favored 'General case' 0 C--N 1.285 -2.212 0 CA-C-O 121.557 0.694 . . . . 0.0 110.275 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.414 ' HA ' ' HD3' ' A' ' 77' ' ' PRO . . . 72.67 139.75 0.07 OUTLIER Pre-proline 0 CA--C 1.514 -0.404 0 C-N-CA 126.088 1.755 . . . . 0.0 114.378 174.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 76' ' ' ALA . 53.0 Cg_exo -60.06 146.83 95.17 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.445 2.096 . . . . 0.0 110.505 173.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -56.35 -29.78 61.82 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.819 0.848 . . . . 0.0 112.644 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 67.6 p-90 -82.39 -11.2 58.71 Favored 'General case' 0 C--O 1.209 -1.042 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.407 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 58.5 tp -88.18 115.86 25.96 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 107.816 -1.179 . . . . 0.0 107.816 179.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' TYR . . . -108.39 144.03 36.51 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.425 -174.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.499 ' HB1' ' SG ' ' A' ' 25' ' ' CYS . . . -137.77 132.11 32.23 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 123.725 0.64 . . . . 0.0 110.24 -179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 70.3 mt-10 -128.74 133.51 25.27 Favored Pre-proline 0 C--N 1.317 -0.822 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 178.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -63.37 140.81 78.59 Favored 'Trans proline' 0 CA--C 1.535 0.574 0 C-N-CA 122.971 2.447 . . . . 0.0 112.402 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 50.3 t80 . . . . . 0 C--N 1.304 -1.372 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 -177.711 . . . . . . . . 0 0 . 1 stop_ save_